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Abstract 
Plants are becoming increasingly important as a production system for 
biopharmaceuticals and industrially important proteins. Early work focused on the 
production of these novel proteins in crop plants such as tobacco, potato and tomato. The 
work presented in this dissertation showed that maize can be used as a source and delivery 
vehicle for edible vaccines. Antigenic proteins from two economically important pathogens, 
enterotoxigenic strains of Escherichia coli (E. coli) and the swine transmissible 
gastroenteritis virus (TGEV) were expressed in transgenic maize. 
This study showed that the subunits of the E. coli heat labile enterotoxin (LT) can be 
synthesized in transgenic maize tissues. The B subunits of the labile toxin (LT-B) were 
expressed in transgenic maize kernels, and data obtained showed that the protein was 
accumulated, correctly processed and assembled in maize tissue. The role of plant regulatory 
sequences such as promoters, targeting and retention signals in accumulation of LT-B in 
transgenic maize kernels was studied. It was established that the seed specific 27 kDa 
gamma zein promoter achieved a significantly higher level of LT-B expression in kernels 
compared to the constitutive CaMV 35S promoter. The use of the endoplasmic reticulum 
retention motif SEKDEL significantly enhanced kernel accumulation of LT-B. The LT-B 
gene was normally transmitted over three generations as expected. Analysis of the 
greenhouse and field grown LT-B expressing maize indicated that the level of LT-B 
expression increased in each successive generation. 
Sub-cellular localization of LT-B using immunogold labeling and electron 
microscopy techniques indicated that the LT-B was encapsulated in transgenic maize kernel 
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starch. Targeting of antigens to kernel starch granules could have important implications for 
the expression of other vaccines and industrially important proteins in starch. Maize 
generated of LT-B had biochemical and biophysical, and immunogenic properties of the 
bacterial protein. Oral administration of transgenic maize expressing LT-B in BALB/c mice 
induced elevated titers of serum and mucosal antibodies, which protected the immunized 
animals from subsequent challenge with LT and Cholera toxin (CT). Transgenic maize 
induced a significantly higher level of antibody titers compared to an equivalent amount of 
bacterial LT-B added to non-transgenic maize meal pellets. 
Using two synthetic genes for the LT toxin subunits, LT-A and LT-B, a non-toxic 
derivative of the heat labile toxin, LTK63, was expressed in transgenic maize callus. This 
mutant toxin assembled in maize callus tissue, showing that complex folding of foreign 
antigens could be achieved in transgenic maize tissues. This mutant derivative was shown to 
be more immunogenic than the bacteria derived LT-B. 
We fused an N-terminal domain of the spike (S) protein of the swine transmissible 
gastroenteritis virus to the A subunit of LT, and coexpressed this fusion with LT-B in 
transgenic maize callus. Expression of the fusion proteins and LT-B was observed in callus. 
This work demonstrates that maize, a key ingredient in food and feed industry, can be 
used as a source and delivery vehicle of functional antigens for use as oral vaccines. Maize 
holds great potential for the generation of human and livestock vaccines, and this work lays 
the foundation for the development of vaccines against other pathogens in transgenic maize. 
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CHAPTER 1 
Introduction 
1.1 General introduction 
Genetic transformation has added plants to the list of biological systems in which 
novel proteins can be generated, extending the use of plants beyond the traditional uses of 
feed and fiber. Plants can be engineered to produce antigens, antibodies, and other proteins 
for industrial, pharmaceutical and veterinary use. The concept of production of oral vaccines 
in plants was put forward by Mason et al (1992), who expressed a hepatitis-B surface antigen 
in transgenic tobacco plants. The surface antigen assembled to give virus-like particles in 
transgenic tobacco tissue, and had physical properties similar to the human serum derived 
antigen. Since then, progress has been made in the production of different proteins in plants 
for use as vaccines to be administered orally or by other routes. Most of these novel proteins 
were produced in tobacco, potato, tomato and Arabidopsis, plants that are easily amenable to 
Agrobacterium tumefaciens based transformation (Mason et al, 1992, 1996 and 1998; Haq et 
al, 1995; Mcgarvey et al, 1995). There are several benefits in producing antigens for use as 
edible vaccines in maize. Maize is a major crop world wide, and maize kernel can be used 
directly as feed and food. This dissertation investigates the possibility of adding maize, an 
important commercial and staple cereal crop, to the list of plants that are suitable for antigen 
production. 
There are important genetic considerations in the production of a foreign protein in 
plants. These include regulation and stability of foreign gene expression and the 
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functionality of the plant synthesized proteins. The research presented in this dissertation 
investigated the feasibility, from a plant genetics perspective, of using maize as a source of 
functional antigens. Proteins from microbial and viral pathogens were some of the first 
examples chosen to show the feasibility of transgenic plant expression systems for 
pharmaceutical production (Daniell et al, 2001). The rationale was that key immunogenic 
proteins of major pathogens could be synthesized in plant tissues, and then fed as edible 
subunit vaccines to humans or livestock. 
In this study, antigens from two important pathogens, enterotoxigenic Escherichia 
coli (£. coli) and the swine transmissible gastroenteritis virus (TGEV) were used as models. 
These are gut pathogens for which mucosal immunity is important for protection, which 
makes them appropriate candidates against which an edible vaccine could be produced. The 
A and B subunits of the heat labile toxin (LT) from E. coli, and the spike (S) protein of 
TGEV were selected as antigens for expression in maize. The physical and biochemical 
properties of these proteins allow detection and quantification of gene expression using 
relatively simple techniques such as enzyme linked immunosorbent assay (ELISA). LT and 
its B subunit (LT-B) are potent oral immunogens, eliciting high titers of mucosal and serum 
antibodies upon oral administration. As such, the immunogenicity of maize-synthesized 
antigens could be easily detected in experimental animals. 
In this study, synthetic genes encoding the LT toxin subunits were expressed in 
transgenic maize. Codon usage in these genes was adjusted for expression in maize. The 
LT-B gene regulated by the CaMV 35S promoter was transformed into maize callus. 
Evaluation of callus protein indicated that LT-B was accumulating in transgenic callus 
tissues and that it was tolerated in maize. The LT-B gene was also fused to the seed-specific 
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27 kDa maize gamma zein promoter and expressed LT-B in transgenic maize kernels. The 
level and stability of LT-B gene expression in maize kernels over three generations was 
determined. The role of promoters in LT-B gene expression in maize was studied by 
comparing the expression levels achieved by the maize 27 kDa gamma zein and the 
constitutive CaMV 35S promoters. The role of targeting and retention signals in LT-B 
accumulation in maize kernels was examined. The integrity of the LT-B produced in maize 
was determined by testing for biochemical and biophysical properties displayed by the native 
bacterial protein. The subcellular localization of LT-B in the cells of transgenic maize 
kernels was established. The immunogenicity of maize derived LT-B was established by oral 
immunization of laboratory mice. The genes encoding the A and B subunits of LT and non-
optimized TGE S protein genes were expressed in transgenic maize callus. Computer-based 
analysis of the evolutionary relationships of coronaviruses based on the S protein sequences 
was also made. Regulation of release of genetically engineered organisms into the 
environment for field-testing is a critical aspect that was addressed in this study. 
1.2 Dissertation Organization 
This dissertation begins with a broad review of the current literature on production of 
oral vaccines in plants, and proceeds to research contributions made to this body of 
knowledge by the present study. The literature review primarily describes the research 
reported about the production of oral vaccines in plants and highlights the advantages and 
opportunities presented by the development of this technology. A portion of the review-
evaluates the characteristics of LT that make it an ideal choice of protein to test in transgenic 
maize. Justification is also presented on why maize was selected as the crop of choice in this 
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study. The literature review in this introductory chapter is by no means exhaustive, as each 
of the subsequent chapters is presented with a literature review in the introduction and 
discussion. 
Chapter 2 presents the expression of LT-B in maize, and examines the role of 
promoters and ER retention sequences in LT-B expression. The stability of LT-B gene 
expression over three generations was also studied. This work has been submitted to 
"Molecular Breeding" for publication and is currently under review. Chapter 3 presents the 
role of regulatory sequences, in particular the LT-B and maize zein signal peptides, in 
subcellular localization of LT-B in transgenic maize kernels. A manuscript describing this 
work is in progress. The functionality of maize synthesized-LT-B as an immunogen is 
presented in Chapter 4. This work is currently in press in the journal "Transgenic 
Research Chapter 5 presents progress made towards the development of a subunit vaccine 
against the swine transmissible gastroenteritis coronavirus. A manuscript summarizing these 
results is in progress. Chapter 6 is a paper on the evolutionary relationships of coronaviruses, 
of which TGEV, a subject of my dissertation, is an economically important member. This 
work was a class assignment (Genet592; Evolutionary Genetics) and recommended for 
publication in a virology journal by the Instructor Dr Gavin Naylor. This paper examines 
conservation of antigenic epitopes that were used for the development of a subunit vaccine 
against TGEV in this study. Chapter 7 contains general conclusions on the work described in 
this dissertation. Appendix I focuses on the regulatory procedures for the release of 
transgenic maize containing a biopharmaceutical into the environment. 
Chapters 2 through 6 are presented in manuscript format and several names appear in 
the authorship. Dr Kan Wang is my Major Professor and the principal investigator on this 
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research project. She provided the guidance and direction for the course of this project. 
Collaborators on this project include Drs Hugh Mason, Ronald Wesley, Joan Cunnick and 
Paul Scott. Dr Mason is from the Boyce Thompson Institute of Plant Research at Cornell 
University and he provided the synthetic LT-B and LTK.63 genes used in this study, as well 
as technical input on analyses of expression of these genes. Dr Ronald Wesley of the 
National Animal Disease Center (NADC) in Ames, Iowa, provided the porcine respiratory 
coronavirus (PRCV) total viral RNA from which viral antigens were amplified. He also 
provided technical input, especially on viral neutralization assays. Dr Cunnick of the 
Department of Microbiology and Immunology provided hands-on training on animal 
handling procedures and guidance in experimental design and execution of the mice feeding 
studies. Dr Paul Scott, a USDA collaborator in the Agronomy Department provided training 
and technical input on protein analysis and aspects of maize kernel biochemistry. Bronwyn 
Frame and Sue Ellen Peg of the Plant Transformation Facility performed maize 
transformation and greenhouse care for all constructs described in this dissertation. Jennifer 
McMurray was an undergraduate assistant who worked with me on routine analyses 
presented in the dissertation. Diane Hathaway was a graduate student who worked with me 
on the edible vaccines project and contributed on the formulation of maize pellets for mice 
feeding experiments used in Chapter 4. Huixia Shou is a graduate student who contributed 
with statistical and molecular analyses described in Chapter 2. 
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1.3 L itéra tu re Review 
1.3.1 Production of recombinant proteins in plants 
Genes can be expressed in many different systems, and the choice of which system to 
use in the generation of a recombinant protein will depend on the system that offers the most 
advantages. An ideal system would be the one that produces the safest biologically active 
protein at the lowest cost (Daniell et al, 2001). There are many potential advantages in the 
production of antigens for use as vaccines as well as other proteins in plants. From a 
biological perspective, the plant's eukaryotic protein production system is capable of 
performing the post-translational modifications such as glycosylation, which, in some cases 
are essential for biological activity of some proteins. Plants are perceived as more 
economical than the industrial facilities using fermentation or bioreactor systems (Pen et al, 
1996). The amounts of protein produced by plants are comparable to those produced by 
industrial approaches (Hood et al, 1997). Technology already exists for harvesting and 
processing plants and plant products on a large scale. The purification requirement can be 
eliminated from the processing in cases where the recombinant protein is produced in plant 
tissue that can be used as food or feed (edible vaccine). The proteins can be targeted into 
intracellular compartments in which they are more stable. Alternatively, they can be 
expressed directly in those compartments or organelles such as chloroplasts. Production of 
recombinant proteins in plants minimizes the health risks associated with contamination of 
the recombinant product with potential human or animal pathogens (Streatfield, 2001). 
There are practical, ethical and genetic issues to be considered in the production of 
these foreign proteins in plants. These aspects include selection of appropriate plant tissues 
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in which to express and deliver the desired amount of antigenic protein. Novel protein can 
be produced in green tissue, tubers or grain, depending on the plant. Recombinant protein 
production has been reported in green tissues of tobacco, alfalfa and soybean. Attractive 
attributes of these plants include production of large volumes of green tissue in tobacco and 
alfalfa, which can produce several crops per year by cutting foliage. Annual foliage yields 
can be 25 and >100 metric tons (MT) per hectare for alfalfa and tobacco, respectively 
(Daniell et al, 2001). However, these plants have their drawbacks, especially for the purpose 
of convenient oral vaccine production and delivery. Green leaf tissues in which proteins are 
produced in these plants tend to have high amounts of phenolic and other potentially toxic 
compounds. Tobacco and Arabidopsis are not palatable, necessitating a purification or 
extraction step, which may add to the cost of production. An advantage of producing 
pharmaceuticals in potato is that the tuber is a good tissue for production and storage of 
proteins. Nevertheless, potato may require cooking to improve its palatability. Arakawa et 
al (1998) have shown that boiling CT-B generating transgenic potato denatures up to 50% of 
the antigen. 
Grain yields of cereal grains such as wheat, rice and maize are less abundant (3,6 and 
12 metric tons per hectare respectively) than that of the green tissues of tobacco and alfalfa 
(Daniell et al, 2001). However, high seed production in grains makes scaling up production 
quite easy. Unlike proteins synthesized in vegetative plant tissues, seed storage proteins are 
compartmentalized in protein bodies in mature seed. These provide a stable environment 
devoid of significant amounts of enzyme activity prior to germination. Production of 
recombinant proteins has the added advantage of long-term storability of functional protein 
in grain. Levels of scFV antibody in rice seeds or potato tubers did not show a significant 
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decline after storage at room temperature for 6 months (Daniell et al, 2001). 
Maize is a major food and feed ingredient worldwide. Production of an efficacious 
maize-based oral vaccine will provide effective and inexpensive control of some important 
gut pathogens, for which mucosal immunity is important for protection. The production of 
oral vaccines in maize grain or silage presents an opportunity to add value to unprocessed 
maize and to increase income for farmers. Successful vaccine production in maize will pave 
the way for the production of other edible vaccines in the crop, contributing significantly to 
the development of maize as a novel bio-manufacturing system. 
1.3.2 Plant genetics considerations 
Practical production of a protein in any given system has to be efficient, reliable and 
stable. The quantity of plant tissue constituting a vaccine dose must be of a practical size for 
consumption; therefore, transgenic lines should therefore have high expression levels of the 
gene of interest in appropriate tissues. In addition, the recombinant proteins produced in 
plants should be structurally and functionally active. Moreover, transgenic plants should be 
fertile and able to express the transgene predictably over generations. For this reason, 
expression of a foreign protein in plants requires optimization. Parameters that can be 
manipulated to achieve high expression levels are discussed below. 
1.3.2.1 Stable versus transient expression 
Expression of novel proteins in plants can be achieved by either transient expression 
using modified plant viruses (Mason and Amtzen, 1995) or by stable transformation of the 
nuclear genome. In transient expression, DNA encoding the gene of interest is introduced 
into the plant cell where it is recognized by the transcription machinery and expressed. 
Stable transformation, on the other hand, involves the introduction into the plant cell of a 
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foreign gene and its stable integration into the genome of the recipient plant. Each of these 
methods has its advantages and disadvantages. Viral vectors are usually more appropriate for 
expressing products in leaf tissue for extraction and purification. The expression of foreign 
protein occurs 2-4 weeks post inoculation, production of antigen is rapid and so is the scale 
up process (Cramer et al, 1999). Transient expression usually achieves substantially higher 
levels of protein, but requires inoculation of large number of plants with the recombinant 
virus. With viral vectors, the inserted gene is often lost over time, which is important for 
containment of the transgene. 
Stable transformation is particularly suitable for expression in edible plant tissue like 
fruits and tubers, which are not suitable for viral inoculation. Promoters are available that are 
suitable for organ specific expression and can be developmentally regulated. The ability to 
sexually cross transgenic lines adds the flexibility of being able to express multiple foreign 
proteins in the same plant. However, stable transformation requires meticulous selection and 
breeding of the high expressing transgenic lines, and there are concerns about transgene 
transfer into relatives. Stable transformation can be achieved, depending on the crop, either 
by Agrobacterium tumefaciens-mediated transformation or microprojectile bombardment, 
among other methods. For both transformation methods, there is need to construct the 
expression vector, in which the gene of interest is inserted along with DNA regulatory 
elements that control mRNA transcription and maturation in plant cells (Tacket and Mason, 
1999). For this purpose, promoters and other leader and polyadenylation signals, targeting 
and retention signals are important. The cassettes may or may not contain a selectable 
marker gene, to allow for selection of transgenic cells. In both stable and transient 
transformation methods, the site of transgene insertion is variable, and so is the gene copy 
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number, although the microprojectile method is associated with a higher number of transgene 
copies. This results in variability in the level of gene expression in the different 
transformants. Because insertion sites are random, transgenes may sometimes interfere with 
endogenous genes, leading to abnormalities in the transgenic plant. For these reasons, 
selection has to be carried out to determine high expressing non-defective lines. 
Stable transformation offers multigenerational stable expression, compared to the use 
of viral vectors. Expression of recombinant proteins has been achieved by the use of strong 
promoters, a range of leader and polyadenylation signals and optimization of codon usage for 
plant expression (Mason et al, 1998; Hood et al, 2001). Some of these regulatory sequences 
are discussed below. 
1.3.2.2 Gene regulatory sequences 
1.3.2.2.1 Promoters 
Promoters are available for tissue or organ-specific, temporal, and/or induced 
expression. Promoter elements can be either constitutive or tissue specific, allowing 
developmental control of expression of the novel protein. Some of the promoters used for 
foreign gene expression in maize include the maize ubiquitin promoter (Christensen et al, 
1992), the Cauliflower Mosaic Virus 35S (CaMV 35S) promoter (Nagy et al, 1985) in its 
tandem arrangement and the maize seed specific 27 kDa gamma zein promoter (Marks et al, 
1985). Seed-specific promoters derived from genes that encode proteins that are abundant in 
the seed could theoretically result in higher expression of a foreign protein; however, other 
groups have reported higher expression using constitutive promoters. Hood et al (1997) 
achieved high avidin expression using the constitutive maize ubiquitin promoter. Expression 
of a foreign protein with a strong constitutive promoter can have a detrimental effect on cell 
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processes and plant growth. Mason and co-workers (1998) noticed stunting of transgenic 
potato plants expressing a high level of the Escherichia coli heat labile-B subunit under the 
control of the enhanced CaMV 35S promoter. 
1.3.2.2.2 Subcellular localization 
Sub-cellular localization is important for biological activity of a protein. Proper 
folding and stability of the plant-synthesized protein is critical and is dependent upon the 
cellular environment where the protein is expressed and stored. For this reason, subunit 
vaccine components have been targeted to the cell surface, mitochondria, chloroplasts, 
vacuoles, the endoplasmic reticulum (ER) and the Golgi apparatus. Signal peptides have 
been used to influence level of transgene accumulation and spatial distribution within 
transgenic plant tissue. Hood et al (1997), and Zhong et al (1999) have used the barley a-
amylase signal peptide to target avidin and aprotinin respectively, to the endoplasmic 
reticulum during translation (Stachelin and Moore, 1995). In plants, the default pathway for 
proteins transported through the ER is secretion, hence the proteins were localized in the 
extracellular space. The expectation was that higher levels of the foreign protein would be 
obtained if the newly synthesized protein was targeted to the extracellular compartment. 
Conrad and Fiedler (1998) observed that targeting recombinant antibodies to the secretory 
pathway significantly increased antibody yield compared to targeting to the cytosol. 
Targeting avidin to the cytosol was completely toxic to engineered maize cells (Hood et al, 
1997). However, a protein's ultimate sub-cellular localization may depend on features other 
than just the signal peptides, including topological information in the protein itself. 
High expression of a gene product, which accumulates in the cytoplasm may result in 
toxicity to the plant cell (Mason et al, 1998). For this reason, sequestering the protein into a 
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compartment or organelle or transporting it to the extracellular matrix may allow higher 
expression levels. While targeting proteins to the intercellular space beneath the cell wall has 
been shown to increase expression levels, retention in the endoplasmic reticulum can also 
result in 10- to 100-fold higher yields (Conrad and Fiedler 1998). The SEKDEL (Ser-Glu-
Lys-Asp-Glu-Leu) or KDEL (Lys-Asp-Glu-Leu) amino acid motifs have been used to retain 
the foreign proteins in the endoplasmic reticulum. The SEKDEL amino acid motif binds to 
the SEKDEL receptor in the endoplasmic reticulum (Munro and Pelham, 1987). Haq et al 
(1995) showed that the SEKDEL motif resulted in significantly higher LT-B accumulation 
when compared with the LT-B gene without SEKDEL. These authors proposed that the 
cellular compartmentation of the SEKDEL protein could have facilitated oligomerization of 
LT-B monomers into pentamers detectable by ganglioside-dependent ELIS A. 
1.3.2.2.3 Codon usage 
The pattern of codon usage in plants is different from that of microorganisms. 
Altering the composition of the heterologous coding sequence to meet the plant pattern can 
increase the rate of translation (Kusnadi et al, 1997). The codon bias of a transgene is 
important in enhanced expression of a foreign protein (Gribskov et al, 1984). Mason et al 
(1998) synthesized the LT-B gene used in this study with a codon bias optimized for 
expression in potato and maize and demonstrated that the synthetic gene could be expressed 
in potato. This group observed that the codon optimized LT-B gene achieved higher LT-B 
expression in transgenic potatoes than the non-optimized gene. 
1.3.2.3 Stability of gene expression and transmission of the transgene 
Differences in gene expression between transgenic events have been reported. This 
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phenomenon is often attributed to differences in gene copy numbers of the transgene and the 
relative position of insertion in the nuclear genome of the transgenic plants (Matzke and 
Matzke, 1995). Hood et al (1997) observed variation of avidin expression ranging from 
2.1% to 5.7% of aqueous-extractable protein between plants within the same transgenic 
event. They reported increased gene expression in some transgenic maize plant lines and total 
silencing of the transgene in others. For this reason, only those transgenic lines with the 
desired level of expression were pursued. Other workers have reported variation in gene 
expression between different generations of plants in the same transgenic events. Zhong et al 
(1999) and Streatfield et al (2001) reported increase in the expression of aprotinin and LT-B 
respectively between different generations of the same transgenic lines. 
A reliable plant antigen production system requires the normal transmission of the 
foreign gene from generation to generation. Abnormalities in foreign gene transmission have 
been reported. In two extreme cases, Hood et al (1997) observed that transgenic plants 
expressing avidin were male sterile as a result of the effect of the transgene, while Sangtong 
et al (2001) observed that transgenic maize plants expressing the wheat glutenin 1DX5 gene 
did not transmit the gene through the pollen. 
1.3.3 Mucosal vaccination and choice of suitable antigens 
Vaccination continues to be the most successful method of preventing infectious 
diseases in humans and livestock. Vaccination induces an immune response that is capable 
of limiting infection after exposure to the pathogen. Vaccines can be administered by a 
variety of means, including injection, intranasal or oral presentation (Bowersock and Martin, 
1999). Pathogens responsible for the greatest burden of human disease make initial contact 
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with the human host at a mucosal site such as the respiratory, gastrointestinal, or genital 
tracts (Simmons et al, 1999). Oral vaccination targets the vaccine to the mucosal surface and 
results in stronger immune responses at the site of interaction of the pathogen and the host. 
Mucosal vaccines applied to the mucosal surface, may induce systemic antibodies and 
cellular immune responses as well as local immune responses (Ogra et al, 1980). 
There are practical problems associated with oral vaccination. Oral vaccines must be 
protected during passage through the hostile environment (low pH, digestive enzymes) of the 
stomach en route to the Peyers patches of the small intestine where immune stimulation 
occurs (Bowersock and Martin, 1999). Strategies have been developed to protect vaccines 
from degradation in the harsh gastric and enteric environment, including encapsulation in 
liposomes, proteosomes, cochleates, virus-like particles, and immune-stimulating complexes 
(Simmons et al, 1999). Production of a vaccine in plant cells may protect it from the harsh 
stomach environment as it passes to the gut. Expression of antigens in transgenic plant 
tissues may provide an efficient bioencapsulation system. Viral and bacterial vectors for oral 
delivery of non-living antigens have been developed and tested in animals and humans for 
safety and immunogenicity (Tacket and Mason, 1999). This review will not be dwelling on 
that subject but would consider this aspect in production of a vaccine in maize. 
Not all antigens are antigenic when delivered orally. One of the key problems with 
oral vaccinations is that non-living antigens delivered orally are in general poorly 
immunogenic, requiring multiple doses or large doses to stimulate modest immune 
responses, or a strong mucosal adjuvant to enhance the immune response (Bowersock and 
Martin, 1999). For this reason, the choice of antigen is critical. The most potent mucosal 
immunoadjuvants known to date are the labile toxin (LT) produced by some strains of 
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enterotoxigenic E. coli and cholera toxin (CT) produced by Vibrio cholerae, which are 
closely related. This makes them unique among soluble proteins, which are generally poorly 
immunogenic. The E. coli labile toxin (LT) and its derivatives were selected for their 
immunogenic properties, and are discussed below. 
1.3.3.1 The E. coli heat labile toxin 
LT is an 84-kilodalton polymeric protein composed of two major non-covalently 
associated immunologically distinct polypeptides designated (LT-A and LT-B). The A 
region (27 kDa) is responsible for increasing intracellular levels of cAMP and subsequent 
secretion of water and electrolytes into the small intestine, which is characteristic of the 
debilitating E. coli induced watery diarrhea (Spangler et al, 1992). LT-B is 55 kDa and 
consists of five non-covalently bound 11.6 kDa B subunits. These non-toxic B sub-units are 
responsible for binding the protein to receptors located on the surface of intestinal epithelial 
cells. Pentameric LT-B is responsible for binding of the toxin to the host cell receptor, GMI 
(galactosyl-N-acetylgalactosaminyl-sialyl galactosyl glucosyl ceramide), which is commonly 
found on the surface of eukaryotic cells. 
LT has two important characteristics for use in oral vaccination. LT-B has been 
shown to enhance the immune response to co-administered antigens and to abrogate the 
induction of oral tolerance to these antigens. Clements et al (1988) studied the effect of LT 
on oral tolerance non-target dietary antigens, and showed that prior exposure to the antigen 
reduces the effectiveness of LT in influencing tolerance and its ability to act as an adjuvant. 
LT was not able to abrogate tolerance once it was established. This implies that it can be 
safely used without the risk of an immune response being raised against normal dietary 
antigens 
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The molecular basis of the adjuvanticity and immunogenicity of LT appears to be 
poorly understood and is the subject of controversy in the literature. Both the toxic ADP-
ribosylation activity of the LT-A subunit and the cellular toxin receptor, ganglioside, GMr 
binding properties of the LT-B-pentamer have been suggested to be involved (Dickinson and 
Clements, 1996). The general mechanism of holotoxin attachment and entry into the cell is 
that the B sub-unit binds to the GMI gangliosides and internalizes the toxin into a vesicle 
from where it is transported to the trans-Golgi. There, the A and B sub-units dissociate and 
the A subunit is transported to the ER. From the ER the Al subunit enters the cytosol where 
it interacts with the ADP ribosylation factor and it gets activated to initiate its toxic effects 
(Spangler, 1992). The characteristics of the LT subunits are important for the approach used 
in this dissertation and are therefore described below. 
1.3.3.1.1 Role of the A subunit 
The literature has different reports on the role of the A subunit. Some literature 
suggests that the A domain is the part of the molecule to which the adjuvanticity of these 
toxins should be attributed (Dickinson and Clements, 1996). In particular, the ADP 
ribosylation activity of the A subunit is thought to be critical. The A subunit can be cleaved 
into A1 and A2 subunits. The A2 fragment functions as an adapter between A and B 
subunits, and has a RDEL in LT (or KDEL in CT) that is associated with the retrieval of 
proteins from the trans-Golgi to the ER. This process is important in the delivery of the A1 
subunit to the appropriate cellular component (Williams et al, 1999). ADP ribosylation by the 
A subunit probably contributes towards modulating the immune response where it is present. 
However, the A subunit is also thought to stabilize the conformation of the B subunit and to 
modulate vesicular trafficking through binding to K(R)DEL receptors by the A2 domain. 
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Mutants lacking ADP ribosylation activity have been shown to retain adjuvant activity (Pizza 
et al, 2001). 
1.3.3.1.2 Role of the B subunit 
There is disparity between studies of the effectiveness of B subunit alone as an 
adjuvant. Millar and co-workers (2001) showed that, contrary to previous opinion (reviewed 
by Dickinson and Clements, 1996), the non-toxic subunits of CT and LT, CT-B and LT-B. 
are potent oral immunogens, avoiding tolerance induction when administered mucosaliy and 
generating strong serum and mucosal responses (reviewed by Snider, 1995). They are 
arranged in a pentameric ring and contain five receptor-binding pockets for high avidity 
association with cellular GMI gangliosides. Guidry et al (1997) examined the role of receptor 
binding in toxicity, immunogenicity and adjuvanticity of LT by comparing LT to a B-subunit 
receptor-binding mutant. The mutant was unable to serve as an effective oral adjuvant, and 
elicited negligible serum and mucosal immune responses. The conclusion from this work 
was that toxicity, immunogenicity and oral adjuvanticity of LT are dependent upon binding 
of the B subunit to ganglioside GMI- The B subunit is thought to be the principal mediator of 
activity and its interaction with cell surface receptors triggers the key immunomodulatory 
events associated with adjuvant activity. LT-B can also serve as an immunologic carrier in 
traditional hapten-carrier configuration (Cebra et al, 1986). Other antigens conjugated to LT-
B can therefore be immobilized for processing by the gut-associated lymphoid tissue 
(GALT). 
1.3.3.1.3 Detoxification/Attenuation of LT 
To facilitate its use as an adjuvant, researchers have attenuated the toxicity of LT 
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through genetic engineering of the A subunit (Yamamoto et al. 1997). Attempts to alter the 
toxicity of LT have focused on site-directed mutagenesis to change amino acids associated 
with the crevice where enzymatic activity is thought to occur. Progress appears to have been 
made towards detoxifying LT. To date, several mutant LT zootoxins have been developed, 
including LTK63, LTR72 and LTG192, among others (Pizza et al, 2001). In LTK63, Ser63 
was changed to Lys through site directed mutagenesis. This mutation was expected to reduce 
the toxicity of LT by interfering with NAD+ binding. Pizza et al (2001 ) showed that LTK63 
was a strong and safe oral immunogen, and it consistently elicited higher antibody titers than 
bacterial LT-B. The mutant retained its adjuvant activity. 
1.3.3.1.4. Potential of LT in design and production of mucosal vaccines 
LT, its mutants and subunits have significant immunoregulatory potential as a means 
of preventing the induction of oral tolerance to specific antigens and as adjuvants for orally 
administered antigens. They also elicit the production of both serum IgG and mucosal IgA 
against antigens with which they are delivered. This makes these molecules potentially very 
useful in immunization programs against a variety of pathogens involving the oral 
administration of killed or attenuated agents or relevant virulence determinants of specific 
agents. Co-expression in transgenic crops of these adjuvant molecules with antigens from 
other economically important pathogens could further increase the utility of plant-based oral 
vaccines. LT-B and LT-A have been used as carrier molecules for other antigens whose 
small size or solubility limits their use as vaccines, or are not sufficiently immunogenic on 
their own. Conjugation of antigens to these subunits physically retains the antigen at high 
concentrations at the components of the immune system, stimulating an immune response. 
Virus neutralizing epitopes from the swine transmissible gastroenteritis virus (TGEV) were 
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selected for conjugation to the LT-B subunits. 
1.3.3.2 Transmissible Gastroenteritis Virus (TGEV) 
Transmissible gastroenteritis virus (TGEV) causes a highly contagious enteric disease 
characterized by vomiting, severe diarrhea and high mortality in young swine. In piglets 
younger than one week of age, mortality from this disease can be up to 100%, particularly 
under conditions of intensive farming. While progress made to understand the biology of the 
disease has led to improved management practices to control the disease, TGEV remains a 
major herd health problem in the United States. The economic losses due to this disease 
were conservatively estimated to be between 25 and 75 million dollars in the US (Paul et al. 
1990) annually. Passive immunity is of primary importance in protecting newborn piglets 
against TGEV (Saif and Wesley, 1992). This type of immunity can be achieved by the 
induction of lactogenic immunity in the sow, which in turn can be induced by presentation of 
selected antigens to the immune system in the gut associated lymphoid tissues (Saif and 
Wesley, 1992). Pigs that survive a first infection are immune to subsequent infections of 
virus, probably due to local induction of secretory IgA. For this reason, vaccines that target 
the activation of the mucosal surface of the intestine are particularly attractive in the control 
of TGE and other mucosal diseases. Federally licensed vaccines are available, although they 
each have their limitations. The vaccines contain either inactivated virus or modified live 
attenuated virus. Inactivated viral vaccines are given intramuscularly in gilts and sows, and 
intraperitonially in baby pigs. The administration of both types of vaccine requires a lot of 
animal handling. With the oral vaccine approach, simply feeding the animals with transgenic 
plants expressing a suitable antigen can elicit a protective immune response. This approach 
potentially reduces the amount of animal handling required during animal vaccination. 
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TGEV is an enveloped, single stranded RNA virus. It belongs to the genus 
Coronavirus of the family Coronaviridae (Holmes and Lai, 1996). The virus consists of three 
structural proteins; the membrane protein, designated M, the phosphoprotein that 
encapsulates the viral RNA genome, designated N, and the large surface glycoprotein, 
designated S. The mature S protein forms the characteristic club-shaped peplomers or 
spikes, hence its designation. In this protein, four antigenic sites (A, B, C and D) have been 
defined (Delmas et al, 1986, 1990), all of them in the N-terminal half. Of these antigenic 
sites, site A is antigenically dominant, sites A and D and to a minor extent site B, have been 
involved in the neutralization of TGEV (Delmas, 1990). The S gene is therefore a suitable 
candidate for the development of recombinant subunit vaccines in baculovirus, plants and 
other expression systems (Callebautt et al, 1996; Shoup et al, 1997; Tuboly et al, 1994; 
Welter et al, 1996; Streatfield et al, 2001). This dissertation focused on the antigenic N-
terminal half of the S protein common to TGEV and its mutant derivative, porcine 
respiratory coronavirus (PRCV) (Paul et al, 1990). 
1.4 Research strategy 
The potential of oral vaccination with a plant-produced antigen is beginning to be 
realized. Plant expressed antigens have been shown to be able to induce mucosal and 
systemic immunity when administered orally (Arakawa et al, 1998, Mason et al, 1998). A 
few of these vaccine candidates have been successfully tested in clinical trials or, where 
appropriate, in livestock. 
There are several challenges to be addressed for the plant-based oral vaccine 
approach. Firstly, the transgenic plants must efficiently produce proteins that are antigenic, 
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that is, recognized by the host antibodies in response to authentic challenge. Secondly, the 
proteins produced must be immunogenic, eliciting antibodies when used for oral 
immunization and finally, the vaccines must generate a sufficient memory response to protect 
the test system from subsequent challenge with the disease causing agent (Artzen, 1997). 
This dissertation focused on the expression of LT-B and a domain from the TGEV 
virus S protein. Expression of these two antigens in crops has been reported. Mason and co­
workers (1998) used both an optimized and a non-optimized gene to express LT-B in 
transgenic potato. In both cases the CaMV 35S promoter regulated the gene. Their work 
showed that LT-B could be expressed in potato using either gene, but optimization of the LT-
B gene resulted in increased amounts of LT-B protein in accumulation in potato tubers. The 
use of the ER retention signal SEKDEL also enhanced LT-B protein accumulation and up to 
0.19% LT-B of total soluble protein was observed. They established the immunogenicity in 
mice and humans of the potato expressed LT-B, indicating that it was fully functional. 
Recently, Streatfield et al (2001, 2002) reported the expression of LT-B in maize, and 
established its immunogenicity in mice. 
A number of attempts have been made to express the S gene of TGEV in transgenic 
plants (Welter et al, 1996; Streatfield et al, 2001) for use as a vaccine. Streatfield et al (2002) 
expressed the whole S protein in transgenic maize using a synthetic gene with codon usage 
optimized for expression in maize. They observed 0.01% S protein in maize kernel total 
soluble protein. In a pig feeding trial, they established that the maize-synthesized LT-B 
conferred some protection against challenge with TGEV when orally administered in piglets. 
However, the level of protein accumulation observed (0.01%) was low. 
The strategy adopted in this study was to use the adjuvant and carrier molecule 
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properties of LT-B to deliver peptides carrying critical epitopes of TGEV to stimulate the 
immune system in the gut. The goal was to achieve high-level stable expression of the 
selected antigens in transgenic maize. Where possible, synthetic genes that had codon usage 
optimized for maize expression were used. The constitutive CaMV 35S promoter was used 
for gene expression in callus and the 27 kDa gamma zein promoter was used for kernel-
specific expression of antigens. The bacterial and maize gamma zein signal peptides and the 
SEKDEL retention motif were used for subcellular targeting of the antigens in maize. TGE 
viral epitopes from the S protein were conjugated to subunits of LTK63, a non-toxic mutant 
derivative of LT, and expressed in transgenic maize callus. LTK63 was also used to 
determine whether higher order assembly was possible when separate subunits were 
expressed in maize as a control for the TGE/subunit fusion experiments. Immunogenicity of 
the maize synthesized proteins was determined in laboratory mice. 
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CHAPTER 2 
Expression of a synthetic E. coli heat-labile enterotoxin B sub-unit (LT-B) 
in maize 
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Abstract 
We have produced the B subunit of the enterotoxigenic Escherichia coli (ETEC) 
heat-labile enterotoxin (LT-B) in transgenic maize seed. LT-B is a model antigen that 
induces a strong immune response upon oral administration and enhances immune responses 
to conjugated and co-administered antigens. Using a synthetic LT-B gene with optimized 
codon sequence, we examined the role of promoters and the SEKDEL endoplasmic reticulum 
retention motif in LT-B accumulation in callus and in kernels. Two promoters, the 
constitutive CaMV 35S promoter and the maize 27 kDa gamma zein promoter, which directs 
endosperm-specific gene expression in maize kernels, regulated LT-B expression. 
Ganglioside-dependent ELISA analysis showed that using the constitutive promoter, 
maximum LT-B level detected in callus was 0.04% LT-B in total aqueous-extractable protein 
(TAEP) and 0.01% in R, kernels of transgenic plants. Using the gamma zein promoter. LT-
B accumulation reached 0.07% in R, kernels. The SEKDEL resulted in increased LT-B 
levels when combined with the gamma zein promoter. We monitored LT-B levels under 
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greenhouse and field conditions over three generations. Significant variability in gene 
expression was observed between transgenic events, and between plants within the same 
event. A maximum of 0.3% LT-B in TAEP was measured in R3 seed of a transgenic line 
carrying CaMV 35S promoter/LT-B construct. In R3 seed of a transgenic line carrying the 
gamma zein promoter/LT-B construct, up to 3.7% LT-B in TAEP could be detected. We 
conclude that maize kernels can be used as a production system for functional antigens. 
Key words: 
Functional antigen, gene expression, LT-B, Zea mays 
Abbreviations: 
BSA, bovine serum albumin; CaMV 35S, Cauliflower Mosaic Virus 35S RNA Promoter; 
EOTA, ethylene-diamine tetraacetic acid; ELISA, enzyme-linked immunosorbent assay: 
GMI, galactosyl-N-acetylgalactosamyl-sialyl-galactosylglucosyl ceramide; LT-B, heat-labile 
toxin from E. coli; PBS, phosphate-buffered saline; PMSF, phenylmethanesulfonyl fluoride: 
SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; Tris. Tris 
hydroxymethyl aminomethane. 
Introduction 
Recombinant DNA technology and advances in plant transformation have expanded 
the utility of plants beyond the traditional uses of food, feed and fiber. Plants are now used 
as a source of proteins for industrial, pharmaceutical, and other purposes (Krebbers et al., 
1993; Pen et al., 1993; Austin et al., 1994). Production of recombinant proteins in transgenic 
plants is emerging as a competitive and safe alternative to the traditional protein expression 
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systems. This is particularly relevant for the production of monoclonal antibodies and 
antigens for use as vaccines in humans and animals. A major advantage of producing 
antigens for this purpose in a crop like maize is that plant-derived antigens are free from 
human and animal pathogens normally associated with vaccines produced in conventional 
mammalian cell culture systems. To use plants as an efficient system for antigen production, 
a number of issues need to be considered. Transgenic lines should have high expression 
levels of the gene of interest in appropriate tissues. In addition, the recombinant proteins 
produced in planta should be have structural integrity and be functionally active. Moreover, 
transgenic plants should be fertile and transmit and predictably express the transgene over 
generations. Novel protein production in plants has been reported in potato, tobacco, and 
Arabidopsis. Advances in maize transformation have allowed us to investigate the 
possibility of using this crop as a source of antigens to be used as oral vaccines. 
In this study we report the production of a functional Escherichia coli (£. coli) heat 
labile enterotoxin B sub-unit (LT-B) in maize. LT-B is part of the heat-labile toxin (LT) 
produced by enterotoxigenic strains of E. coli, a leading cause of diarrhea in dev eloping 
countries (Spangler, 1992). The bacterium is ingested in contaminated food or water and 
colonizes the gut, where it secretes toxins, including LT. LT is an 84-kilodalton (kDa) 
oligomeric protein composed of two major noncovalently associated immunologically 
distinct peptides designated LT-A and LT-B. The A peptide (27 kDa) is responsible for the 
diverse biological effects of the toxin. LT-B is a 55 kDa homopentamer of 11.6 kDa peptides 
responsible for binding of the toxin to the host cell receptor GMI (galactosyl-N-
acetylgalactosaminyl-sialyl galactosyl glucosyl ceramide), which is found on the surface of 
eukaryotic cells. Adjuvants are substances that, either alone or linked to protein antigens. 
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can stimulate mucosal responses and therefore significantly enhance the potency of vaccines 
in general. They are particularly important in local vaccination with nonreplicating antigens, 
which can be ineffective because they are poorly immunogenic. LT-B has been shown to be 
an excellent oral adjuvant, stimulating immune responses against co-fed antigens, enhancing 
their value as vaccines (Millar et al., 2001). LT-B can serve as an immunologic carrier in 
traditional the hapten-carrier configuration as well (Spangler, 1992). Other antigens 
conjugated to LT-B can be immobilized for processing by the gut-associated lymphoid tissue 
(GALT) because of LT-B's affinity to GMI gangliosides on the surface of the intestinal 
mucosa. 
LT-B produced in potato and maize has been shown to be immunogenic in mice 
(Mason et al., 1998; Streatfield et al., 2001; Chikwamba et al., 2002) and humans (Tacket et 
al., 1998). This protein is an ideal model for an oral vaccine, and its adjuvant properties 
make it attractive for use in co-expression or co-administration with other plant-synthesized 
or conventional vaccines. We have generated transgenic maize plants expressing LT-B in 
kernels using several constructs. We investigated the role of promoters and the SEKDEL 
amino acid motif, an endoplasmic reticulum-retention signal, in the accumulation of LT-B in 
transgenic maize. A high level of expression is important for meeting dosage requirements 
for plant-based biologies. We also examined the expression of LT-B over three generations 
in the greenhouse and the field. Our data indicate that maize kernels, a key ingredient in 
livestock feed, can be used to produce functional antigens for use as feed-based vaccines. 
36 
Materials and methods 
Constructs 
A plant codon-optimized LT-B subunit gene (Mason et al., 1998) was cloned into 
four different constructs (Figure 1). Construct pTH210 (Mason et al., 1998. Figure 1 A), has 
the LT-B gene regulated by the CaMV 35S promoter, the tobacco etch virus (TEV) leader as 
a translational enhancer (Gallic et al., 1995), and the soybean vegetative storage protein 
(VSP) terminator (Rhee and Staswick, 1992) in the 3'terminus. Transgenic maize calli and 
plants carrying this construct were designated P51. Construct pTHK210 (Mason, 
unpublished, Figure IB) is identical to pTH210, except a SEKDEL (Ser-Glu-Lys-Asp-Glu-
Leu) encoding sequence is included in the C-terminus of the LT-B encoding sequence. 
Plants carrying this construct were designated P65. In construct pRC4 (Figure 1C). the 
CaMV 35S promoter was replaced by the maize 27 kDa gamma zein promoter (Marks et al.. 
1985). To construct pRC4, a 1.15 kb Xho I-£coR I fragment including the TEV 5'. the 
synthetic LT-B coding sequence and the VSP terminator from pTH210 was cloned 
downstream of the gamma zein promoter in the vector pUC19. Plants carrying this construct 
were designated P77. Construct pRC4-l (Figure ID) is identical to pRC4 except it carried 
the LT-B gene with the SEKDEL motif in its C-terminus. Plants with this construct were 
designated PI 12. This construct was made by subcloning the 1.15 kb Xho I and EcoR I 
fragment from plasmid pTHK210 downstream of the maize 27 kDa gamma zein promoter in 
a pUC19 vector. In all cloning work, the resultant plasmids were sequenced to ensure correct 
orientation and fidelity of ligation junctions. DNA for maize transformation was obtained 
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using the Qiagen (Qiagen GmbH, Germany) Maxiprep kit according to the manufacturer's 
instructions. 
Maize transformation 
Maize transformation was conducted by the Iowa State University Plant 
Transformation Facility using the procedure described by Frame et al. (2000). Briefly, 
embryogénie calli generated from immature embryos of the Hi-II genotype were transformed 
using microprojectile bombardment. The constructs carrying the LT-B gene were co-
bombarded with pBAR184 (Frame et al., 2000), a plasmid that carries the maize ubiquitin 
promoter-6ar gene cassette as a selectable marker conferring resistance to the herbicide 
bialaphos. The bialaphos-resistant calli were analyzed by PGR, Southern blot, and Northern 
blot and ELISA analyses as described below. Calli of transgenic events were regenerated 
and brought to maturity in the greenhouse. Ri seed were obtained by out-crossing, with the 
transformants as female parents and untransformed inbred lines B73 and/or Hi-II as male 
parents. Seeds from LT-B-expressing events were planted to give Rl plants. 
PCR analysis 
Transgenic calli were initially selected on the basis of resistance to bialaphos, and the 
presence of the LT-B gene was confirmed by PCR analysis. The LT-B gene was amplified 
from 10 to 100 ng of total genomic DNA extracted from 0.1-0.25 g of callus as described by 
Chikwamba et al. (2002). Callus DNA was extracted in 400 |il extraction buffer [200 mM 
Tris-Cl (pH 7.5), 250 mM NaCl, 25 mM EDTA, and 0.5% SDS (w/v)], followed by 
extraction in an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1, V:V:V). PCR 
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primers and conditions, used as described (Chikwamba et al., 2002), were the same in all 
cases: LTB-PCRF1 (5'-ate gat aca aaa caa acg aat ctc aag c-3') and LTB-PCRR1 (5'-cca tgg 
cgt gga ttt tat gac att tta t-3'). These 28 bp primers amplify an 842 bp fragment from the 
TEV leader at the 5' end to part of the VSP terminator at the 3' end, including the LT-B-
coding sequence. 
Southern blot analysis 
Southern blot analysis was undertaken on DNA from leaf tissue of young putative 
transformants or Rj plants to confirm transformation and to estimate the copy number of the 
LT-B gene. Genomic DNA was extracted from leaves of maize plants using a 
cetyltrimethylammonium bromide (CTAB) protocol (Murray and Thompson, 1980). Ten 
micrograms of leaf genomic DNA was digested with restriction enzyme Hind III for P51 and 
P65, and Nco I for P77 and PI 12, at 37°C overnight and separated on a 0.8% agarose gel. 
Linearized DNA gel blot analysis (Sambrook et al., 1989) was conducted on DNA samples 
using a 32P-labeled LT-B gene fragment excised from pTH210 using the enzymes Nco I and 
Kpn I as probe (Figure 1). 
Northern blot analysis 
Northern blot analysis was conducted using the leaf tissue of selected transgenic 
plants. Total RNA was extracted from leaf tissue of Ro and R, plants using Trizol reagent 
(Gibco Life Sciences, Rockville, MD, USA) according to the manufacturer's directions. 
Twenty micrograms of total RNA was separated on a 1% agarose gel under RNAse-free 
denaturing conditions and then blotted onto a nitrocellulose membrane. The LT-B gene 
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fragment was also used as a probe in the hybridization procedure as described for Southern 
blot analysis. 
Evaluation of protein production 
Evaluation of protein expression was carried out in callus and maize kernels. About 
0.25 g of fresh callus was homogenized in 500 gl of protein extraction buffer [25 m M 
Sodium phosphate (pH 6.6) 100 mM NaCl, 0.5% Triton X-100 (v/v), 10 pg/ml Ieupeptin 
(w/v)]. Two methods were used for processing dry maize kernels, one manual and the other 
partially mechanized. In the manual procedure, individual kernels were partially crushed 
with a mortar and pestle, frozen in liquid nitrogen, and then ground to a fine powder. In the 
mechanized method, individual kernels and a single ball bearing (3/8 inch, Dynasteel) were 
placed in a polycarbonate tube (1/2x2 inches, Spex CertiPrep, Metuchen, NJ. USA). The 
tubes were shaken in a Spex CertiPrep GenoGrinder for 5-10 minutes at 1400 rpm, 
depending on the hardness of the kernels, until the kernels were reduced to a fine powder. 
Protein extraction buffer was added at a ratio of 10 pi per mg of dry, finely ground 
kernel tissue in an Eppendorf tube; 30 to 50 p.g of tissue was used per sample. The samples 
were placed on a vortex shaker for 30 to 60 minutes for complete resuspension and allowed 
to sit on the bench for another hour, after which they were centrifuged at 14,000 rpm in a 
microcentrifuge for 15 minutes at room temperature. One hundred microliters of the 
supernatant (50 |il per well, 2 replications/sample) was used for ganglioside-dependent 
ELISA analysis as previously described (Mason et al., 1998). Total soluble protein 
concentrations were determined by the Bradford Assay (Bradford, 1976) with the BioRad 
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(Hercules, CA, USA) protein dye concentrate using a standard curve derived from bovine 
serum albumin (BSA). 
To identify kernels expressing LT-B for planting for the next generation, individual 
kernels from each ear (two ears per event) were analyzed by a partial destruction method 
(Sangtong et al., 2001). With the use of a fine drill and without damaging the embryo, part 
of the endosperm from each kernel was removed for ELIS A analysis. Protein was extracted 
from the endosperm as described for whole kernels. Kernels expressing LT-B were planted 
to give rise to the subsequent generation. 
Quantitation of LT-B expression in maize 
LT-B expression in maize was determined using ganglioside-dependent ELISA 
(Mason et al., 1998; Chikwamba et al., 2002). Reagents and antisera for the ELISA were 
obtained from Biogenesis, Inc . (Kingston, NH, USA) and KPL (Gaithersburg, MD. USA). 
Volumes of 50 (il were used throughout all ELISA assays unless otherwise specified. Wells 
were washed three times between each step using 300 pi of phosphate-buffered saline 
Tween-20 [PBST; 0.01 M Na2HP04, 0.003 M KH2P04, (pH 7.2), 0.1 M NaCl, 0.05% 
Tween-20 (v/v)]. Each step of the ELISA was carried out at 37°C throughout the process 
unless otherwise specified. Briefly, LT-B from plant extracts was captured in microliter 
plates (Costar 3590, Fisher Scientific, PA, USA) coated with Type III GMI gangliosides (1.5 
pg/well) from bovine brain (G2375, Sigma, St Louis, MO, USA), dissolved in sodium 
carbonate coating buffer [15 mM Na2COj, 35 mM NaHCOs, 3 mM NaNj, (pH9.6)] for 1 
hour at room temperature. The plates were blocked to prevent nonspecific antibody binding 
with 5% dry milk (w/v, DIFCO, Becton Dickinson, MD, USA) for one hour at room 
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temperature. The LT-B in crude extracts was captured for one hour at 37°C or 4°C 
overnight, followed by incubation with goat anti-LT-B antiserum (1:1500 dilution. 
Biogenesis, Kingston, NH, USA) at 37°C for one hour. Rabbit anti-goat alkaline 
phosphatase conjugate [1:2500 dilution in 1% dry milk (w/v) in PBS] was added, and the 
plate incubated for one hour. This was followed by addition of phosphatase substrate, which 
consisted of 1 mg/ml p-nitrophenyl phosphate (pNPP, Sigma) in alkaline phosphatase buffer 
[0.1 M Tris. (pH 9.5), 0.05M MgCh, 0.1 M NaCl], Absorbance at 405 nm was immediately 
measured spectrophotometrically over a two-hour period in a Dynatech MRX Plate Reader 
(Dynex Technologies, VA, USA). Sample wells were blanked against nontransgenic maize 
protein extracts, and all measurements were performed in duplicate. Raw ELISA data were 
converted to percentage of LT-B of total aqueous extractable protein by reference to an 
ELISA standard curve constructed using purified bacterial LT-B (kindly provided by John 
Clements, Tulane University, New Orleans, LA, USA). 
Screening of transgenic plants in field 
To identify transgene-expressing plants in the field, the segregating R: plants were 
sprayed with 200 mg/L Liberty®(w/v) with 0.05% Tween-20 (v/v) two weeks post-
emergence. The gene expressing plants were either self pollinated or crossed with their 
siblings. The segregation ratio of herbicide resistance was approximately 3:1 (resistant: 
susceptible), as expected, and the herbicide-resistant plants were tagged for identification. 
Both tassels and ears were bagged, and because plants were both male- and female-fertile, 
they were, in most cases, self-pollinated to produce Rj seed. 
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Data analysis 
To determine the expression level for each ear, twenty kernels per ear were analyzed 
for LT-B expression, and an average expression level was obtained from only the LT-B 
positive kernels. The data are presented as the mean ± standard deviation. For P51 and P77 
R3 kernels, ELISA analyses were carried out on eight ears, 20 whole kernels per ear as 
described. For each ear, 10 values of 10 randomly selected LT-B positive kernels and used 
to determine the mean expression per ear. Ten kernels were picked for convenience of 
statistical analysis as each segregating ear had a different number of gene expressing kernels. 
Statistical analysis (analysis of variance) were carried out using the package SAS (The SAS 
Institute Inc., Cary, NC, USA). 
Results 
Generation of LT-B-producing transgenic maize plants 
The constructs used for maize transformation are shown in Figure 1. The LT-B gene 
in all constructs was synthesized with a codon bias for expression in potato and maize 
(Mason et al., 1998). In constructs pTH210 and pTHK210, the CaMV 35S promoter, the 
TEV enhancer, and the VSP terminator regulated the LT-B gene. In construct pTHK.210. a 
DNA sequence encoding the SEKDEL amino acid motif, which binds to the SEKDEL 
receptor in the endoplasmic reticulum (Munro and Pelham, 1987), was included in the C-
terminus of the LT-B coding sequence. This motif has been shown to enhance the expression 
of a non-optimized LT-B gene in transgenic potato (Haq et al., 1995). Transgenic maize 
events carrying these two constructs were designated P51 and P65, respectively. In 
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constructs pRC4 and pRC4-l, the maize 27 kDa gamma zein promoter replaced the CaMV 
35S promoter in pTH2lO and pTHK210, respectively. PRC4-1 has the SEKDEL motif in the 
C-terminus of LT-B. Transgenic events carrying these two constructs were designated P77 
and PI 12, respectively (Figure 1 ). 
PGR analyses of the LT-B transgene insertions were carried out on herbicide-resistant 
calli. The co-transformation rate for the selectable marker gene bar and the gene of interest 
LT-B in all four constructs ranged from 58 % to 89 %, with an average of 77%. Southern 
blot analysis was carried out on genomic DNA isolated from leaf tissue of putative 
transformants. Results of representative events from construct pTH210 (P51) and pRC4-l 
(PI 12) are shown in Figures 2A and B, respectively. Genomic DNA was digested with 
restriction enzymes that cut once within the construct; Hind III was used for P51 (Figure 2A) 
and P65 (data not shown). EcoR I and Nco I were used for P77 (Chikwamba et al.. 2002) 
and PI 12 (Figure 2B), respectively. Results showed integration of the LT-B gene cassette 
into the maize genomic DNA. Each event had a unique insertion pattern, and plants from the 
same event had similar transgene insertion patterns (P51-20, Figure 2A). Most of the events 
were shown to contain multiple copies of the transgene. Estimated copy number ranged from 
two to more than, as is typical of plants transformed via microprojectile bombardment 
(Christou, 1996). 
Figure 3 shows the Northern blot analysis results on representative events of P51. A 
transcript with ~700 nucleotides hybridized with the LT-B probe and could be detected in 
RNA from leaf of transgenic plants that had been regenerated on the basis of herbicide 
resistance, PGR analysis, and callus expression of LT-B (see below). Different levels of 
mRNA expression were observed, and Event #23 had no detectable LT-B RNA, despite 
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having been shown to contain multiple copies of the transgene (data not shown). These 
results showed the LT-B gene was being transcribed in maize leaf tissue in transgenic plants 
carrying pTH210. 
Constitutive expression of LT-B protein 
Table 1 summarizes the level of LT-B protein expression in callus under the 
constitutive promoter CaMV 35S in maize. LT-B was quantified using the ganglioside-
dependent ELISA procedure (Haq et al., 1995; Chikwamba et al., 2002). Because 
ganglioside binds only multimeric LT-B protein, these positive ELISA results indicate that 
the protein was being properly assembled in maize tissue. Of the 54 independent P51 
transgenic events, 42 (78%) were shown to express LT-B at levels less than 0.005% of total 
aqueous-extractable protein (TAEP). Nine events (17%) had LT-B protein levels between 
0.005 and 0.01% in TAEP. Only three (6%) of the callus lines had LT-B protein level above 
0.01% in TAEP. A similar range of LT-B expression was observed for P65 transgenic 
events. Of 51 events tested, five callus events (10%) had LT-B levels higher than 0.01% of 
TAEP. The majority of events (90%) had LT-B levels less than 0.01% of TAEP. Maximum 
expression for both constructs (Events P51-62 and P65-69) was 0.04% LT-B of TAEP. 
While the number of events with LT-B protein above 0.01% of TAEP, the SEKDEL 
microsomal retention signal included in the construct pTHK210 (P65) did not substantially 
increase LT-B protein accumulation in maize callus compared with P51 events (Table 1 ). 
The level of LT-B protein in young leaf tissue of P51 and P65 plants was also 
analyzed. In general, LT-B levels in transgenic leaf tissue were consistent with levels in 
corresponding callus tissue, with a few exceptions in which the LT-B level declined in leaf 
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tissue (data not shown). We also observed that plant regeneration, vigor, and seed set were 
generally poor in both P51 and P65 events that showed high expression of LT-B protein in 
callus (data not shown). 
For determination of the level of LT-B protein in seed, R, kernels from each event 
were homogenized manually or mechanically and assayed individually. Based on the levels 
of total protein extracted from kernels using these two methods, there were no differences in 
the protein yield between these two methods. A total of three P51 events and nine P65 
events were tested. Poor seed set was a limiting factor for P51 events. Most events tested 
showed less than 0.005% LT-B in TAEP in whole seed. The maximum level of LT-B 
(0.01% LT-B in TAEP) was detected in one P51 event (P51-62) and one P65 event (P65-69) 
(data not shown). When embryo and endosperm tissue from a single kernel were analyzed 
separately, the LT-B protein was detected primarily but not exclusively in the embryo as 
expected (data not shown). 
Kernel-specific expression of LT-B 
Transgenic maize plants carrying the constructs pRC4 and pRC4-1 (Figure 2C and D) 
were also produced. Since the LT-B gene in these constructs was regulated by the 27 kDa 
gamma zein promoter, a kernel-specific promoter, LT-B expression was not detected in 
callus tissues as expected (data not shown). A total of 19 P77 events and 20 PI 12 events 
were generated. For analysis of the LT-B protein levels in R, kernels, proteins from 20 
kernels per ear representing each event were extracted separately and assayed for LT-B 
expression by ELISA. Data from all LT-B positive kernels in each ear were pooled to 
determine the mean and standard deviation (SD) for each ear. 
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Levels of LT-B accumulation in P77 (one ear per event) and PI 12 (two ears per 
event) are presented in Figures 4 and 5, respectively, and summarized in Table 2. Of 19 LT-
B-expressing P77 events, 11 (58%) had LT-B protein levels higher than 0.01% of TAEP 
(Figure 4). Two events (P77-2 and P77-3) had LT-B levels of up to 0.07%. 
PI 12 transgenic events showed the highest level of LT-B accumulation in R, seeds 
(Figure 5). PI 12 events carry the construct pRC4-l, which included the endoplasmic 
reticulum-retention signal sequence SEKDEL in the C-terminus of LT-B gene. All 15 PI 12 
events tested had LT-B levels of 0.01% or higher (Table 2). In addition, six events had LT-B 
levels higher than 0.1%. One event (PI 12-44) accumulated up to 0.9% of LT-B in TAEP. 
about 13-fold higher than the highest-expressing P77 R, event (P77-3). This is in contrast to 
the observations for transgenic events P51 and P65, in which the SEKDEL motif did not 
increase the LT-B protein level in callus tissue. Inclusion of the SEKDEL motif in the LT-B 
gene under the regulation of the seed-specific promoter greatly enhanced the LT-B level in 
PI 12 events. 
Plant performance comparison 
Compared to transgenic maize plants carrying CaMV 35S promoter/LT-B constructs 
(P51 and P65), plants carrying zein promoter/LT-B constructs (P77 and PI 12) were more 
vigorous in overall performance. Table 3 summarizes the seed set from transgenic lines P51. 
P65, P77, and PI 12. The seed set of P51 was the poorest; only 23% of events set more than 
50 kernels per event. For P65, although the level of assembled LT-B protein did not 
increase, the fertility of transgenic plants was markedly increased over that of P51 plants. 
Sixty-four percent of events set more than 50 seeds. Both P77 and PI 12 had good fertility. 
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Seventy-four percent of P77 events and 55% of PI 12 events produced more than 50 kernels 
per event, respectively. The transgene segregated 1:1 or 3:1 as expected in most cases. 
Evaluation of LT-B protein levels in R2 and R3 seeds 
To evaluate stability of LT-B gene expression under control either of a constitutive 
promoter or a seed-specific promoter over generations, further analysis was performed using 
one event of P51 (Event P51-62) and eight events of P77 (Events P77-2, 3, 7. 9. 10. 11. 17. 
and 18) (Tables 4 and 5). 
P51-62 had the highest LT-B accumulation (0.01% TAEP) in R, seed. Five plants of 
this event were grown in the greenhouse, and two were successfully self-pollinated to 
produce R2 seeds. The LT-B levels measured in R2 seeds had a fourfold increase compared 
with R| kernels, with 0.04% LT-B of TAEP (data not shown). P51-62 R2 seeds were grown 
in the field in the summer of 2001. Transgene-expressing plants were first identified by-
resistance to the herbicide bialaphos sprayed two weeks post emergence and subsequent self-
pollination to produce R3 seeds. LT-B expression was tested in eight ears (20 kernels per 
ear) of event P51-62 (Table 5). Mean expression was obtained from 10 randomly selected 
LT-B expressing kernels. The levels of LT-B varied greatly between ears derived from the 
same event. These values ranged from 0.026% (ear #8) to 0.28% (ear #1) with an average of 
0.14% in TAEP. Within the same ears, large standard deviation values indicate differences 
in expression from kernels on the same ear. The LT-B level in R3 ear #7 (0.28%) represented 
a further six-fold increase when compared with the level in the R2 seed (0.04%). 
Eight P77 events with LT-B levels ranging from 0.017% (Event P77-10) to 0.069% 
(Event P77-3) were followed to the R2 generation. Two to three plants representing each 
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event were self-pollinated to give rise to R3 seeds. Table 4 summarizes the LT-B levels in R, 
seeds (one ear per event) and corresponding R2 seeds (one to two ears per event). The LT-B 
levels in the R, seeds were greatly increased for all events (up to 100-fold in Event P77-9). 
compared with the LT-B levels in R| seeds. While Event P77-7 had a moderate LT-B level 
in R, seed (0.029%), it reached over 2% of TAEP in two ears tested in R? seeds. The R: 
plants of this event were grown in the field in the summer of 2001 for R3 seeds. Results of 
LT-B levels from eight R3 ears representing Event P77-7 are presented in Table 5. 
Significant differences (p>0.0001), were observed between ears descending from the same 
Ri plant, and like P51 R3 kernels, large standard deviations indicate differences in expression 
from kernels on the same ear. The highest reached 3.7% in ear #1. Based on the mass of the 
powder used and the volume of buffer added, the LT-B level in the ear could be expressed as 
350 jag/g or 35 kg/ton LT-B of dry ground kernel. 
Unlike P51 plants, in which the Rj plants produced several-fold more LT-B than the 
Ri generation, differences in LT-B gene expression between the Ri and Rj generations of 
event P77-7 were not very large. Levels of 2-3% observed in the R, generation are within 
the range of expression of most of the P77-7 plants analyzed in the R3 generation, where 
levels of expression varied from 0.5 to 3.7% LT-B in TEAP. 
Discussion 
We describe the generation and characterization of LT-B expressing maize plants 
transformed with four different constructs. Several factors can be manipulated to control the 
level of expression of foreign genes in transgenic plants. These include foreign gene 
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sequence optimization, promoters, terminator sequences, and targeting and retention 
sequences. We examined the role of two of these factors, promoters and the microsomal 
retention signal SEKDEL, in expression of the synthetic LT-B gene and accumulation of the 
functional product in callus and seed. 
For all constructs, transformation was confirmed by PCR analysis of herbicide-
resistant callus clones, followed by genomic Southern blot hybridization analysis of DNA 
from the regenerated plants or their progeny. The rate of co-transformation of bar and LT-B 
genes ranged from 58 to 89% as determined by PCR. Results of Southern blot analysis show 
that most transgenic events had multiple copies of the transgene cassette, ranging from two to 
more than 10 copies in most cases. While we could not conclusively associate the level of 
LT-B expression with transgene copy number within individual constructs, high LT-B 
expression was generally associated with relatively low gene copy number. Event P51 -62 
was estimated to have about three copies of the gene, event P77-7 had about five copies and 
event PI 12-51 had about three copies. All these events had substantially higher LT-B 
expression relative to other events transformed with the same construct. Northern analysis 
was undertaken for the P51 events to determine the size of the transcription unit. An -700-
nucleotide transcript was observed, a size consistent with a transcript containing part of the 
TEV leader, the LT-B gene, and part of the terminator sequence. In most cases, plants that 
were confirmed to be transgenic by Southern blotting were also shown to express the 700-
nucleotide gene transcript in Northern blot analysis and to express the protein in ELISA 
analysis. 
The codon bias of a transgene is important in enhanced expression of a foreign 
protein (Gribskov et al., 1984). Mason et al. (1998) synthesized the LT-B gene used in this 
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study with a codon bias optimized for expression in potato and maize and demonstrated that 
the synthetic gene could be expressed in potato. The construct pTH210 (P51). with the 
constitutive CaMV 35S promoter, was used to determine if the codon usage in the synthetic 
LT-B gene had been adequately optimized for expression in maize. Expression of LT-B in 
callus of P51 and P65 events indicated that the synthetic LT-B gene was adequately 
optimized for expression in maize. LT-B levels in both P51 and P65 plants varied 
considerably between events, and did not exceed 0.04% of aqueous extractable protein. 
We observed that transgenic callus events with high levels of LT-B protein in P51 but 
not P65 were associated with poor plant growth and fertility. Reduced performance in plant 
growth, vigor, and seed set in P51 plants relative to plants carrying other constructs could be 
attributed to several possible causes. Poor plant performance in some events could have been 
induced by in vitro tissue culture stress. Alternatively, it could be attributed to possible toxic 
effects of the LT-B protein in the tissues of the growing plant and tissues involved in seed 
development. We did not examine enough high LT-B-expressing P51 and P65 events to 
distinguish between these possibilities. This phenomenon was also observed by Mason et al. 
(1998) in transgenic potato plants producing high levels of LT-B protein. One of their 
higher-expressing transgenic potato events had poor growth and stunting, leading to the 
speculation that LT-B could in fact be toxic if expressed in the growing plant cells. P65 
events did not have enhanced expression but had improved plant vigor compared with P51 
plants. Retention of the LT-B protein in the ER could have limited its secretion into the cell 
wall and thus have reduced the effect of the protein on cell growth. It was concluded that 
low LT-B expression levels with the CaMV 35S promoter warranted investigation of LT-B 
expression using a seed-specific promoter. 
51 
Zeins constitute 50-60% of the seed protein in maize (Marks et al., 1985), and the 27 
kDa gamma zein promoter is one of the strongest seed-specific promoters characterized to 
date. Substantially higher levels of LT-B expression were observed in the R, kernels of P77. 
up to 0.07% LT-B in TAEP, compared with 0.01% in P51 R, kernels. In the R> generation, 
the gamma zein promoter resulted in 13-fold higher levels (0.28% in P51-62 compared with 
3.7% in P77-7) of LT-B in the seed than the constitutive CaMV 35S promoter. In P77 plants. 
LT-B protein accumulation was observed predominantly in the endosperm. This was 
determined through embryo vs. endosperm extraction and quantitation of LT-B (data not 
shown). Events from PI 12 had the highest level of expression in the R, seed (Figure 5). 
Since this construct was identical to P77 except for the SEKDEL motif included in the LT-B 
gene in construct pRC4-l, this increase in LT-B level could be attributed to the presence of 
this endoplasmic reticulum-retention sequence in the transgenic plants carrying pRC4-l. The 
SEKDEL motif is expected to sequester the protein in the ER (Munro and Pelham, 1987). 
Haq et al. (1995) showed that the SEKDEL motif resulted in significantly higher LT-B 
accumulation when compared with the LT-B gene without SEKDEL. These authors 
proposed that the cellular compartmentation of the SEKDEL protein could have facilitated 
oligomerization of LT-B monomers into pentamers detectable by ganglioside-dependent 
ELISA. We observed no marked increase in the level of LT-B protein in maize callus of P65 
events in which the LT-B gene had the SEKDEL motif compared with P51 callus events, 
which did not. Why the enhancement effect of the SEKDEL motif was not observed in 
callus is not clear. It is possible that callus is a tissue that inherently does not contain as 
much protein as seed, and so does not accumulate protein beyond a certain level. No 
substantial SEKDEL enhanced expression was observed in kernels using the constitutive 
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promoter either; the highest level of expression observed in P65 R, kernels was 0.01% in 
event P65-69. 
There appears to be an interaction between promoter and/or target tissue and the 
SEKDEL motif. More likely there is an interaction between the tissue and the SEKDEL 
motif; SEKDEL works in some tissues better than others due to differences in 
endomembrane system functions. To propose promoter SEKDEL interaction would imply 
interaction at the DNA level, which could be possible but not likely. These observations 
suggest the possible benefits of using the SEKDEL motif in improving the expression of a 
novel protein in maize kernels could be dependent on target tissue and promoter used, among 
other factors. 
In all constructs, variability in LT-B levels was observed in plants from different 
transgenic events in all generations studied, and also between plants within the same event. 
Variability between events within the same generation could be explained as differences in 
transgene copy number and position effects in independently transformed events. Plants 
representing different transgenic events for each construct were analyzed for the presence of 
the LT-B gene by Southern blot analysis. The LT-B gene copy number in most cases was 
present in multiple copies for all constructs, ranging from two to greater than ten. Plants 
from the same transgenic event appeared to have the same band pattern as expected. 
However, despite having similar genetic makeup, significant differences in LT-B expression 
were sometimes observed between plants from the same event, especially in the R; 
generation (Table 5). Large standard deviation values were observed for kernels within the 
same ear. While some of this deviation could be attributed to experimental error, 
measurement of sample values in duplicate for each kernel was undertaken to reduce the 
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measurement error and so most of this variation is not due to experimental. Hood et al. 
(1997) observed variation of avidin expression ranging from 2.1% to 5.7% of aqueous-
extractable protein between plants within the same transgenic event. These observed 
variations between individual plants in the same event are less readily explained. Some 
variation could be attributed to the microenvironment in which the plants developed, and 
some could be attributed to the genotypes of the plants. While the plants should be similar in 
genetic makeup, the Hi ll germplasm used for transformation was generated from crossing 
Hi-11 parents A and B, which are derived from the inbred lines A188 and B73. The 
germplasm is therefore to a certain extent heterozygous and segregating to give some of the 
observed variation (Armstrong at al., 1991; M. Lee, personal communication). Some of the 
variation could be attributed to epigenetic effects. Other researchers have reported similar 
variation and proceeded to select the highest-expressing plant for subsequent generations 
(Zhong et al., 1999). These observations have important implications for commercial 
production of a novel protein. It cannot be assumed that plants from the same event have 
similar levels of expression, and it may take several generations of selection of individual 
lines to establish a stable transgenic line with a desired and consistent level of transgene 
expression. 
Substantial increases in LT-B protein were observed between subsequent generations 
for both P51 and P77 events. In one case an increase of more than a 100-fold was achieved 
(Event P77-9, Table 4). It is possible that a foreign protein is poorly expressed in the R, 
generation because of the stress of the in vitro culture, transformation, and regeneration 
processes. Self-pollination in subsequent generations may increase the dose of the transgene 
in the endosperm, which might result in increased LT-B levels. Other workers have observed 
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that subsequent generations have been shown to have increasing novel protein levels relative 
to the R| generation (Zhong et al., 1999). 
In the expression of an antigen in maize, the issue of dosage requirement is critical. 
Using the gamma zein promoter, LT-B levels of up to 350 |ig/g of dry kernel tissue were 
attained. This is more than was required to induce a protective immune response in 
experimental mice. Mason et al. (1998) suggested that up to 1.1 mg would be required to 
induce a protective immune response in humans, and this dosage requirement could be met in 
3g grams of dry maize meal. We harvested three generations of functional LT-B-expressing 
plants; the gene was not silenced in these generations and transmission was in a normal 
Mendelian fashion. Assays of LT-B in greenhouse and field showed an increase in 
expression of LT-B over the generations. Stability of expression is critical for high-
expressing events that would be used for protein production in a practical situation. 
Variation in protein expression would have important implications on the amount of maize 
required for a specific dosage under direct administration or for product purification. In this 
study, the observed variation in LT-B levels could be attributed to environmental effects, 
segregation of the Hi-II background, epigenetic regulation of the transgene. or a combined 
effect of all these factors. Our observations have important implications on how to select the 
transgenic event with the appropriate level of gene expression for practical production of the 
candidate protein. The gamma zein promoter is certainly better than the CaMV 35S the 
promoter of choice for seed expression of LT-B, directing gene expression in the target organ 
at levels required for dosage. Other modifications such as the SEKDEL motif show a 
marked improvement in expression of this gene when combined with the gamma zein 
promoter. Out-crossing the transgenic plants to an elite line with good agronomic qualities 
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could potentially enhance the absolute amount of LT-B produced even further by increasing 
general agronomic performance. 
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Construct Transgenic LT-B 
maize expression 
event ID in 
PUC19 
Hind III Xho I Nco I Kpn I EcoRI 
35S Promoter 
pucie 
pTH210 P51 Callus and 
whole plant 
B. 
PUC19 
Hind III Xho I Nco I Kpn I EcoR I 
35S Promoter 
BSP 1ÏEKDEL* 
pucie 
pTHK210 P6S Callus and 
whole plant 
Hind ill 
PUC19 
• zein Promoter 
Xho I Nco I KpnI EcoR I 
PUC19 
pRC4 P77 Seed 
D. 
PUC19 
Hind Xho I Nco I Kpn I EcoR I 
zein Promoter 
Tvsp 
I PUC19 
BSP "Sekdel* 
pRC4-1 P112 Seed 
Figure 1. Schematic diagram of constructs used for maize transformation to generate LT-B-
expressing transgenic plants. All constructs contain the synthetic gene encoding the B 
subunit of LT in pUC19 vector background. 35S Promoter, CaMV 35S promoter; y-zein 
promoter, 27 kDa gamma zein promoter from maize; TEV, tobacco etch virus translations! 
enhancer leader sequence; sLT-B, the synthetic LT-B gene; Tvsp, soybean vegetative storage 
terminator; SEKDEL, endoplasmic reticulum-retention sequence motif; BSP, bacterial signal 
peptide from LT. 
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P51 Events P112 Events 
Figure 2. Southern blot of total leaf genomic DNA of P51 (A) and PI 12 (B) events digested 
with Hind III and Nco I respectively and probed with the LT-B gene. 
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Figure 3. Northern blot (A) analysis of total leaf RNA of P51 (B) probed with a ":"P-labeled 
LT-B gene fragment RNA from non-transgenic B73 plant used as negative control. 
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Figure 4. LT-B level (% in total aqueous extractable protein) in R1 seeds of P77 events. 
Error bars represent ± standard deviation. 
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Figure 5. LT-B [% in total aqueous extractable protein TAEP in RI seeds of PI 12 events. Data from ears in the same event 
are shaded similarly. Errors bars indicate ± standard deviation. 
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Transgenic 
plant ID 
Total # events 
tested 
# Events expressing LT-B at various levels* 
<0.005 0.005-0.01 0.01-0.04 
P51 
P65 
54 
51 
42 
33 
9 
13 
3 
5 
* Level of assembled LT-B protein in total aqueous extractable protein was determined by 
ganglioside-dependent ELISA. 
Table 1. Level of assembled LT-B protein (% LT-B in total aqueous-extractable protein) in 
transgenic maize callus. 
Transgenic Total # # Events expressing LT-B at various levels* 
plant ID events 
tested <0.005 0.005-0.01 0.01-0.1 >0.1 
P77 19 2 6 H Ô~~ 
PI 12 15 0 0 9 6 
* Level of assembled LT-B protein in total aqueous extractable protein was determined by 
ganglioside-dependent ELISA. 
Table 2. Level of assembled LT-B protein (% LT-B in total aqueous-extractable protein) in 
R1 transgenic seeds. 
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Transgenic Total # # of events with seed set* % events set 
plant ID events seed >50 
tested 0 <50 50-100 101-200 kernels 
P51 13 5 5 1 2 23 
P65 14 0 5 7 2 64 
P77 19 0 5 5 9 74 
PI 12 20 1 8 8 3 55 
Table 3. Summary of seed set from transgenic maize carrying four different constructs 
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Ri seed 
Event ID Mean SD 
Rzseed 
Ear ID Mean SD 
Fold increase 
(R2/R1) 
3 
7 
9 
10 
11 
17 
18 
0.068 0.015 1.155 
1.356 
0.342 
0.029 0.008 0.816 
0.817 
OOlSr 
0.005 0.017 0.324 
0.327 
0.141 
0.140 
0.023 0.005 17-1 0.127 0.057 
18.5 
9.1 
84.5 
104.7 
19.3 
14.3 
5.6 
16.9 
Table 4. Levels of assembled LT-B protein (% LT-B in total aqueous-extractable 
protein) in R, and R., seeds of P77. 
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Event ED Ear ID Mean SD t Grouping* 
P51-62 1 0.282 0.168 a 
2 0.252 0.199 a 
3 0.183 0.111 ab 
4 0.167 0.039 b 
5 0.166 0.091 abc 
6 0.148 0.052 c 
7 0.121 0.086 cd 
8 0.026 0.019 d 
P77-7 1 3.660 2.740 a 
2 2.096 1.334 b 
3 1.743 1.094 be 
4 1.350 0.552 be 
5 1.318 0.780 be 
6 1.299 0.752 bed 
7 0.949 0.659 cd 
8 0.190 0.123 d 
* values with same letter(s) were not significantly different from each other (p>0.05). 
Table 5. Comparison of LT-B levels (% LT-B in total aqueous extractable protein) in 
R3 seed of P51 and P77. 
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CHAPTER 3 
Localization of a bacterial antigen in starch granules of transgenic maize 
kernels 
Rachel Chikwamba, Paul Scott, Hugh Mason, Kan Wang (Authorship Tentative) 
Manuscript in preparation. 
Abstract 
The B subunit of Escherichia coli heat labile enterotoxin (LT-B) is a potent oral 
immunogen, with potential for use as a vaccine and an adjuvant to other co-administered 
vaccine antigens. LT-B expressed in plants was shown to be functional and immunogenic in 
animals and humans. Using immunogold labeling/electronmicroscopy and western analysis, 
we show here that the LT-B proteins with the native bacterial signal peptide (BSP), 
accumulate in starch granules of transgenic maize kernels. No LT-B accumulation in starch 
granules was observed when a signal peptide from maize 27 kDa y-zein protein was used to 
replace BSP in LT-B production. This represents the first case in which a bacterial protein 
with a native signal peptide is transported into the starch granules of a higher plant. 
Introduction 
The Escherichia coli heat labile enterotoxin B subunit (LT-B), a potent oral 
immunogen, has been used as a model antigen to demonstrate the feasibility of producing an 
effective oral vaccine in transgenic plants (Mason et al., 1998, Streatfield et al., 2001, 
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Chikwamba et al., 2002). Orally administered LT-B has been shown to elicit strong mucosal 
and serum antibody responses. When administered together with other antigens, LT-B 
stimulates strong immune responses to the co-fed proteins. LT-B's receptor binding capacity 
in the gut makes it an ideal adjuvant and carrier molecule for the delivery of other antigenic 
epitopes to the gut's mucosal system (Spangler 1992). 
The likelihood of protein degradation in the stomach and uncertainty about the 
effectiveness of orally delivered antigens have raised concerns about the oral vaccination 
approach. The delivery of an oral vaccine in transgenic plant tissue could protect it from the 
low pH and digestive enzymes of the stomach as well as and prolong the antigen's exposure 
to the gut's immune system. The sub-cellular location of any novel protein expressed in 
plants is also important for their accumulation, folding and assembly, and, depending on their 
intended use, may have an effect on their functionality (Hood et al, 1997). Proteins are 
commonly targeted to extracytosolic compartments in both eukaryotic and prokaryotic cells, 
and this occurs by a variety of mechanisms. Translocation mechanisms usually involve the 
synthesis of a protein with a specific targeting signal, and the recognition of this signal by the 
appropriate translocation machinery (Walter, 1994). Numerous bacterial and viral proteins 
have been produced in transgenic plants. Some proteins could be transported into 
chloroplasts when they were fused to a chloroplast-targeting domain. However, little is 
known about the sub-cellular destinations for those prokaryotic proteins produced in 
transgenic plants with their native signal peptides. In this study, we examined the sub­
cellular localization of the LT-B protein in transgenic maize kernels. 
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Materials and Methods 
Constructs for maize transformation 
A synthetic LT-B coding sequence (sLT-B) with codon usage optimized for both 
potato and maize expression was fused to DNA sequences encoding either the native LT-B 
signal peptide (BSP; Mason et al., 1998) or maize 27 kDa gamma zein signal peptide (ZSP; 
Marks et al., 1985), as described in Figure 1. The LT-B gene cassettes were regulated by the 
27 kDa gamma zein promoter, an endosperm specific promoter. 
Maize transformation and plant regeneration 
Transgenic maize plants carrying constructs P77 and P81 were generated using the 
biolistic gun method (Frame et al., 2000) and transgenic plants were grown to maturity in the 
greenhouse. Over twenty independent transformation events from each construct were 
evaluated for the expression of the LT-B gene in kernel. 
Evaluation of LT-B expression 
Evaluation of LT-B expression was performed in transgenic maize kernels using 
ganglioside dependent enzyme linked immunosorbent assay as described by Chikwamba et al 
(2002). 
Fixation of tissue for immunolocalization 
Immature (23 days post-pollination) and mature (dried) maize kernels were sectioned 
in fixative (0.1 M carcodylate buffer, 0.5% gluteraldehyde and 2% paraformaldehyde). 
Tissue blocks were incubated in fixative for 2 hours at 4°C and rinsed three times in 0.1 M 
carcodylate buffer; 15 minutes each wash, on a rotating shaker. This was followed by a 
succession of dehydrating treatments as follows; tissue blocks were rinsed with 50% ethanol 
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for 15 minutes on a rotating shaker, followed by incubation with 70% ethanol for 2 hours at 
room temperature. The 70% ethanol was removed and replaced with 95% ethanol for a two-
hour incubation, followed by three two-hour incubations with 100% ethanol. Tissue blocks 
were then incubated in a gradually increasing white London Resin (LR white), starting with 
1:3, 2:1, 3:1 (V:V) LR white to ethanol for 8-12 hours each time and finally with 100% LR 
white overnight. Incubation in pure LR white was repeated twice for 8-12 hours each time 
after which the tissue blocks were cast for in gelatin capsules for 24-48 hours at 60°C. Ultra 
thin sections were cut and mounted on grids for scanning transmission electron microscope 
(STEM) by the Bessey Microscopy Facility at the Iowa State University. 
Immunogold labeling 
To detect sub-cellular localization of LT-B expression in transgenic maize kernels, 
tissues were analyzed by immunogold labeling at electron microscopic level following 
fixation of kernel tissue. Kernel sections mounted on grids were incubated in TBS blocking 
buffer [0.05M Tris, pH8.3, 0.85% NaCl, supplemented with 0.5% BSA, 0.5% normal donkey 
serum and 3% dry milk] for 2 hours at room temperature. This was followed by incubation of 
grids in goat anti-LT-B polyclonal sera (KPL) diluted 1:100 (V:V) in blocking buffer for two 
hours at 37°C. Negative control grids were incubated in fresh blocking buffer. Grids were 
washed three times, 10 minutes each wash in TBS buffer supplemented with 0.5% normal 
donkey serum and 0.5% BSA (no milk), and incubated at room temperature in donkey anti-
goat polyclonal serum conjugated to 18nm gold, diluted 1:20 (V:V) in TBS buffer 
supplemented with 0.5% normal donkey serum and 0.5% BSA, 0.1% fish gelatin. Grids 
were washed three times, 10 minutes each wash in distilled water and allowed to air dry. 
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Starch isolation 
To isolate starch, dry kernels were soaked in glass vials containing 2 to 4 mis of 
0.45% Na^SiOs for 3 days, and the pericarp and embryo were removed using a razor blade. 
Endosperms were placed into a 50ml conical tube with 10ml water and homogenized with 
polytron. The polytron was rinsed three times with water in between samples. Homogenate 
was filtered with the aid of a vacuum pump through plastic Millipore stopper apparatus 
(250ml) with a 30gM nylon filter cut to size (Spectrum cat# 146506) in a side-arm flask, and 
the filtrate collected in a 50ml conical tube. Homogenates were allowed to settle at for at 
least one and a half hours at 4°C. Water was removed from the sample by aspiration, and the 
remaining starch water slurry transferred to a 2ml tube and the slurry was centrifuged at low 
speed for 5 minutes. Water was carefully removed and the starch washed three times with 
1.5ml water. The starch was again washed three times with one of three reagents, 75% 
ethanol, 95% ethanol or 75% ethanol with 3% P-mercaptoethanol. Samples were dried 
completely in a speed-vac. To remove exogenous proteins, samples were incubated with 
5mM CaCli with lOOng/ml Thermolysin (Sigma) at 62°C for about 16 hours (overnight). 
Samples were then boiled in SDS sample buffer (1 ml per 50mg starch) for 10 minutes at 
100°C for western analysis. 
Western Blot analyses 
Western blot analyses were performed with goat polyclonal serum against LT-B 
followed by goat anti-rabbit polyclonal serum conjugated to alkaline phosphatase as 
described (Chikwamba et al, 2002, Chapter 4). 
75 
Results and discussion 
The maize-synthesized LT-B proteins produced by plants carrying the BSP/sLT-B 
construct (P77) were structurally and functionally identical to the bacterium-derived LT-B 
protein. Oral immunization with maize-synthesized LT-B induced a strong immune response 
in BALB/c mice, protecting them from challenge with the E. coli labile toxin (LT) and its 
homologue Cholera toxin (CT) (Chikwamba et al, 2002, Chapter 4 of dissertation). 
Immunogold labeling was used to detect the sub-cellular localization of LT-B within 
transgenic maize kernels. Ultra thin sections of 23-day old immature kernels from P77 
transgenic maize plants were processed as described and viewed under the transmission 
electron microscope. As shown in Figure 2B, LT-B protein was detected exclusively in the 
starch granules within the amyloplasts of immature kernels of P77. No gold particles could 
be detected in the non-transgenic maize immature kernel control (Figure 2C). In P77 kernels, 
gold particles were not detected near or within cell walls, intercellular spaces, in the 
endoplasmic reticulum (ER), Golgi apparatus or secretory vesicles. 
To distinguish whether the LT-B proteins were localized at the surface or inside of 
the starch granules, starch samples from mature transgenic seeds were collected, treated to 
remove surface proteins and examined using western analysis. The approach was based on 
the fact that polypeptides that are within the starch granules are not susceptible to hydrolysis 
upon treatment of intact granules with exogenous proteases (Mu-Forster and Wasserman, 
1998). Starch samples were isolated from individual mature kernels of transgenic maize P77, 
using three different methods (75% ethanol, 95% ethanol or 75% ethanol plus 3% (3-
mercaptoethanol) to remove external proteins. The starch samples were then treated with 
Thermolysin overnight to remove the remaining external proteins that were not embedded in 
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the starch granules. The samples were washed 5 times in 1.5 ml distilled water to remove the 
Thermolysin. The samples were boiled to release any proteins that are embedded in starch. 
Duplicated gels containing equal amounts of protein sample were analyzed by western 
blotting using antibodies against either LT-B or zein proteins. The zein proteins are the 
major seed storage protein in maize, comprising 50-60% of endosperm protein (Marks et al. 
1985) and are localized outside of the starch granules (Mu-Forster and Wasserman, 1998). 
We used the zein antibody as a control to indicate the presence or absence of the external 
proteins of starch samples. As shown in Figure 3 A and B, both LT-B and zein proteins could 
be detected in the starch preparation treatments using 75% or 95% ethanol (Lanes 2 and 3). 
However, only LT-B protein could be detected when the starch samples were prepared from 
the treatment of 75% ethanol plus 3% B-mercaptoethanol (Lanes 1). LT-B was not detected 
in non-transgenic samples following any of the treatments (Lane 4 in Figure 3A&B). This 
result strongly indicated that the LT-B proteins were present within the starch granules. This 
further confirmed the observation made with immunogold localization that LT-B proteins 
localized in starch granules of immature kernels. 
To verify whether the starch localization of LT-B protein required the bacterial signal 
peptide, starch samples of transgenic maize kernels (P81) carrying construct ZSP/sLT-B 
cassette (Figure IB) were prepared as for P77. In contrast to P77 starch sample, P81 starch 
sample treated with the 75% ethanol plus 3% B-mercaptoethanol showed no accumulation of 
LT-B proteins inside of the starch granules (Lanes 3 vs 4, Figure 3C), while the LT-B could 
be detected in P81 seed (Lane 2, Figure 3C). This result indicated that the native signal 
peptide of LT-B is necessary for the starch localization of the LT-B protein in transgenic 
maize kernel. 
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We have demonstrated here the localization of a bacterial protein with its native 
signal peptide in the starch granules of transgenic maize seed. This observation was contrary 
to our expectation, in which LT-B protein in transgenic maize kernels would be ER targeted 
and ultimately secreted to the extracellular spaces (Ellgaard et al, 1999). In E. coli, LT-B is 
targeted to the periplasmic space (Hirst et al., 1995). LT-B expressed in yeast was shown to 
be ER targeted, assembled into pentamers and retained within the endomembrane system 
without secretion (Schonberger et al., 1991). Studies in E. coli showed that enzyme-
catalyzed disulfide bond formation was necessary for LT-B assembly (Hirst et al., 1995), and 
in eukaryotic cells this process is facilitated by protein disulfide isomerase (PDI) in the ER. 
The ER is the site of synthesis and maturation of proteins destined for secretion, for the 
plasma membrane, and for the secretory and endocytic organelles. Mason et al, (1998) 
expressed LT-B in potato tubers and speculated it to be targeted to the ER where the essential 
enzymes that catalyze folding reside. In plants, the default pathway for proteins that are 
transported through the ER is secretion, although a protein's ultimate sub-cellular 
localization may also depend on factors other than just the presence of signal sequence, 
including topological information on the protein itself (Stachelin and Moore, 1995). 
Molecular weight analysis in SDS-PAGE (Chikwamba et al., 2002) of maize-
synthesized LT-B protein indicated that the peptide had an apparent mass 11.6 kDa, which is 
consistent with the expected mass of LT-B from which the signal peptide was removed. The 
combination of this with the observation that no LT-B accumulation in starch was detected 
when the bacterial signal peptide was replaced with the zein signal peptide described in this 
study provide evidence that the 21 amino acid LT-B signal peptide is responsible for the 
targeting of LT-B into the amyloplast, where it is then integrated into the starch granules. 
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Computer analysis on the signal peptide (Signal? VI.1 World Wide Web Server) did not 
reveal any obvious sequence characteristic of plastid targeting peptides. 
The mechanism for the plant starch granule targeting by a signal peptide bacterial 
protein described in this study is not clear. It is possible that the bacterial signal peptide can 
target the conjugated protein into a plant plastid, due to its prokaryotic origin (Shih et al.. 
1986). Most plastid proteins are nuclear encoded, synthesized as large precursors in the 
cytosol and post-translationally imported into the organelle, and into the appropriate 
compartments across outer and inner membranes. Protein entry into the stroma plastids has 
been termed the general import pathway and is directed by the stroma-targeting domains in 
transit peptides (Cline and Henry, 1996). The majority of precursor proteins have a cleavable 
transit peptide, which includes a stromal targeting domain that initiates transport of the 
precursor through the general import pathway (von Heijne et al, 1989). Using the barley 
aleurone a-amylase signal peptide, During et al (1990) successfully targeted immunoglobulin 
chains to intracellular spaces in transgenic tobacco. This group observed localization of the 
assembled monoclonal antibodies in the endoplasmic reticulum and unexpectedly, in the 
chloroplasts. No particular features of the immunoglobulins they were working with were 
expected to target the chloroplasts, and therefore they could not explain the specific 
localization, which they observed. The fact that the antibodies were assembled in 
chloroplasts suggests that there may be folding machinery in the organelles, which can 
handle external proteins. 
It is also possible a retro-translocation mechanism is involved, where by proteins are 
exported from the lumen or membrane of the ER into the cytosol (Tsai et al, 2002). 
However, in such a case, the LT-B proteins would be targeted to the ER with the amyloplast 
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as the final destination. This process would require a mechanism for the relocation of the 
LT-B out of the ER into the cytoplasm, and from the cytoplasm into the amyloplast. where 
the LT-B then becomes imbedded in starch as observed. Retro-translocation is poorly 
understood, and it is thought to be involved in the quality control of proteins, where 
misfolded proteins are returned to the cytosol and degraded (Tsai et al, 2002). Retro-
translocation from the ER has been reported for the translocation of the A subunits of the 
Cholera and E. coli labile toxins (Lord and Roberts, 1998, Sandvig et al, 2000. Tsai et al, 
2002). Whether the B subunits undergo a similar process was not determined. Analysis of 
LT-B (SOSUI, World Wide Web Server) shows two major hydrophobic domains other than 
the signal peptide. The presence of these hydrophobic domains on the LT-B protein, 
suggests that this method of translocation could be responsible for the exit of LT-B from the 
ER, if it was targeted there to begin with. In this scenario, the subsequent insertion into the 
amyloplast could occur as described for transportation of a protein without a cleavable signal 
peptide. At least one pathway has been elucidated for translocation of peptides without a 
cleavable signal into the amyloplast. Insertion of these proteins does not require hydrolysis 
of nucleotide triphosphates, nor does it appear to depend on the proteins of the plastid 
membranes. It is likely that the partitioning into the lipid bilayer of hydrophobic domains 
within these proteins controls their insertion into the membrane (Li and Chen, 1996). 
Further investigation on the starch targeting property of the LT-B signal peptide using 
marker genes will contribute to the elucidation of mechanisms of protein translocation to 
plastids. In addition, the localization of LT-B protein in maize starch has important 
implications on the effectiveness of a maize-based vaccine. Animal studies (Chikwamba et 
al, 2002) showed that mice orally immunized with maize meal expressing LT-B induced a 
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much higher serum and mucosal response than non-transgenic maize meal mixed with an 
equivalent amount of bacterial LT-B. Encapsulation of the antigen in starch granules could 
result in protection from the harsh environment of the stomach and possibly in slow release 
from the starch and a consequent prolonged exposure of antigen to the gut associated 
mucosal system. The bacterial signal peptide could find utility in encapsulation of novel 
proteins in starch. By translationally fusing a novel protein to the LT-B signal peptide, the 
novel protein could be targeted within the starch grain, and because starch extraction from 
maize is a well established procedure, protein extraction would be greatly facilitated. 
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pUC19 pUC19 
Figure 1. Schematic diagram of constructs used for maize callus transformation to generate 
LT-B-expressing transgenic plants. Both constructs are in a pUC19 vector and contain the 
maize 27 kDa; TEV, tobacco etch virus trans lational enhancer leader sequence; sLT-B. the 
synthetic LT-B gene; The Tvsp, soybean vegetative storage terminator; BSP, bacterial signal 
peptide from LT-B; ZSP, bacterial signal peptide from the maize 27kDa zein protein. Amino 
acids constituting each signal peptide are shown in their single letter form. 
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Figure 2. Immunolocalization of LT-B in immature maize kernels. (A) Section of maize 
kernel showing a cell beneath the aleurone layer, CM, cell membrane, N; nucleus, S; starch 
granules. (B) and (D), P77 transgenic kernel showing LT-B localization in starch grains, 
indicated by arrows. D is a close up of B. (C), Non-transgenic maize kernel as negative 
showing no gold labeling. . 
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Figure 3. Western blot analyses of total proteins from starch samples treated to remove 
external proteins. Starch samples from mature maize seeds were treated with three different 
ethanol treatments prior to Thermolysin treatment as described in materials and methods. 
Samples were then boiled for 10 minutes at 100°C to release granule bound starch. Proteins 
were separated on a 12% SDS-PAGE and transferred to a 0.45 micron nitrocellulose 
membrane and probed with goat anti-LT-B antibodies (A, C) or rabbit anti-zein antibodies 
(B), followed by rabbit anti-goat and goat anti-rabbit alkaline phosphatase conjugate 
respectively. (A and B), P77 transgenic starch treated with 75% ethanol plus 3% (3-
mercaptoethanol (Lane 1); 95% ethanol (Lane 2), 75% ethanol (Lane 3), B73 treated with 
75% ethanol plus 3% P-mercaptoethanol (Lane 4), respectively. (C), P77 transgenic kernel 
starch washed with 75% ethanol plus 3% P-mercaptoethanol (Lane 1), P81 starch sample 
washed with 75% ethanol plus 3% P-mercaptoethanol (Lane 2), P81 transgenic kernel total 
protein extracts (Lane 3). 
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CHAPTER 4 
A functional antigen in a practical crop: LT-B producing maize protects 
mice against Escherichia coli heat labile enterotoxin (LT) and Cholera 
Toxin (CT) 
Transgenic Research 1122: 1-15 (2002) 
Rachel Chikwamba, Joan Cunnick, Diane Hathaway, Jennifer McMurray, Hugh Mason. Kan 
Wang 
Key Words: transgenic maize, plant-synthesized edible vaccine, functional LT-B. oral 
immunization, serum and mucosal immunity. 
Abstract 
We have produced a functional heat labile enterotoxin (LT-) B subunit of Escherichia 
coli in maize. LT-B is a multimeric protein that presents an ideal model for an edible 
vaccine, displaying stability in the gut and inducing mucosal and systemic immune 
responses. Transgenic maize was engineered to synthesize the LT-B polypeptides, which 
assembled into oligomeric structures with affinity for Gmi gangliosides. We orally 
immunized BALB/c mice by feeding transgenic maize meal expressing LT-B or 
nontransgenic maize meal spiked with bacterial LT-B. Both treatments stimulated elevated 
IgA and IgG antibodies against LT-B and the closely related cholera toxin B subunit (CT-B) 
in serum, and elevated IgA in fecal pellets. The transgenic maize induced a higher anti-LT-B 
and anti-CT-B mucosal and serum IgA response compared to the equivalent amount of 
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bacterial LT-B spiked into maize. Following challenge by oral administration of the diarrhea 
inducing toxins LT and CT, transgenic maize-fed mice displayed reduced fluid accumulation 
in the gut compared to non-immunized mice. Moreover, the gut to carcass ratio of 
immunized mice was not significantly different from the PBS (non-toxin) challenged control 
group. We concluded that maize synthesized LT-B had features of the native bacterial LT-B 
such as molecular weight, Gmi binding ability, and induction of serum and mucosal 
immunity. We have demonstrated that maize, a major food and feed ingredient, can be 
efficiently transformed to produce, accumulate and store a fully assembled and functional 
candidate vaccine antigen. 
Abbreviations: E. coli: Escherichia coli; LT-B: labile toxin B subunit; PMSF: 
phenylmethanesulfonyl fluoride; PBS: phosphate buffered saline; SDS-PAGE: sodium 
dodecyl sulfate polyacrylamide gel electrophoresis; BSA: Bovine serum albumin; ELISA: 
enzyme linked immunosorbent assay; EDTA: ethylene-diamine tetraacetic acid; Tris: Tris 
hydroxymethyl aminomethane; Gmi: galactosyl-N-acetylgalactosamyl-sialyl-
galactosylglucosyl ceramide. 
Introduction 
The E. coli heat labile enterotoxin B subunit protein (LT-B) has qualities of an ideal 
oral vaccine, showing stability upon ingestion resulting in stimulation of secretory IgA 
antibodies against specific virulence determinants of invading pathogens in the gut. 
Functional LT-B is synthesized as monomers, which assemble into pentameric structures 
with high affinity for Gmi (galactosyl-N-acetylgalactosamyl-sialyl-galactosylglucosyl 
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ceramide) gangliosides. It is a potent oral immunogen and has been demonstrated to elicit 
specific serum and mucosal antibodies (Spangler, 1992; Dickinson and Clements, 1996). In 
addition, the protein is relatively small and has immunological and other physiochemical 
properties that could be readily tested to determine its functionality. These features made it 
an ideal gene for plant expression and production. 
The potential of crop plants for the production of biopharmaceuticals and other novel 
proteins is beginning to be realized. To date, efforts to produce these proteins in plants have 
focused on the dicotyledonary plants such as potato, tobacco, alfalfa and Arabidopsis (Moffat 
et al., 1995; Kusnadi et al., 1997; Mason et al., 1996; 1998; Tackaberry et al., 1999). These 
plants have well established and reliable transformation procedures via Agrobacterium 
tumefaciens-mediated transformation. Other attractive attributes of these plants include 
production of large volumes of green tissue in tobacco and alfalfa, which can produce several 
crops per year by cutting back foliage. Annual yields can be 25 and >100 metric tonnes 
(MT) per hectare for alfalfa and tobacco, respectively (Daniell et al., 2001). However, these 
plants have their drawbacks, especially for the purpose of convenient oral vaccine production 
and delivery. Green leaf tissues in which proteins are produced in these plants tend to have 
high amounts of phenolic and other potentially toxic compounds. Tobacco and Arabidopsis 
are not palatable, necessitating a purification or extraction step, which may add to the cost of 
production. An advantage of producing pharmaceuticals in potato is that the tuber is a good 
tissue for production and storage of proteins. Nevertheless, potato may require cooking to 
improve its palatability. Arakawa et al. (1998) have shown that boiling CT-B generating 
transgenic potato denatures up to 50% of the antigen. By contrast, although yields of cereal 
grains such as wheat, rice and maize are less abundant than that of the green tissues of 
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tobacco and alfalfa, high seed production in these plants makes scaling up quite easy. Unlike 
proteins synthesized in vegetative plant tissues, seed storage proteins are compartmentalized 
in protein bodies, specialized vacuoles in mature seed. These provide a stable environment 
devoid of significant amounts of enzyme activity prior to germination. Another advantage of 
producing functional proteins in cereal grains is the stability of protein during long-term 
storage. Levels of scFV antibody in rice seeds or tubers did not show a significant decline 
after storage at room temperature for 6 months (reviewed by Daniell et al., 2001). 
Maize is a convenient and practical crop for production of an edible vaccine. It has 
high yield, is a major ingredient in livestock feed and is a staple food in many countries. 
Additionally, maize does not require extensive heat during processing, which might lead to 
denaturation of antigens, among other advantages. 
Work by Mason et al. (1998) and Tacket et al. (1998) showed that potato produced 
LT-B subunits were capable of inducing both systemic and mucosal antibodies in mice and 
humans respectively. In this study we investigated the ability of maize-synthesized LT-B to 
retain properties of the native bacterial protein such as antigenicity, pentameric structure. 
Gmi ganglioside receptor binding capacity, and immunogenicity in mice. We used maize the 
gamma zein promoter (Marks et al., 1985), a seed endosperm specific promoter, to direct LT-
B expression in maize kernels. We demonstrated that maize synthesized LT-B folded 
properly into pentameric structures with affinity for Gmi gangliosides, like the native LT-B. 
When fed to mice, the maize synthesized LT-B stimulated a protective immune response 
against diarrhea inducing toxins LT and its closely related cholera toxin (CT). In addition, 
feeding transgenic maize to mice did not result in the induction of tolerance to LT-B, as 
shown by the presence of significant systemic and mucosal anti-LT-B and CT-B antibodies. 
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Our results indicated that maize could be efficiently transformed to produce, accumulate and 
store fully assembled and functional antigen. 
Material and Methods 
Cloning and bacterial transformation 
The enzymes Xho I and EcoR I were used to cut out the 1.15 kb fragment including 
the tobacco etch virus (TEV) 5' untranslated region that mediates enhancement of translation 
initiation (Gallic et al., 1995), the synthetic LT-B gene (Mason et al., 1998) and the soybean 
vegetative storage protein (VSP) terminator (Mason et al., 1993) from the plasmid pTH210 
(H. Mason, unpublished). This fragment was cloned in front of the maize 27 kD gamma zein 
promoter (Marks et al., 1985) in a pUC19 vector to give the plasmid pRC4 (Figure 1 ). The 
resultant plasmid pRC4 was sequenced to ensure correct orientation and fidelity of ligation 
junctions. DNA for maize transformation was obtained using the Qiagen (Qiagen GmbH. 
Germany) Maxiprep kit according to the manufacturers instructions. 
Maize transformation 
Embryogénie maize Hi II callus was transformed using microprojectile bombardment 
as described by Frame et al. (2000). Briefly, the plasmid pRC4 (Figure 1) encoding the 
synthetic LT-B gene was co-bombarded with a selectable marker gene construct, pBAR184. 
This construct contains an ubiquitin promoter/fear gene cassette that confers resistance to the 
herbicide bialaphos (Frame et al., 2000). Herbicide resistant calli were analyzed using the 
polymerase chain reaction (PGR) for presence of the LT-B gene cassette. Calli of transgenic 
events were regenerated and plants brought to maturity in the greenhouse 
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DNA extraction front maize callus and leaf tissue 
Plant DNA was extracted from callus as follows: 0.1-0.25 g of callus were collected 
in a 1.5 ml eppendorf tube and ground up with a plastic Kimble pestle (Fisher Scientific. 
Pittsburgh, PA, USA) in 400 |il extraction buffer [200 mM Tris-Cl (pH 7.5), 250 mM NaCl, 
25 mM EDTA and 0.5% SDS]. An equal volume of phenol chloroform isoamyl alcohol 
(25:24:1, v/v/v) was added and mixed well by inverting the tube several times. The tubes 
were centrifuged at maximum speed on a bench top centrifuge for 10 minutes. The aqueous 
phase was transferred to a clean eppendorf tube and the DNA precipitated with 2-propanol 
and washed with 70% ethanol. Leaf genomic DNA was extracted from R, maize plants 
using a cetyltrimethylammonium bromide (CTAB) protocol, as described by Murray and 
Thompson (1980). Three grams of fresh leaf tissue were ground to a fine powder in liquid 
nitrogen and resuspended in 25ml of CTAB buffer (1% CTAB, 50 mM Tris, 0.7 M NaCl. 1 
mM phenathroline, pH 8.0) supplemented with 0.5% beta-mercaptoethanol just before use. 
Samples were incubated for 30 minutes at 65°C, then allowed to cool to room temperature. 
Twenty milliliters of chloroform : isoamyl alcohol (24:1, v/v) were added and the samples 
mixed by inverting on an orbital shaker for 10 minutes. The tubes were centrifuged at 2,500 
g and the aqueous phase was collected. DNA was precipitated from the aqueous phase in 2/3 
volume of 2-propanol, with gentle inversion, and removed with a glass hook. The DNA was 
washed for 30 minutes at room temperature in 80% ethanol plus 15 mM ammonium acetate. 
The liquid was removed and DNA air-dried and dissolved in TE (10 mM Tris, 1 mM EDTA, 
pH 8.0). 
93 
Polymerase Chain Reaction 
Transgenic calli were initially selected on the basis of resistance to bialaphos and the 
presence of the LT-B gene was confirmed by PCR analysis. The forward and reverse 
primers, respectively, used were, LT-B-PCRF1 (5'-ate gat aca aaa caa acg aat ctc aag c-3') 
and LT-B-PCRR1 (5'-cca tgg cgt gga ttt tat gac att tta t-3'). These primers amplify an 842 
bp fragment from the TEV leader to part of the VSP terminator, including the LT-B gene. 
PCR reactions were carried out in a total volume of 50 gl containing 50-250 ng of maize 
callus genomic DNA, 5 nl of 10X PCR buffer, 2 (il of dNTP mix (containing 10 mM of each 
dNTP), 12 |il of each primer (2.5 |iM stock), and 1 jil of Biolase Taq Polymerase (Biolase 
USA Inc., City, NJ, USA). Reaction conditions were as follows: Initial PCR activation 
(95°C, 3 minutes) was followed by 30 amplification cycles (denature, 94°C, 30 seconds; 
annealing, 60°C, 30 seconds, and extension, 72°C, 45 seconds) and a final extension step at 
72°C for 5 minutes. 
Southern blot analysis 
Ten micrograms of leaf genomic DNA were digested with restriction enzyme Ncol at 
37°C overnight and separated on a 0.8% agarose gel. Linearized DNA gel blot analyses 
(Sambrook et al., 1989) were conducted on DNA samples using the 32P-labeled LT-B gene 
fragment as probe (Figure 1). 
Protein extraction from maize kernel 
Individual mature dried kernels frozen in liquid nitrogen were ground to a fine 
powder in a mortar and pestle. The fine powder was transferred into a 1.5 ml eppendorf tube 
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and weighed. For ELISA analysis, 25 mM sodium phosphate buffer (pH 6.6) containing 100 
mM NaCl, 10 mM EDTA and 0.5% Triton X-100 (v/v) was added at the rate of 10 pi buffer 
per milligram of maize powder. For Western analysis, extraction buffer [200 mM Tris-HCl. 
(pH 8.0), 100 mM NaCl, 400 mM sucrose, 10 mM EDTA, 14 mM 2-Mercaptoethanol. 
0.05% Tween-20] was added at the rate of 10 (il buffer per milligram of maize powder. The 
powder was soaked for one hour on a vortex shaker at room temperature and centrifuged at 
maximum speed on a bench top centrifuge for 15 minutes to remove insoluble debris. 
Protein concentrations were determined as total soluble protein (TSP) by the Bradford Assay 
(Bradford, 1976) with the BioRad (Hercules, CA, USA) protein dye concentrate using a 
standard curve derived from bovine serum albumin (BSA). 
To identify transgenic Ro events expressing LT-B, individual kernels from each ear 
(two ears per event) were analyzed by a partial destruction method, where kernels were 
partially drilled to remove part of the endosperm without damaging the embryo as described 
by Sangtong et al. (2001). Protein was extracted from endosperm as described for whole 
kernels. Kernels expressing LT-B were planted to give the R, generation. 
Quantitation of LT-B expression in maize 
LT-B expression in maize was determined using ganglioside dependent enzyme 
linked immunosorbent assay (ELISA). Reagents and antisera for the ELISA were obtained 
from Biogenesis Inc. (Kingston, NH, USA) and KPL (Gaithersburg, MD, USA). Volumes of 
50 (il were used throughout all ELISA assays unless otherwise specified. Wells were washed 
three times between each step using 300 (il of phosphate buffered saline Tween-20 [PBST; 
0.01 M Na2HP04, 0.003 M KH2P04, 0.1 M NaCl, (pH 7.2), 0.05% Tween-20 (v/v)]. ELISA 
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was carried out at 37°C throughout the process unless indicated otherwise. 
Microtiter plates (Costar 3590, Fisher Scientific, PA, USA) were coated with Type III 
Gmi gangliosides (1.5 ng/well) from bovine brain (G2375, Sigma, St Louis, MO) in sodium 
carbonate coating buffer [15 mM Na2COs, 35 mM NaHCXb, 3 mM NaN3 (pH9.6)] for one 
hour. The plates were blocked to prevent non-specific antibody binding with 5% dry milk 
(w/v, DM, DIFCO, Becton Dickinson, MD, USA) for one hour at room temperature. The 
protein extracts were added to the ganglioside coated microtiter dish, incubated for one hour, 
followed by incubation with goat anti-LT-B antiserum (1:1500 dilution. Biogenesis) for one 
hour. Rabbit anti-goat alkaline phosphatase conjugate [1:2500 dilution in 1% DM (w/v) in 
PBS] was added, and the dish incubated one hour. This was followed by addition of 
phosphatase substrate, 1 mg ml"1 p-nitrophenyl phosphate (Sigma) in alkaline phosphatase 
buffer (pH 9.5). Absorbance at 405 nm was measured spectrophotometrically over a two-
hour period in a Dynatech MRX Plate Reader (Dynex Technologies, VA, USA). Sample 
wells were blanked against non-transgenic maize protein extracts and all measurements were 
performed in duplicate. Raw ELISA data were converted to ng ml"1 of LT-B of total soluble 
protein by reference to an ELISA standard curve constructed using purified bacterial LT-B 
(kindly provided by John Clements, Tulane University, LA, USA). 
Immunoblot analysis 
A 10-20 nl aliquot containing 50-100 jig of total protein from maize kernels was 
analyzed by SDS-PAGE (Laemmli, 1970). Protein samples were either boiled for five 
minutes at 95°C or loaded directly on the gel without heat treatment. The separated proteins 
were transferred to a 0.45 |im nitrocellulose membrane using the BioRad Transblot apparatus 
96 
according to the manufacturer's instructions. Proteins were evaluated for presence of 
monomeric or oligomeric LT-B in boiled and non-boiled samples, respectively, by Western 
Blot analysis. The analysis used goat anti-LT-B antiserum and an alkaline phosphatase 
conjugated anti-goat IgG (KPL) at 1:3000 and 1:10,000 dilutions, respectively, using the 
procedures of Blake et al. (1984). 
Preparation of Feeding Pellets 
Kernels harvested from individual ears of transgenic R, plants were milled separately 
in a coffee grinder (Braun, Type 4041: Model KSM2). The LT-B content of each batch of 
maize powder was determined by ELISA and results are shown in Table 1. Maize powder 
from self-pollinated transgenic event P77-2 was selected for feeding mice. The LT-B 
concentrations in milled maize powder ranged between 10 to 13 gg g"1. Non-transgenic 
maize kernels were added to adjust the concentration of LT-B to 10 gg g'1. To prepare the 
pellets for feeding mice, a fixed amount of maize meal was weighed out and sterile distilled 
water added to make firm dough. The dough was then molded into a cylinder (Figure 5) 
using a 3 ml disposable syringe barrel with the Leur tip cut off. The cylindrical dough was 
cut into blocks (2 cm in length) that weighed 0.9-1.2 gram each when dried. The pellets were 
allowed to air-dry overnight and then weighed again prior to feeding to ensure that they 
weighed as close to one gram as possible. One extra pellet was prepared for each feeding, to 
be assayed for LT-B content at the end of the experiment. Non-transgenic maize meal was 
treated in a similar manner to make negative control pellets. To make the positive control, 
the non-transgenic maize powder was weighed out and mixed with bacterial LT-B in sterile 
water. Each dried pellet weighed one gram and contained lOfig of the bacterial LT-B 
protein. 
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Mice feeding 
Five-week old female inbred BALB/c mice were obtained from Harlan (Indianapolis. 
IN, USA) and were allowed a two-week adjustment period with reverse light dark cycle prior 
to onset of experiment. The mice were kept in the Iowa State University animal facility. All 
animal procedures were approved by the Iowa State University Laboratory Animal 
Resources Committee on Animal Care prior to experimentation. 
Mice were fasted 12 hours prior to feeding with water ad libitum. Three feed 
categories were used for this experiment, non-transgenic B73 maize pellets, non-transgenic 
maize spiked with 10 |ig g"' bacterial LT-B and LT-B expressing transgenic maize pellets. 
These feed types are referred to in the figures as Negative, Spiked and Transgenic 
respectively. Twelve mice were used per feed category. Two mice were placed in each cage 
and two pieces of the appropriate maize pellets were placed in a 15 x 60 mm dish on either 
end of the cage just before lights out. Bedding in the feeding cages was removed to ensure 
that all pellets were completely consumed during feeding. The dishes were then removed 
three hours later and the mice returned to their main cages with their normal rodent food. At 
the end of the three-hour period the mice had consumed all the maize pellets supplied. Mice 
were fed on days 0, 3, 7, and 21. 
Serum and fecal sample preparation 
For anti-LT-B and anti-CT-B antibody quantity determination, fecal pellets were 
collected and blood (approximately 100 |il) obtained once a week prior to fasting and feeding 
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and once before euthanasia (days -1,6, 13, 20 and 27). Mice were not bled prior to feeding 
at day 3. Mice were bled sephanously. Immediately after collection, the blood sample from 
each animal was centrifuged at 17 OOOxg in a microcentrifuge for 10 minutes to separate 
serum from clotted blood, and the sera collected and stored at -20°C until assayed. For 
ELISA evaluation of anti-LT or CT antibodies, sera collected on day 27 were diluted in PBS 
at 1:50 ratio for IgG assays and 1:20 ratio for IgA assays. Lower dilutions (1:10 to 1:25 for 
IgG and I; 10 to 1:20 for IgA) were used for sera from earlier bleeds with lower antibody 
titers. Fecal pellets were stored at -80°C until assayed. Fecal pellets were removed from -
80°C and lyophilized for 36-48 hours in open eppendorf tubes set upright in a Virtix 
Freezemobile 12LX lyophilizer. Dry fecal pellets were weighed, and PBS buffer 
supplemented with 0.2 mg ml"1 (w/v) trypsin inhibitor, 12.5% sodium azide (w/v) and 1 mM 
PMSF was added at 10|il for every milligram of dry fecal matter. Samples were soaked in 
buffer overnight at 4°C, and then centrifuged at 17,OOOxg on the micro centrifuge for 10 
minutes and the supernatant removed for ELISA analysis as described below. 
Determination of anti-LT-B and anti-CT-B antibodies 
Reagents and antisera for the ELISA were obtained from Sigma. Antisera for ELISA 
were diluted in PBS buffer as described above. For anti-LT-B or anti-CT-B determinations, 
microtiter plates were pre-coated with 1.5 pg of mixed gangliosides (Type III form Bovine, 
Sigma G2375) per well diluted in sodium carbonate coating buffer (see above) for 1 hour. 
This was followed by incubating with 1 ^ ig/well purified LT-B (John Clements) or CT-B 
(Sigma C9903) at 37°C for 1 hour. Plates were blocked with 5% DM (w/v) in PBS for one 
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hour at room temperature. Diluted serum samples were added and the dishes incubated at 
37°C for one hour. Anti-LT-B or anti-CT-B IgG levels in serum were determined by 
incubating with rabbit anti-serum against mouse IgG conjugated to alkaline phosphatase 
(Sigma A2418, diluted 1:7000 in 1% dry milk) at 37°C for 1 hour. IgA antibodies were 
similarly determined in parallel using rabbit anti-serum against mouse IgA conjugated to 
alkaline phosphatase (Sigma A4937, also diluted 1:7000 in 1% dry milk). Plates were read 
over a two-hour period as described above. Extracted fecal samples were measured without 
further dilution. Values for IgG and IgA were determined from a standard curve with 
purified mouse myeloma proteins [MOPC 21yGl, MOPC 315 yA(IgAA.2)] obtained from 
Sigma. 
Patent mouse assay 
The patent mouse assay (Guidry et al., 1997) was used to determine protection from 
toxin challenge. It is a modification of the sealed adult mouse assay (Richardson et al.. 
1984). The mice were challenged with LT (John Clements) and CT (Sigma C3012) toxins. 
The mice were fasted for 12 hours prior to the challenge with water available ad libitum and 
orally gavaged with 200 |al of PBS (pH 7.2) containing (25 or 50 |ig) LT or CT toxins. After 
toxin administration (three hours), the mice were euthanized by carbon dioxide inhalation, 
dissected and the gut removed from the duodenum to the anus. The gut, with the fat pad and 
the mesentery left intact, and the remaining body were weighed separately. The gut/carcass 
ratio (Richardson et al., 1984) was then calculated to determine the extent of toxin induced 
water influx into the gut. 
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Statistical Analysis 
Data was analyzed using the package Statistic for Windows, Version 4.0 (Analytical 
Software, Tallahassee, FL) and the Students t-test. The results are reported as mean values ± 
standard deviation (SD). 
Results 
Analysis of transgenic maize lines 
A plant optimized coding sequence of LT-B (sLT-B) from E. coli strain H10407 
(Yamamoto et al., 1982) was designed and synthesized by Mason et al. (1998). Construct 
pRC4 (Figure 1) was introduced into a maize hybrid line Hi II via particle bombardment as 
described (Frame et al., 2000). Transformed maize callus lines were analyzed by polymerase 
chain reaction (PCR) to confirm the presence of the sLT-B gene. Because an endosperm 
specific promoter was used, it was expected that the transgene would only express in 
endosperm of transgenic maize. Therefore, herbicide resistance and presence of the LT-B 
gene in PCR analysis were the criteria for selecting transgenic calli. Sixty independent 
herbicide resistant events were analyzed, forty-seven were found to contain the LT-B gene. 
Three plants per event were regenerated from 20 of these events and grown in the greenhouse 
to maturity. 
Nineteen of the twenty regenerated transgenic events were fertile. These plants were 
crossed with pollen from the non-transgenic inbred line B73. Mature transgenic kernels were 
analyzed for expression of the LT-B gene using ganglioside dependent ELISA as described 
by Haq et al. (1995) and in Material and Methods. The LT-B expression in R, seed from 
these events is summarized in Figure 2. LT-B expression ranged from less than 0.01% to 
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greater than 0.05% LT-B of total soluble protein as shown. Nine events expressed less than 
0.01% LT-B of total soluble protein, eight events had LT-B levels between 0.02-0.05% and 
two events shown expression above 0.05%. 
Six events were chosen to increase seed for further analysis on the basis of seed 
availability and level of expression of LT-B. Seeds were planted from the expressing R,, 
events to give R, generation plants, which were grown to maturity in the greenhouse. These 
plants were either self- pollinated or pollinated with non-transgenic inbred line B73 or hybrid 
line Hi II (Table 1). 
Southern analysis was carried out on selected events P77-2, -7 and -9 using leaf 
material of R, plants to determine transgene copy number (Figure 3). Since Ncol cut only 
once in the transgene cassette, the hybridization banding pattern should give an estimation of 
the number of LT-B gene copies present in the maize genome. From the number and 
intensity of bands in the autoradiograph, it can be concluded that all three events had multiple 
gene insertions and possible tandem repeats in the same insertion site. 
Immunoblot analysis was performed on five transgenic events using the R: kernels to 
detect the presence of the assembled LT-B subunits. The molecular weight of an LT-B 
monomer is 11.6 kD. However, only properly assembled LT-B subunits in a pentameric 
structure (55 kD) have GM, binding capacity and hence native antigenic function (de Haan et 
al., 1998). As reflected in Figure 4, maize synthesized LT-B from R1 seeds of events P77-2. 
-7, -17 and -18 had similar molecular weight to the bacteria derived LT-B in either 
pentameric form (Figure 4A) or monomeric form (Figure 4B). No LT-B protein was 
detected from event P77-1 by western analysis. ELISA analysis also indicated that the LT-B 
expression of this event was low (Table 1). 
102 
For mice feeding experiments, dry kernels from each R: ear were harvested and 
ground to a fine meal. LT-B of the meal was assayed using ELISA (Table I). Since the LT-
B transgene in the Rj seed population was segregating at a ratio of either 3:1 (for sel fed 
plants) or 1:1 (for out-crossed plants, data not shown), the maize meal obtained from these 
events were a mixture of LT-B expressing and non-expressing seeds. 
The expression observed in the meal of six events ranged from 0.004 - 0.19% LT-B 
of total soluble protein (Table 1). In event P77-9, the LT-B expression increased 10-fold 
compared to the level detected in their R, kernels. The LT-B expression level varied not 
only between independent events, but also between ears within one event. Event P77-2 was 
used for the mice feeding experiment for its adequate LT-B expression and sufficient seed 
yield at the time of experiments. A total of five P77-2 ears from sel fed plants were pooled 
for the feeding experiment. 
Anti-LT-B antibody response in mice 
Mice were fed with maize pellets (Figure 5) containing 10 ng of maize synthesized or 
bacterial LT-B on days 0, 3, 7 and 21. Figure 6 depicts the anti-LT-B antibody responses 
detected in the blood and fecal pellets of orally immunized mice. Results are presented as 
mean±SD. Serum anti-LT-B IgG levels in blood were first detected on day 13 following 
initial immunization. For mice fed with both transgenic maize pellets and maize pellets 
spiked with the bacterial LT-B, this was reflected as a late stage primary response in (Figure 
6A) as antibody class switching to IgG occurred. A secondary immune response is observed 
as a peak mean antibody response (5.7±1.1 mg ml"1) at day 27 (one week after the fourth 
feeding). The IgG concentration is about double the amount observed in the primary 
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response. The response of the transgenic maize fed group was similar to that observed in 
mice immunized with bacterial LT-B, which also peaked (5.8±0.7 mg ml"1) at day 27. There 
were no changes in specific antibody production in mice fed with maize pellet made from 
non-transgenic maize (negative group) through out the experiment. 
Fecal secretory IgA plays an important role in attenuation of toxin effects, possibly 
more so than the serum IgG and IgA because it is secreted in the gut at the point of contact 
with the toxin. Figure 6B shows the anti-LT-B IgA concentrations detected from fecal 
pellets of immunized mice. The secretory IgA of transgenic maize-fed mice increased 
gradually over the course of the experiment and peaked (278±50 p.g g"1 of dry fecal matter) at 
day 27. Mice fed with maize spiked with the bacterial LT-B also developed anti-LT-B IgA 
in their fecal pellets. However, the secondary response of these mice was significantly lower 
(149±21 |*g g"1 dry fecal matter, p<0.001) than that of transgenic maize-fed mice. No 
substantial production of fecal anti-LT-B IgA was detected in mice fed with non-transgenic 
maize pellet. 
The serum anti-LT-B IgA was determined during the course of the experiment and 
the results are shown in Figure 6C. Both the maize synthesized and bacterial LT-B protein 
induced serum anti-LT-B IgA in mice, and both show clearly defined primary and secondary 
antibody responses. However, transgenic maize induced a significantly higher serum IgA 
(428±68 ng ml*1, pO.OOl) on day 27, compared to the bacterial LT-B (250±36 jag ml"1), 
which also induced a significantly higher serum IgA response than the negative control 
(pO.OOl). 
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Anti-CT-B antibody response in immunized mice 
The cholera toxin (CT) is physically, chemically and antigenically similar to LT 
(Dickinson and Clements, 1996). To investigate whether mice immunized with maize 
synthesized or bacterial derived LT-B protein would also generate cross-reacting antibodies 
that would bind CT-B, we performed anti-CT-B antibody analysis on mouse serum and fecal 
samples (Figure 7). Figure 7A shows the concentration of serum anti-CT-B IgG over the 
course of the experiment. In contrast to anti-LT-B IgG, no marked responses to primary 
immunization were detected in mice fed with either transgenic maize or bacterial LT-B 
spiked maize pellets. Elevated serum anti-CT-B IgG antibodies were detected at day 27. 
The IgG level in transgenic maize-fed mice was significantly higher (2.3±0.8 mg ml"') than 
that of LT-B spiked maize-fed mice (1.0±0.5 mg ml"1). No anti-CT-B IgG antibodies were 
detected in the negative control mice fed with non-transgenic maize pellets. 
Figure 7B shows the cross-reacting anti-CT-B fecal IgA antibody production. 
Although some anti-CT-B IgA antibody was detected in mice fed with either maize 
synthesized or bacterial LT-B over the course of experiment, they were not very high above 
the background. Mice fed with the control maize pellets (Negative group) also display 
measurable production of anti-CT-B antibody. The fecal anti-CT-B cross-reacting antibodies 
are only marginally higher (p<0.02) in mice immunized with transgenic maize at the end of 
the experiment (day 27). 
Figure 7C shows the cross-reacting serum anti-CT-B IgA antibodies at the end of the 
experiment (day 27). The antibody production over the course of immunizations could not 
be tracked over the course of the experiment because of limitations in serum availability from 
earlier bleeds. Transgenic maize pellet induced a higher response (196+69 jig ml"1, p<0.01) 
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compared to the bacterial LT-B spiked maize pellet in mice. Interestingly, spiked LT-B 
maize pellets did not induce significantly higher (69±40 ng ml"1) serum anti-CT-B IgA in 
mice compared to non-transgenic negative control pellets. 
Response of immunized mice to challenge with toxins LT and CT 
To investigate whether maize synthesized LT-B provides protection against toxin 
challenge, we performed the patent mouse assay (Guidry et al., 1997) in the orally 
immunized mice (Figures 6 and 7), using LT or CT to challenge the mice. These toxins 
activate adenylate cyclase and result in fluid secretion into the lumen of the bowel. The fluid 
secretion exceeds the bowel's capacity to reabsorb it and therefore it accumulates (Mason et 
al., 1998). The movement of fluid from the body into the lumen of the bowel decreases the 
weight of the carcass and increases the relative weight of the gut. The gut/carcass ratio 
therefore changes in a dose dependent fashion. In a toxin dose-response experiment (Figure 
8A), we measured the gut/carcass ratio of non-immunized mice gavaged with two levels of 
LT and CT (25 and 50 (ig). Significant fluid influx was detected in mice gavaged with both 
levels of LT and CT toxins when compared to mice gavaged with phosphate buffered saline 
(PBS) as a negative control (p<0.02 for 25 |ig and pO.OOl for 50 jag). A significant 
difference in gut/carcass ratio between LT and CT (p0.02) was observed when 50p.g of 
toxin were administered. The CT was significantly more potent than the LT as expected 
(Bowman and Clements, 2001). There was no significant difference in fluid influx observed 
between LT and CT at 25 gg/dose level. 
Figure 8B shows the results of the patent mouse assay performed on day 28 of the 
experiment. Compared to mice that were fed with non-transgenic maize, mice immunized 
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with LT-B expressing transgenic maize had reduced gut/carcass ratio when challenged with 
25 pg LT toxin. The gut/carcass ratios for transgenic maize-fed mice challenged by LT toxin 
was not significantly different from non-transgenic maize-fed mice gavaged with PBS only 
(0.109±0.001 vs 0.095±0.0002), indicating that mice orally immunized with transgenic maize 
were protected from challenge with 25 pg LT toxin. Mice fed with LT-B-spiked maize also 
showed a similar reduction in the gut/carcass ratio. There was significant fluid influx in mice 
that were given the non-transgenic maize meal compared to the PBS control group (0.130 vs 
0.095, p<0.01). The gut of mice from all feed categories gavaged with PBS (shown as PBS 
group in Figure 8B) did not accumulate fluid indicating that the gavage procedure itself did 
not cause an inflammatory response resulting in fluid accumulation. 
Similar results were observed when orally immunized mice were challenged with 25 
Hg CT-B (Figure 8B). Mice fed with either transgenic maize meal and LT-B-spiked maize 
meal also had reduced fluid influx compared to mice fed with non-transgenic maize and 
gavaged with CT toxin. The gut to carcass ratio for mice in these two categories (transgenic 
maize and spiked) was not significantly different from mice fed with negative maize and 
gavaged with PBS (0.095±0.0002). 
Discussion 
We have demonstrated that a synthetic gene encoding E. coli LT-B can be 
successfully expressed in transgenic maize seed and accumulating in pentameric Gvu binding 
form. Oral immunization of BALB/c mice with maize synthesized LT-B induced elevated 
IgA and IgG serum antibodies and elevated fecal IgA against diarrhea-inducing toxins LT 
and CT. In addition, transgenic maize-fed mice challenged with LT or CT toxins displayed 
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reduced gut/carcass ratios that were not significantly different from the PBS challenged 
negative control group, indicating that the maize synthesized LT-B has biological and 
immunological functions comparable to the native LT-B protein that can protect immunized 
mice from LT or CT toxins challenge. 
In this study, we inserted into the maize genome a synthetic LT-B gene that was 
optimized for expression in both potato and maize (Mason et al., 1998). To achieve a high 
level of gene expression, we used the 27 kD maize gamma zein promoter to drive the 
transcription of the sLT-B gene. The 27 kD gamma zein promoter is one of the strongest 
seed specific promoters in maize, and zeins comprise 50-60% of the total seed storage 
proteins (Marks et al., 1985). In contrast to other plant tissues, seeds provide a relatively dry 
and stable environment for protein storage. Seeds also present potentially practical and 
protective delivery vehicles for targeting edible vaccines into the gut because of their 
palatability and high protein content. The antigenic protein may be delivered within protein 
bodies, and therefore not in readily soluble form. Presentation of proteins in soluble form 
has been shown to be conducive to oral tolerance (Simmons et al., 2001). The initial level of 
LT-B expression in Ri seed ranged from less than 0.01% to 0.07% LT-B of total soluble 
proteins (TSP). Considerable variation in LT-B expression was observed between and within 
each independent event. Southern analysis was conducted on the best performing events 
P77-2, -7, and 9. The events have multiple transgene copy numbers and variable insertion 
patterns. Gene copy numbers and the relative positions of transgene insertion in the plant 
genome (position effects) may be factors that affect level of transgene expression (Christou 
et al., 1996). 
Compared to the LT-B expression in R, seed, we observed an increased LT-B 
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expression in the R2 seed for the same event. LT-B expression ranged from 0.004 - 0.2 % of 
TSP. The reason for this increase is not clear. However, this phenomenon has also been 
reported by Hood et al. (1997), they observed a similar increase in avidin gene expression 
was observed in transgenic maize in subsequent generations from R, generation. We 
observed but did not follow up events with decreased LT-B expression over the generation. 
It is worth noting that the LT-B levels obtained from R2 seed was from a mixture of 
segregating seed population from each event, with expression ratio of 3:1 for sel fed and 1:1 
for out-crossed plants. It is conceivable that the LT-B yield would be higher if only 
expressing kernels had been included in the meal. 
The ganglioside dependent ELISA used to determine level of LT-B expression 
demonstrated the ability of maize synthesized LT-B to bind Gmi gangliosides, a property of 
native pentameric LT-B (Dickinson and Clements, 1996). Our ELISA results indicated that 
the maize produced LT-B was similar to the bacterial LT-B that properly folded and 
assembled into pentamers. Immunoblot analysis indicated that the maize synthesized LT-B 
was similar in molecular weight to the bacterial LT-B, the non-boiled form was oligomeric 
and dissociated into monomers upon boiling. 
Mice fed with LT-B expressing transgenic maize developed serum and mucosal 
antibodies that are specific to LT-B and cross-react with the closely related CT-B. It is 
difficult to accurately quantify the secretory IgA in the gut as the amounts measured in fecal 
pellets may be a reflection of the remaining antibody after degradation by microbes that live 
in the gut, among other processes. Serum IgA, while not involved in protection of host from 
invading pathogens and toxins, was used to corroborate the differences in effect of the 
different feed types (compare Figures 6B and C). 
109 
Interestingly, compared to spiked LT-B-fed mice, we observed a significantly higher 
level of anti-LT-B IgA in fecal and serum samples of transgenic maize-fed mice (Figure 6B 
and C) especially at day 27 when the maximum amount of antibody was expected. One 
possible explanation could be that the maize synthesized LT-B is more stable within the 
maize tissues and was released slowly as the meal was digested. The spiked bacterial LT-B. 
on the other hand, could be more vulnerable to proteolytic degradation during the process of 
pellet preparation and feeding as it is merely mixed in with regular maize meal. An 
alternative explanation could be that there was more LT-B in transgenic maize than the 
ELISA assay indicated depending on the fineness of the meal. We observed that the finer the 
maize meal was ground, the higher the LT-B yield we measured, suggesting that a finer 
maize powder allows better protein extraction. However, very fine maize meal did not 
mould well to make pellets for feed, so we used an average textured meal to make the pellets 
for feeding. 
Cross-reacting anti-CT-B antibodies could also be detected in mice fed with LT-B 
expressing transgenic maize or LT-B-spiked maize. There were overall more LT-B binding 
antibodies compared to CT-B binding IgG and IgA (compare Figure 6A with 7A and Figure 
6B with 7B). This is not unexpected since the B subunits from the two toxins share some 
common epitopes but are not identical. There is a 20% difference in nucleotide and amino 
acid sequence levels (Dallas and Falkow, 1980). Therefore among antibodies produced in 
response to LT-B immunization, only those produced to the common epitopes will cross-
react with CT-B. 
It is important that an oral vaccine should elicit an immune response in the gut. It has 
been shown that in many cases, it is possible to prevent the initial infection by stimulating 
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production of mucosal secretory IgA against specific virulence determinants on the pathogen. 
Specific secretory IgA prevents interaction of the pathogen with the mucosal surface by 
blocking attachment and/or colonization to prevent invasion of host cells or by neutralizing 
surface acting toxins (Dickinson and Clements, 1995). We show here that the maize 
synthesized LT-B stimulates secretory IgA in the gut and is therefore functional in that 
regard. 
We have demonstrated that mice orally immunized with transgenic maize or LT-B 
spiked maize have reduced fluid influx in their guts (gut/carcass ratio) compared to the 
negative maize-fed mice, indicating that the LT-B-immunized mice were protected from the 
toxin challenge. In this study, 25 |ig of LT used for challenge was determined previously 
(Mason et al., 1998). It was found that in a dose response curve, the gut/carcass ratio reached 
a plateau at 0.16 at a dose of 25 p.g of LT (Mason et al., 1998). This level of LT and CT used 
for the challenge was quite substantial for mice considering their low body mass. For 
comparison, in one human trial, 25 |ig of native CT administered orally was shown to elicit a 
20-liter cholera purge in human volunteers (Levine et al., 1993), while 25(ig of LT 
administered with a whole cell B subunit cholera vaccine was shown to elicit up to 6 liters of 
fluid (Bowman and Clements, 2001). 
The gut/carcass ratio used for the efficacy assessment is toxin dose dependent. In our 
patent mouse assay, challenge with 25 fj.g of toxin showed attenuation of both LT and CT 
toxin effects in orally immunized mice (Figure 8B). When 50 gg of toxin were used, the 
gut/carcass ratio of the transgenic maize fed group was no longer different from that of toxin 
challenged negative maize group (data not shown), suggesting that at this level of toxin, 
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orally immunized mice were not protected from these diarrhea-inducing toxins. 
While we detected more LT-B binding IgG and IgA compared to CT-B binding 
antibodies, there was no significant difference in protection between LT and CT challenged 
mice. The apparent low anti-CT-B antibody concentrations observed could merely be a 
reflection of the limit of detection of the ELISA. Data for anti-CT-B binding antibodies 
showed more variability compared to anti-LT-B serum data, especially at lower titers. This 
may be an artifact in measuring these antibodies. Alternatively, this could be due to the 
simple reason that there are not as many cross-reacting anti-CT-B antibodies, and the few 
that are present are adequate to attenuate the effect of CT. 
Despite the attractiveness of mucosal vaccination, mucosally administered proteins 
are frequently not immunogenic (Bowman and Clements, 2001) and require more antigen 
relative to parenteral vaccination (Simmons et al., 2001). A number of strategies have been 
developed to facilitate and enhance the immune response obtained after mucosal vaccination 
and to prevent induction of oral tolerance. The use of adjuvants is one such strategy and LT-
B has been shown to be a potent one. Millar and co-workers (2001) showed that contrary to 
previous opinion (reviewed by Dickinson and Clements, 1996), the non-toxic subunits LT-B 
and CT-B are potent oral immunogens. These subunits avoid tolerance induction when 
administered mucosally and generate strong serum and mucosal responses (reviewed by 
Snider, 1995). They are arranged in a pentameric ring and contain five receptor-binding 
pockets for high avidity association with cellular Gmi gangliosides. We have demonstrated 
here that maize synthesized LT-B has a mitigating effect against both LT and CT toxins. 
Protein less immunogenic than LT-B may not stimulate an immune response when orally 
administered in an edible transgenic plant or may even induce tolerance against itself. LT-B 
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can therefore be co-expressed in the same plants with the less immunogenic vaccines to 
achieve a more vigorous immune response. As an adjuvant, LT-B could therefore play a key 
role in providing safe and cost effective mucosal immunization against enteric pathogens, 
which can be effectively controlled by recombinant subunit vaccines. 
LT-B could be also used as a cost effective carrier for induction of an increased 
mucosal response to antigens to which it is chemically or genetically conjugated. Because of 
its ganglioside binding properties, LT-B has the capacity to bring conjugated antigens in 
contact with the mucosal system, making oral vaccination more efficient. Increased 
immunogen concentration in the mucosal lymphoid tissues may reduce the requirement for 
high levels of antigen biosynthesis in transgenic plants. 
Maize synthesized LT-B did not induce tolerance as indicated by the production of 
antibodies over the vaccination period. We have shown that maize synthesized LT-B 
conferred protection against both LT and its closely related CT. Maize is highly palatable 
and as such, a reasonable crop for vaccine production. The fasted mice easily consumed one 
gram of pellet containing LT-B protein within three hours. Production of LT-B in kernels 
and palatability of maize pellets made it easier and convenient to administer an oral vaccine 
in maize relative to other plants. Feeding periods for administration of adequate doses with 
potato reported by Mason et al. (1998), were quite prolonged, up to 24 hours. Because of the 
high level of expression of the LT-B that could be achieved in maize, only one gram was 
required to administer an adequate dose (10 |ig) of LT-B. 
Recent research has demonstrated the potential of plant-derived antigens for 
immunization against infectious agents that invade through mucosal surfaces (Tacket et al.. 
1998). Maize is a major feed ingredient and could potentially play a key role in the 
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production of edible vaccines for livestock. Oral vaccine delivery from maize seed would be 
convenient, practical and would allow long-term storability and stability of the proteins. 
Storage of antigen in protein bodies is expected to protect it from immediate enzymatic 
degradation and from the acidic environment in the stomach (Simmons et al., 2001). In 
addition, it will allow the protein to be released slowly. This is advantageous because 
delivering oral vaccines in soluble form is conducive to oral tolerance. Questions under 
further investigation in our laboratory include increased expression to address dosage 
requirement and dosage stability in grain. 
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Figure 1. Schematic diagram of construct pRC4 with the synthetic gene encoding the B 
subunit of LT (sLT-B) under the control of the 27 kD gamma zein promoter, the translational 
enhancer leader sequence of tobacco etch virus (TEV) and the soybean vegetative storage 
protein terminator (vsp) in a pUC19 background. The 0.4 kb Ncol - Kpnl fragment was used 
as a probe in Southern analysis. 
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Figure 2. Accumulation of LT-B protein in endosperm of mature seed from nineteen 
independent P77 Ro transgenic events. Endosperm tissue was sampled as described in 
Materials and Methods and the LT-B expression assayed by ELIS A. Twenty kernels from 
two ears per event were analyzed. The LT-B expression level (% of total soluble protein) of 
each event was determined as the mean of all ELISA positive kernels. 
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Figure 3. Southern blot analysis of selected transgenic events P77-2, -7 and -9. Ten 
micrograms of total leaf genomic DNA of R1 plants was digested with Ncol, a restriction 
enzyme with a single cut within the sLT-B gene cassette (Figure 1). DNA was separated in a 
0.8% agarose gel, blotted onto a Zeta-probe nitrocellulose membrane (BioRad) and 
hybridized with 32P-labeled LT-B gene as probe. MW, Molecular Marker, lambda DNA 
digested with HindIII. B73, non-transgenic maize DNA as negative control 
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Figure 4. Western analysis of selected transgenic events P77-1, -2, -7, -17 and -18. One 
hundred micrograms of total soluble protein from Rj meal was separated on an analytical 
discontinuous SDS (12%) PAGE, transferred to a 0.45 micron nitrocellulose membrane and 
probed with goat anti-LT-B and rabbit anti-goat alkaline phosphatase conjugate as primary 
and secondary antibodies respectively. Panel A, protein samples not boiled prior to loading. 
Panel B, protein samples boiled (95°C, 5 min) prior to loading. MW, Molecular Weight 
standards; +ve ctr (100 ng), bacterial LT-B as positive control; -ve ctr, non-transgenic maize 
extracts as negative control. 
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Figure 5. Maize meal pellets used to feed BALB/c mice for oral administration of LT-B. 
Pellet was made from either non-transgenic maize kernel meal spiked with 10 pg of bacterial 
LT-B, or transgenic maize kernel expressing 10 fag of LT-B. Each pellet weighed one gram 
(scale in centimeters). 
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Figure 6. Anti-LT-B antibody analysis in orally immunized mice. Twelve mice in each feed 
category were fed with maize meal pellets from non-transgenic maize (negative), non-
transgenic maize spiked with bacterial LT-B (spiked) and transgenic maize expressing LT-B 
(transgenic) at days 0, 3, 7 and 21. A. The levels of serum anti-LT-B IgG. B. The levels of 
fecal anti-LT-B IgA. C. The levels of serum anti-LT-B IgA. 
126 
t 
E 
e 
i 
s 
% 
8000 
7000 
6000 
5000 
4000 
3000 
2000 
1000 
0 
O Negative 
O Spiked 
•Transgenic 
Dav -1 Dav 6 Day 13 
Bleed Day 
Dav 20 Dav 27 
B. 
.2 350 
« 300 
g 250 
S « 200 
U s 150 
I 
O Negative 
[O Spiked 
ITransgenic 
Day -1 Day 6 Day 13 Day 20 Day 27 
Collection Day 
e 
o 
500 
< .2 400 
M |t 300 
5 S M 200 
w 100 
0 
E 1 5 
<n e 
U J±L t 
Negative Spiked Transgenic 
Feed Category 
Figure 7. Cross-reacting anti-CT-B antibody analysis in orally immunized mice. Mice were 
fed with maize meal pellets from non-transgenic maize (negative), non-transgenic maize 
spiked with bacterial LT-B (spiked) and transgenic maize expressing LT-B (transgenic) at 
days 0, 3, 7 and 21. A. The levels of serum anti-CT-B IgG. B. The levels of fecal anti-CT-B 
IgA. C. The levels of serum anti-CT-B IgA at the day 27. 
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Figure 8. Patent mouse assay for toxin challenge of mice. A. Dose responses of LT, CT and 
PBS buffer alone. Mice were gavaged with two levels (25 and 50 mg) of LT and CT toxins 
and dissected 3 hours later to determine the gut/carcass ratio. For each group n=2. B. 
Response of mice fed with maize meal pellets from non-transgenic maize (negative), non-
transgenic maize spiked with bacterial LT-B (spiked) and transgenic maize expressing LT-B 
(transgenic) to toxin challenge. Each mouse was gavaged with 25 mg of LT or CT or PBS 
buffer alone at day 27 and gut/carcass ratio was determined 3 hours later as described in 
Materials and Methods. For each group n=2. 
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Event ID Ear ID Gene 
copy # 
Pollen 
Source 
Seed LT-B Expression (% TSP) 
R, whole Rj meal" 
kernels 
P77-1 
P77-2 
P77-7 
P77-9 
P77-17 
P77-18 
3-1 
2-1 
2-2 
2-3 
2-5 
2-7 
2-9 
2-10 
1-1 
1-2 
1-3 
1-4 
2-1 
2-2 
2-6 
1-1 
2-1 
nd 
4 
5+ 
nd 
nd 
Hi II 
sel fed 
Hi II 
sel fed 
sel fed 
Hi II 
sel fed 
selfed 
B73 
selfed 
selfed 
selfed 
selfed 
selfed 
selfed 
B73 
Selfed 
254 0.01±0.005 
0.07±0.007 
0.05±0.002 
220 
66 
220 
128 
152 
51 
188 
23 
97 
76 
154 
196 0.02±0.002 
53 
35 
23 0.02±0.002 
9 0.02±0.005 
0.004 
0.049 
0.033 
0.034 
0.020 
0.047 
0.036 
0.022 
0.104 
0.120 
0.118 
0.047 
0.099 
0.190 
0.203 
0.008 
0.002 
1 Data from 10 expressing kernels from each event. 
- ELISA was done on pooled kernels from one single ear. 
Table 1. Summary of transgene copy numbers, seed yield and LT-B expression of 
transgenic events 
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CHAPTER 5 
Generation in transgenic maize calli of a functional non-toxic LT mutant 
(LTK63) and an LT based candidate subunit vaccines for swine 
transmissible gastroenteritis virus (TGEV) 
Manuscript in preparation. 
Abstract 
The heat labile toxin (LT) from Escherichia coli and its subunits LT-A and LT-B, are 
potent oral immunogens, which could potentially be used as adjuvants in oral vaccinations 
with other less immunogenic proteins. LT is more potent as an adjuvant than LT-B alone, 
but toxicity hampers its use as an adjuvant in oral vaccination programs. This has led to the 
development of detoxified A subunit LT mutants such as LTK63. We co-expressed LT-B 
and LT-AK63 genes in transgenic maize callus. Western analysis showed the assembly of 
LTK63 in transgenic maize callus. The maize generated LTK63 was functional, inducing 
systemic and mucosal antibodies in orally immunized BALB/c mice. The maize generated 
LTK63 induced higher serum and mucosal antibody titers than the bacterial LT-B. The 
expression and proper assembly of functional LTK63 demonstrates that maize can 
competently produce multimeric proteins that are capable of higher order assembly in 
transgenic maize tissues. We used LT-AK63 as a carrier molecule for antigens from the 
spike (S) protein of swine transmissible gastroenteritis virus (TGEV). We fused a 1.12kb N-
terminus of the S protein containing critical epitopes for TGEV neutralization to the LT-A 
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subunit of LTK.63. This fusion, LT-A/S, was co-expressed with LT-B in transgenic maize 
callus under the regulation of the CaMV 35S promoter. We observed assembly of LT-B 
pentamers and ELISA data suggests possible assembly of these pentamers and the LT-A/S 
fusion proteins. BALB/c mice orally immunized with 4^g LT-B and LT-A/S fusions 
induced anti-LT-B antibodies, but no anti-TGEV antibodies could be detected in mice serum. 
Introduction 
The adjuvant properties of Escherichia coli (E. coli) heat labile toxin (LT) and its 
pentameric LT-B subunits have been established. These proteins are potent oral 
immunogens, which hold great potential in enhancing the value of oral vaccines by eliciting 
high titer serum and secretory antibodies when administered into the gut (Dickinson and 
Clements, 1996). Most proteins are not immunogenic when administered orally, and as such 
have to be either injected, or orally administered along with a strong adjuvant. LT has been 
shown to be a much more potent adjuvant than the LT-B subunit alone, but the utility of LT 
as an adjuvant has been hampered by its toxicity. Recent research has focused on the 
development of non-toxic derivatives of LT (Pizza et al, 2001). 
LT consists of five non-covalently bound B sub-units (LT-B) and one A sub-unit 
(LT-A). The A sub-unit dissociates into two components upon thiol reduction within the 
cell. The A1 piece has enzymatic activity that causes secretion of water and electrolytes into 
the lumen of the small intestine, which is characteristic of the debilitating E. coli induced 
watery diarrhea (Spangler et al, 1992). The non-toxic B bind the toxin to the host cell 
receptor, Gmi (galactosyl-N-acetylgalactosaminyl-sialyl galactosyl glucosyl ceramide), 
which is commonly found on the surface of eukaryotic cells. Interaction of the B subunit 
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with cell surface receptors triggers the key immunomodulatory events associated with 
adjuvant activity. LT-B can also serve as an immunologic carrier in traditional hapten-
carrier configuration (Cebra et al, 1986). Other antigens conjugated to LT-B can therefore be 
immobilized for processing by the gut associated lymphoid tissue (GALT). 
A number of attempts have been made to alter the toxicity of LT (Dickinson and 
Clements, 1996). Most of the attempts used site-directed mutagenesis change amino acids 
associated with the site of enzymatic activity in the A subunit. To date, several mutant LT 
holotoxins have been developed, including LTK63, LTR72 and LTG192, among others 
(Pizza et al, 2001). Van den Akker et al, (1997) developed LTK63, a non-toxic mutant of 
heat labile enterotoxin, by changing Ser63 to Lys through site directed mutagenesis. Pizza et 
al (2001) showed that LTK63 was a strong and safe oral immunogen upon oral 
administration. We demonstrate in this work that transgenic maize callus can synthesize 
from LT subunits and assemble the proteins to a functional LTK63 with immunological 
activity. 
The expression of heterologous antigens as fusion products with the LT-B sub-unit 
has been described as an optimal strategy for the induction of lactogenic immunity against 
foreign antigens (Spangler, 1992, Pierce et al, 1980). Antigenic Site D from the 
transmissible gastroenteritis virus (TGEV) spike (S) protein conjugated to LT-B have been 
expressed in salmonella and shown to induce virus-neutralizing antibodies in rabbits 
(Smerdou et al, 1996). Yu and Langridge (2001) demonstrated that an antigen conjugated to 
the A subunit of CT, a homologue of LT, could be successfully expressed and assembled into 
a recombinant holotoxin in transgenic potato tissues. 
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We attempted to exploit the properties of LT and its subunits to develop a maize-
based recombinant subunit vaccine against TGEV. TGEV causes a diarrhea disease in pigs, 
but is especially severe in newborn piglets less than two weeks old where mortality can be up 
to 100% (Saif and Wesley, 1992). The TGEV S protein is the major inducer of neutralizing 
antibodies (Garwes et al, 1978, Laude et al 1986). In this protein, four antigenic sites (A. B. 
C and D) have been defined (Delmas et al, 1986, 1990). Of these antigenic sites, site A is 
antigenically dominant, sites A and D and to a minor extent site B, have been involved in the 
neutralization of TGEV (Delmas, 1990). Passive immunity is of primary importance in 
protecting newborn piglets against TGEV (Saif and Wesley, 1992). This type of immunity 
can be achieved by the induction of lactogenic immunity in the sow, which in turn can be 
induced by presentation of selected antigens to the immune system in the gut associated 
lymphoid tissues (Delmas, 1986). 
Attempts have been made to develop a plant-based TGEV edible vaccine by 
expressing a whole S gene in plants. Welter et al (1996) produced a truncated N terminal 
domain of the S gene in transgenic potato and Streatfield et al (2001) produced a synthetic 
version of the whole S gene and expressed it in transgenic maize. These efforts were 
hampered by low levels of expression of the S protein, although the maize work was 
promising. We chose an N-terminal domain 1.12 kb common to the S proteins of PRCV and 
TGEV to be fused to the A subunit of LT. This domain contains the critical antigenic sites 
(C, D and A) required for TGEV neutralization. The combination of these sites and LT-B 
with its adjuvant effects constitutes a potentially viable vaccine against transmissible 
gastroenteritis. The S gene N-terminal domain replaced the Al subunit in LTK63 in such a 
way that the assembly of the recombinant A sub-unit to the B5 sub-units would be preserved 
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(the A2 subunit attached to the S gene fragment), and the B sub-units in the resulting 
recombinant "holotoxin" could still bind Gmi gangliosides. 
We observed assembly of LT-B pentamers and ELISA data suggest possible 
assembly of these pentamers and the LT-A/S fusion protein. Animals were orally immunized 
with transgenic maize expressing recombinant proteins. Serum and fecal samples were 
assayed for antibodies against LT-B and TGEV. The callus extract with LT-B and LT-A S 
fusions induced anti-LT-B antibodies, but no anti-TGEV antibodies could be detected in 
mice sera and fecal samples. The mutant LTK63 assembled in transgenic maize calli and 
induced an immune response in BALB/c mice that was stronger than the response induced by 
bacterial LT-B. 
Material and Methods 
Constructs for maize transformation 
A fragment encoding the 1.12 kb N-terminal fragment containing the antigenic 
epitopes A, C and D of S gene was amplified by reverse transcriptase PGR (RT-PCR) from 
total RNA of the porcine respiratory coronavirus (PRCV). The following primers were used: 
pLASgen-Fl; 5'-cag tgt ccc ggg gat aat ttt cct tgt tcc aat-3'and pLASiteA-Rl; 5'-cgt atg acc 
egg gag tcc gtg cag ttt cgc tta aaa ac-3'. These primers contained a Sma I restriction site to 
create the necessary blunt ends for ligation into the Hincll sites in the mutated LT-A subunit 
in pGEM-sLTA-HcHp (Mason, unpublished). The mutated LT-A subunit gene was made 
by site directed mutagenesis such that A1 sub-unit could be taken out using the engineered 
Hincll sites, leaving the signal peptide and the A2 domain intact. The N-terminal half of the 
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S gene generated by RT-PCR was ligated in translational frame with the LT-A bacterial 
signal peptide and the A2 domain. The S gene fragment fused to the A2 gene was excised 
from the resultant plasmid using the restriction enzymes Ncol and Sacl, and used to replace 
sLT-B in pTH210 (Figure 1A). The resultant plasmid has the S gene fragment fused to the 
A2 subunit (LT-A/S fusion) under the regulation of the CaMV 35S promoter and the soybean 
VSP terminator (Figure IB). The resultant plasmid was called pRC9. 
A 2.1 kb fragment from sLTA211 (Mason, unpublished, not shown) including the 
synthetic LT-AK63 gene, was used to replace the synthetic LT-B in construct pTH210 
(Mason et al 1998). The resulting construct pRC9-l Figure 1C) has the synthetic LT-AK63 
gene being regulated by the enhanced CaMV 35S and the soybean vegetative storage protein 
(VSP) terminator (Mason et al, 1993) from the plasmid. The newly constructed plasmids 
were sequenced to ensure correct orientation and fidelity of ligation junctions. DNA for 
maize transformation was obtained using the Qiagen (Qiagen GmbH, Germany) Maxiprep kit 
according to the manufacturer's instructions. 
Maize transformation 
Embryogénie maize Hi II callus was transformed using microprojectile bombardment 
as described by Frame et al (2000). Briefly, the plasmids pRC9 and pRC9-l were each co-
bombarded with the construct pTH210 encoding the synthetic LT-B gene and the selectable 
marker gene construct, P2. The construct P2 contains an ubiquitin promoter/for gene 
cassette that confers resistance to the herbicide bialaphos (Frame et al, 2000). Transgenic 
calli containing plasmid pTH210 encoding the LT-B gene and pRC9 (LT-A/S fusion) and 
were designated P51P94 and transgenic calli containing pTH210 and pRC9 were designated 
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P51P95. Herbicide resistant calli were analyzed using the polymerase chain reaction (PGR) 
for presence of the LT-B, the LT-A/S fusion and the LTAK63 gene cassette. 
PCR analysis 
Transgenic calli were initially selected on the basis of resistance to bialaphos, the 
presence of the LT-B, LT-A/S and LTAK63 genes was confirmed by PCR analysis. The 
transgenes were amplified from 10 to 100 ng of total genomic DNA extracted from 0.1-0.25 
g of callus as described by Chikwamba et al, (2002) (Chapter 4 in this dissertation). To 
amplify the LT-B gene in all transgenic calli, PCR primers and conditions, used as described 
(Chikwamba et al, 2002, Chapter 4) and were the same in all cases: LTB-PCRF1 (5'-ate gat 
aca aaa caa acg aat ctc aag c-3') and LTB-PCRR1 (5'-cca tgg cgt gga ttt tat gac att tta t-3'). 
These 28 bp primers amplify an 842 bp fragment from the TEV leader at the 5' end to part of 
the VSP terminator at the 3' end, including the LT-B-coding sequence. PCR reactions were 
carried out in a total volume of 50 pi containing 50-250 ng of maize callus genomic DNA, 5 
fil of 10X PCR buffer, 2 fil of dNTP mix (containing 10 mM of each dNTP), 12 fil of each 
primer (2.5 fiM stock), and 1 fil of Biolase Taq Polymerase (Biolase USA Inc., NJ, USA). 
Reaction conditions were as follows: Initial PCR activation (95°C, 3 minutes) was followed 
by 30 amplification cycles (denature, 94°C, 30 seconds; annealing, 60°C, 30 seconds, and 
extension, 72°C, 45 seconds) and a final extension step at 72°C for 5 minutes. 
To amplify the LT-A/S gene fusion and the LTA gene, the following primers 
LTAPCR-F1: 5'-ttc tta taa cag att cag gg-3'and LTAPCR-Rl:5'-ttg gta gtc tga gaa gat tt-3'. 
This primer set amplifies the end of the CaMV 35S promoter through to the end of the LT-A 
gene, a 1.6 kb and 900 bp fragment in P51P94 and P51P95 respectively. The composition of 
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PCR mix and PCR cycles were similar to those used for LT-B except that annealing was 
carried out at 58°C for P51P94, and extension was allowed for 1 minute. The PCR reaction 
in P51P95 events was performed as described for LT-B. 
Protein extraction from callus for ELISA 
Evaluation of protein expression was carried out in callus. This procedure was 
described in Chapter 2 of this dissertation. About 0.25 g of fresh callus was homogenized in 
500 pi of protein extraction buffer [25 mM Sodium phosphate (pH 6.6), 100 mM NaCl. 0.5% 
Triton X-100 (v/v), 10 pg/ml leupeptin (w/v)], after which they were centrifuged at 14.000 
rpm in a microcentrifuge for 15 minutes at room temperature. One hundred microliters of the 
supernatant (50 pi per well, 2 replications/sample) was used for ELISA. 
L T-B Expression Assay 
For LT-B assay, ganglioside-dependent ELISA was performed as previously 
described (Mason et al, 1998, Chikwamba et al, 2002) to determine the level of LT-B gene 
expression. 
LTK63 ELISA Assay 
To determine the amount of assembled LTK.63, ELISA was performed as described 
for LT-B expression, using rabbit anti-LTK.63 polyclonal (Provided by Hugh Mason. Boyce 
Thompson Institute at Cornell University, Ithaca, New York). Volumes of 50 pi were used 
throughout all ELISA assays unless otherwise specified. Wells were washed three times 
between each step using 300 pi of phosphate-buffered saline Tween-20 [PBST; 0.01 M 
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NaiHPQ», 3mM M KJH2PO4, (pH 7.2), 0.1 M NaCl, 0.05% Tween-20 (v/v)]. Microliter 
plates (Costar 3590, Fisher Scientific, PA, USA) were coated with Type III Gm( gangliosides 
(1.5 pg/well) from bovine brain (G2375, Sigma, St Louis, MO, USA), dissolved in sodium 
carbonate coating buffer (15 mM Na2(X>3, 35 mM NaHCOj, 3 mM NaN3, pH9.6) for 1 hour 
at room temperature. The plates were blocked to prevent nonspecific antibody binding with 
5% dry milk (w/v, DIFCO, Becton Dickinson, MO, USA) for one hour at room temperature. 
Callus extracts were captured on ganglioside coated dishes for one hour at 37°C or 4°C 
overnight, followed by incubation with rabbit antiserum against LTK63, (1:500 dilution), at 
37°C for one hour. This step allowed us to detect any LTAK63 associated with the LT-B 
and therefore quantify the assembled LTK63. Goat anti-rabbit IgG (KPL) alkaline 
phosphatase conjugate [1:2500 dilution in 1% dry milk (w/v) in PBS] was added, and the 
plate incubated for one hour. This was followed by addition of phosphatase substrate. 1 
mg/ml p-nitrophenyl phosphate (pNPP, Sigma) in alkaline phosphatase buffer [0.1 M Tris 
(pH 9.5), 0.05 M MgCh. 0.1 M NaCl]. Absorbance at 405 nm was immediately measured 
spectrophotometrically over a two-hour period in a Dynatech MRX Plate Reader (Dynex 
Technologies, VA, USA). Sample wells were blanked against non-transgenic maize protein 
extracts, and all measurements were performed in duplicate. Raw ELISA data were 
converted to LT |ig/|il by reference to an ELISA standard curve constructed using purified 
bacterial LT (kindly provided by John Clements, Tulane University Medical School, LA, 
USA). 
Detection of the S protein fragment 
For P51P94, three other ELISA assays were undertaken. To determine the amount of 
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LT-A/S associated with LT-B, plant extracts were captured on CM, gangliosides as 
described, and reacted with McClurkin swine hyperimmune serum (Kindly provided by Dr 
Ron Wesley, NADC, Ames, IA, USA) 1:1000 for one hour at 37°C. This was then followed 
by incubation with rabbit anti-pig horseradish peroxidase conjugate (Sigma, St Louis, MO, 
USA), at 1:7000 dilution. TMB peroxidase conjugate and peroxidase solution B (KPL. 
Gaithersburg, Maryland, USA) were mixed and added according to the manufacturer's 
instructions, and the reaction stopped after five minutes by the addition of 1M phosphoric 
acid. Absorbance at 450 nm was determined and results presented as absorbance (measured 
OD) values. 
Detection of LT-B associated with the LT-A/S fusion 
To determine the amount of LT-B associated with the LT-A/S fusion, microliter 
plates were coated with a mixture of monoclonal antibodies 4F6 and 5D5 (Supplied by Dr 
Ronald Wesley), diluted 1:1000 in coating buffer for 1 hour at room temperature. These 
monoclonal antibodies are specific to the S gene. The plates were blocked with 5% milk in 
PBST. Extracts were captured on the monoclonal antibodies for 1 hour at 37°C, and then 
reacted with goat polyclonal serum against LT-B (Biogenesis), incubated for 1 hour at 37°C. 
Rabbit anti-goat horseradish peroxidase conjugate [1:7000 dilution in 1% DM (w/v) in PBS] 
was added, and the dish incubated one hour. This was followed by addition of peroxidase 
substrate according to the manufacturer's instructions. Absorbance at 450 nm was 
determined and results presented as absorbance (measured OD) values. 
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Determination of total protein in callus extracts 
Total aqueous extractable protein concentrations in callus extracts were determined 
by the Bradford Assay (Bradford, 1976) with the BioRad (Hercules, CA, USA) protein dye 
concentrate using a standard curve derived from bovine serum albumin (BSA) standards. 
Immunoblot analysis 
A 30-50 pi aliquot containing 100-200 pg of total protein from maize callus was 
analyzed by SDS-PAGE (Laemmli, 1970). Protein samples were loaded directly on the gel 
without heat treatment. The separated proteins were transferred to a 0.45 pm nitrocellulose 
membrane using the BioRad Transblot apparatus according to the manufacturer's 
instructions. Proteins were evaluated for presence of assembled LTK.63 in P51P95 
transgenic calli by Western Blot analysis. The analysis used rabbit anti-LT-B antiserum and 
a biotin conjugated anti-rabbit IgG (Sigma, St Louis, MO, USA) at 1:3,000 and 1:30,000 
dilutions, respectively, using the procedures of Blake et al (1984). Identical membranes were 
also analyzed by rabbit anti-serum against LTK.63 and goat anti-rabbit biotin conjugate 
diluted 1:1500 and 1:30 000 respectively. 
To determine molecular weight of LT-A/S fusions, P51P94, extracts blotted onto 0.45 
micron nitrocellulose membrane were analyzed with McClurkin hyperimmune serum and 
anti-pig alkaline phosphatase conjugate (Sigma, St Louis, MO, USA) 1:2500, and 1:10,000 
respectively. Identical membranes were also reacted with goat anti-LT-B antiserum and an 
alkaline phosphatase conjugated anti-goat IgG (KPL) at 1:3,000 and 1:10,000 dilutions, 
respectively, to determine the position of LT-B relative to the S gene fragments. 
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Preparation of callus extracts to gavage mice 
Fifty grams of fresh actively growing callus were homogenized in a mortar and pestle 
into a smooth paste. Five milliliters of extraction buffer [25 mM Sodium phosphate (pH 6.6), 
100 mM NaCI] without Triton X-100 was added to the pastes and the slurry transferred into 
50 ml polycarbonate centrifuge tubes and centrifuged at 11,000 rpm. LT-B protein present in 
supernatant extracts quantified by ELISA as described. Non-transgenic calli were extracted 
in a similar manner and used for gavaging the negative control group. 
Preparation of viral lysates 
TGEV infected swine testicular cell lysates were obtained from Dr Wesley's lab were 
gamma irradiated to inactivate the virus. Viral lysates were used to gavage mice. 
Oral administration of recombinant proteins 
Seven-week old female inbred BALB/c mice were obtained from Harlan 
(Indianapolis, IN, USA) and were allowed a two-week adjustment period with reverse light 
dark cycle prior to onset of experiment. The mice were kept in the Iowa State University 
animal facility. All animal procedures were approved by the Iowa State University 
Laboratory Animal Resources Committee on Animal Care prior to experimentation. 
Mice were fasted 12 hours prior to administration of plant extracts or bacterial toxin 
by gavage with water ad libitum. Seven gavage material categories were used for this 
experiment, as shown in Table 1. These categories were non-transgenic B73 maize callus 
extracts, LT-B, LTK63, LTB/LT-A/S transgenic callus extracts, irradiated TGEV enriched 
viral lysates, bacterial LT-B and LT (see Table 1). Mice gavaged with these feed types were 
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referred to by these categories in the results section. The LT-B, LTK.63, bacterial LT-B and 
LT. were gavaged with 8pg LT-B equivalent in 200gl of plant extract or in the case of 
bacterial proteins, 8 pg LT-B in 200 |il in non-transgenic callus extracts. The group gavaged 
with P51P94 callus extracts contained 4 pg LT-B in 200 |il of plant extract. Measurements 
were based on LT-B levels because LT-B could easily be quantified. Eight mice were used 
per feed category, except the groups gavaged with enriched viral lysates, and P51P94 callus 
extracts (Table 1). Two mice were placed in each cage and gavaged with 200 gl of the 
appropriate callus extracts delivered in a 1 ml syringe attached to standard mice feeding 
needles. Three hours later and the mice returned to their main cages with their normal rodent 
food. Mice were fed on days 0,3,7,21,41 and 53. 
Serum and fecal sample preparation 
Fecal pellets and blood (approximately 100 fil) were collected once a week prior to 
fasting and feeding and once before euthanasia (days -1, 6, 13, 20, 41 and 53). Mice were 
not bled prior to feeding at day 3. Anti-LT-B antibody determination fecal and serum 
samples were prepared and assayed as described by Chikwamba et al, 2002 (Chapter 4). 
Patent mouse assay 
The patent mouse assay was also described previously by Chikwamba et al, 2002. 
The mice were challenged with LT (John Clements) on day 28. The mice were fasted for 12 
hours prior to the challenge with water available ad libitum and orally gavaged with 200 gl 
of PBS (pH 7.2) containing 25\ig LT. After toxin administration (three hours), the mice were 
euthanized by carbon dioxide inhalation, weighed, dissected and the gut removed from the 
duodenum to the anus. The gut, with the fat pad and the mesentery left intact, was weighed 
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separately. The gut/carcass ratio (Richardson et al, 1984) was then calculated to determine 
the extent of toxin induced water influx into the gut. 
Virus neutralization assay 
Three days before the assay, 96-well plates were seeded with ST cells. To check that the 
virus was still viable, a neutralization assay was carried out using rabbit polyclonal serum 
against TGEV diluted 1:100. The assay showed that the virus was indeed viable. The test 
sample sera were heat inactivated at 56°C for 20 minutes before use in test. About 40|il of 
serum sample from each mouse were used in the assay to start a 1:10 dilution assay. To 
make serum dilution plates, empty sterile 96-well plates were filled 50(0.1 per well of F-15 
with 2% fetal calf serum (FCS), except the first columns, which had 90 (il. Four replications 
(4X 12 wells) per sample were used in the test. Ten microliters of the first serum were added 
to the first columns in rows A-D and 10(4.1 of the second serum added to first column in rows 
E-F for each of the dishes used. Two fold dilutions were made by transferring 50 (il between 
rows and mixing before transferring to the next row. Twelve dilutions were made, and 50 [il 
from the last welsl were discarded. Fifty microliters of diluted virus containing 20 p.f.u. in 
F-15 with 2% FCS were added to each well in the dilution plate, and these plates were 
incubated at 37°C for 1 hour with CO2 and humidity. Plates were agitated occasionally. 
After flicking medium off of the 96 well plate with an ST monolayer, 100 (il from each well 
of the dilution plate were transferred to the corresponding well on the 96-well plate with an 
ST monolayer. The virus was incubated on the monolayer for 4 to 7 days, and the titer 
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checked by microscopy. The final titer was determined fixing cells with methanol and 
crystal violet staining. 
Results 
Herbicide resistant transgenic calli were analyzed for the presence of both the LT-B 
and LT-AK63 or the recombinant LT-A/S genes by PCR analysis. The constructs pRC9 and 
pRC9-l were each co-bombarded with pTH2lO, containing the LT-B gene cassette, and P2 
(Frame et al, 2000), encoding bialophos resistance. On average, seventy percent of the 
herbicide resistant transgenic calli contained all three genes based on herbicide resistance and 
PCR analysis. 
Independent callus events confirmed to be transgenic by PCR were further analyzed 
by ELISA. Ganglioside dependent ELISA was used to detect and quantify the expression of 
LT-B in both P51P94 and P51P95 calli. Table 1 summarizes some of the analyses in 
selected transgenic calli. LT-B expression ranged from 0.005 to 0.07% of total aqueous 
extractable protein (TAEP) in P51P94 and 0.005 to 0.15% of TAEP in P51P95 events. Some 
events with substantial LT-B expression did not show a positive PCR reaction or did not 
have a transcript for the second gene of interest, LT-AK63 (P51P95 Events #3, #26) or the 
recombinant LT-A/S (P51P94 Events #27, #28). 
ELISA assays were also carried out to detect expression of the second gene of 
interest. For P51P95, extracts captured on gangliosides were reacted with anti-LTK63 
polyclonal sera developed in rabbit to detect the assembled LTK63. The rabbit polyclonal 
serum had a high degree of non-specific reactivity with maize proteins, and showed very 
high background in non-transgenic maize callus extracts. The antibody reacted poorly with 
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the normal LT holotoxin that was used as a standard. Events with consistently higher relative 
absorbance readings than most of the other transgenic and non-transgenic events in this assay 
were selected for further analysis. RT-PCR and western analysis were used to confirm 
LTK63 expressing events. The events with higher absorbance in ELISA were associated 
with the presence of the LTAK63 transcript in RT-PCR analysis. To determine the 
proportion of the LTAK63 associated with LT-B, western analyses were performed, (Figure 
2). Probing with goat polyclonal sera against CT-B showed bands of an apparent molecular 
weight of about 84 kDa, the size of the assembled native LT. This apparent molecular 
weight suggests that most of the LT-B and LT-A were associated (Figure 2A), although a 
minor band of smaller molecular weight (LT-B alone, or LTAK63 associated with fewer than 
five LT-B monomers) was observed. Similar size bands were obtained when an identical gel 
was reacted with rabbit polyclonal serum against LTK63 (Data not shown). It is not clear 
from Western analysis whether the LTK63 was partially assembled or whether it dissociated 
in SDS-PAGE. Analysis of native LT by SDS-PAGE showed dissociation of the holotoxin 
into the pentamer and smaller aggregates, suggesting its instability in SDS-PAGE (data not 
shown). The amount of LTK63 obtained was based on LT-B expression, then estimated by 
Western analysis (Figure 2). In the case of P51P95 event #30, it was estimated that at least 
half the LT-B present was associated with LT-A. 
For P51P94, four different ELISA analyses were carried out to detect the presence of 
the recombinant proteins. Level of LT-B expression was detected by ganglioside ELISA as 
shown in Table 2. In the second ELISA, plant extracts were captured on Gmi gangliosides 
and reacted with anti-TGEV hyperimmune serum to detect the presence of the N-terminus of 
the S protein associated with the LT-B protein in the plant extracts. It was observed that the 
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TGEV enriched virus lysates had a high affinity for Gm i gangliosides, as did the plant 
synthesized S protein fragments (data not shown) Events P51P94 #7 and #31 had high 
relative absorbance readings. Callus extracts from the same events were captured on a 
mixture of monoclonal antibodies specific to the S protein (4F6 and 5D5), and then reacted 
with polyclonal anti-TGEV antibodies. Transgenic events with high relative absorbance 
were observed, including events #7 and #31. Transgenic event P51P95 #9 was used as an 
internal control to show that the LT-AK63 subunit did not have affinity for anti-S protein 
antibody. 
Extracts expressing recombinant LT-A/S protein were captured by monoclonal 
antibodies specific for S proteins and reacted with goat polyclonal serum against LT-B to 
detect the presence of LT-B associated with the LT-A/S recombinant protein. From these 
analyses, it was shown that events P51P94 #7, 9 and 31 were expressing both the LT-A/S 
fusion and LT-B proteins. These observations were confirmed by western analysis (Figure 
2C and D). These results suggested possible assembly of the LT-B and LT-A/S proteins. 
Western analysis of P51P94 plant extracts showed the presence of S-protein peptides as well 
as LT-B expression (Figure 2C and D). Western analysis did not show the presence of high 
molecular weight products, which would indicate the combination of LT-B and LT-A/S 
fusions. Another possibility is that assembled recombinant toxin could be dissociated in 
SDS-PAGE, and would therefore not be observed in Western analysis. While the co-
expression of both LT-B and LT-A/S proteins in the same transgenic events were confirmed 
by western analysis, immunoprecipitation attempts were not successful. P51P94 event #7 
was chosen to feed mice because of its substantial LT-B expression, at 0.06% LT-B of 
TAEP. 
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Mice feeding experiments were conducted using callus extracts from the transgenic 
events P51P95 event #30 and P5194 event #7. BALB/c mice were gavaged with 
homogenate from the transgenic callus expressing the recombinant proteins and bacterial 
proteins and TGEV infected ST cells as controls. Recombinant and bacterial toxins showed 
serum and mucosal immune responses (Figures 3 and 4). The results are presented as the 
mean antibody titer ± standard deviation (SD). Mice gavaged with 8gg of LT had detectable 
levels of serum IgG at day 13 of the experiment (Figure 3 A). The response by the end of the 
experiment was at 7.2±0.61 mg/ml. The response in mice gavaged with an equivalent 
amount of plant synthesized LTK63 was clearly distinguishable by 27, and peaked at 5.6±2.2 
mg/ml. The response in this group of mice was characterized by higher variability (large SD) 
compared to the group gavaged with bacterial LT (Figure 3A). This antibody response was 
higher than that induced by bacterial LT-B (compare 5.6±2.2 mg/ml to 4.1 ±0.62, Figure 3A). 
The level of immune response induced by an equivalent amount of bacterial and plant 
synthesized LT-B was also assayed over the course of the experiment. The plant derived LT-
B induced a response that was lower than the bacterial LT-B at 3.1±2.16 mg/ml compared to 
the bacterial LT-B at 4.1±0.62 mg/ml (Figure 3A). The plant derived LT-B response was 
also more variable than the bacterial LT-B. 
Fecal anti-LT-B IgA was also determined in fecal pellets over the course of the 
experiment and the results are shown in Figure 3B. Bacterial LT induced 0.090±0.017 
mg/ml, while plant LT-derived induced 0.08±0.007-mg/ml anti-LT-B IgA. Plant LT-B 
induced the lowest anti-LT-B fecal IgA at 0.02±0.008 mg/ml and bacterial LT-B induced 
0.06±0.006 mg/ml. 
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Serum IgA was also measured over the course of the experiment (Figure 30) to 
corroborate the observed fecal IgA. The native bacterial LT had a serum IgA titer of 
l.7±0.261 mg, compared to plant derived mutant LT (1.5±0.910 mg/ml. Figure 3C). Like the 
IgG response observed in mice gavaged with plant derived LT had a larger variation in 
response. Mice gavaged with bacterial LT-B had a higher antibody titer at 0.34±0.012 
mg/ml compared to mice gavaged with plant LT-B at 0.2±0.042 mg/ml. Mice gavaged with 
plant LT-B had a higher level of variation compared to mice gavaged with plant derived LT-
B (Figure 3C). 
Sera and fecal pellets from mice gavaged with P51P94 extracts were also analyzed 
for anti-LT-B and anti-TGEV antibodies and the results are presented in Figure 4. Four mice 
were gavaged with the non-transgenic maize callus extracts (negative group), another group 
of four mice were gavaged with callus extracts from P51P94 #7, which expressed 4 pg LT-B 
in 200 gl of extract and S protein peptides (group designated LTB-TGE). The positive 
control group was gavaged with irradiated TGEV enriched swine testicular cell lysates. and 
this group was designated TGE. The LTB-TGE group extracts induced serum anti-LT-B IgG 
(3.11±2.2 mg/ml, Figure 4A) but only background levels of fecal IgA, 0.011 ±0.008 mg/ml, 
were observed Figure 4B. The TGE had an unexpectedly high serum anti-LT-B IgG 
background titer at 1.8±1.66 mg/ml Figure 4A. Serum anti-LT-B IgA levels (0.112±0.04 
mg/ml, Figure 4C) confirm the production of IgA antibodies to LT-B, which was observed to 
be low (Figure 4B). Anti-TGE serum antibodies were not detected in serum from mice in 
any of these groups. 
On day 28, four mice from each of the negative, plant LT, plant LT-B, bacterial LT 
and bacterial LT groups were subjected to challenge by 25 |ig of LT. In each group, two 
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mice were challenged with 25 gg LT in 200 ml of PBS, and the other two were challenged 
with 200 |il of PBS. No protection was observed in any of the groups challenged as reflected 
by the high gut: carcass ratio (data not shown). 
Discussion 
Synthetic genes encoding E. coli heat labile toxin subunits LT-B and the mutant LT-
AK63 under the regulation of the constitutive CaMV 35S promoter were co-expressed in 
transgenic maize callus. ELISA and western analyses showed the presence of the assembled 
LTK63 holotoxin. An S gene fragment containing the antigenically important A and D 
epitopes of the S gene derived from PRCV strain was co-expressed with a synthetic LT-B 
gene in transgenic calli. ELISA and western analysis showed that the N terminal domain 
fused to LT-A1 subunit was expressed in transgenic maize callus. We demonstrated with 
this work that maize can competently synthesize a functional LTK63 holotoxin, and a non-
optimized fragment of the S gene common to PRCV and TGEV. 
The plant optimized LT-B and LTAK63 genes were co-expressed in transgenic maize 
callus as control for the P51P94 experiment. The two genes had their codon usage (Gribskov 
et al, 1984) optimized for expression in maize and potato. The two subunits were expressed 
and assembled into the mutant LTK.63 in transgenic maize callus. The level of expression 
was based on the level of LT-B analysis, because LT-B could be easily quantified by 
ganglioside dependent ELISA. The rabbit polyclonal antibody against LTK63 could not be 
used to accurately quantify the amount of LTK63 expressed in maize because of its high 
degree of non-specific reaction to other proteins in maize (Chikwamba unpublished). 
Furthermore, in our hands, this antibody reacted poorly with the native bacterial LT that was 
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used as the positive control and standard. No commercial LTK63 was available for this 
purpose. 
While bacterial LT induced elevated levels of antibodies (IgG and IgA) earlier in the 
experiment, by the end of the experiment (Day 53), the mutant LTK.63 induced antibodies 
were not significantly different from the antibody titer induced by LT. Furthermore, 
antibody titers induced by LTK63 were consistently higher than the antibody titer induced by 
bacteria derived LT-B. The anti-IgA assays showed that the fecal anti-IgA titer was lower 
than to the serum IgA. The anti-IgA antibody in serum is usually measured to corroborate 
the observations on fecal IgA assays. These results suggest the possible degradation of 
antibodies in the fecal pellets. Larger variability in antibody titers was observed in mice 
gavaged with the plant derived recombinant proteins compared to those gavaged with 
bacterial LT and LT-B. This variability could be attributed to the stability of recombinant 
proteins in liquid plant extracts. 
The orally immunized mice were challenged with 25 gg of LT at day 27. Results of 
this challenge show that none of the mice had adequate antibodies to be protected from 
challenge by 25 pg of LT. The experiment was therefore continued with the remaining mice 
to monitor the trends in antibody titers. In previous work, oral immunization with maize 
kernel derived LT-B induced a much higher level of anti-LT-B antibodies by day 27, 
although higher amount of LT-B was used (10 pg compared to 8 pg in the current 
experiment). These results suggest that the administration of toxins by gavage may not 
induce as much anti-LT-B antibody as was observed in previous work. These results indicate 
that the formulation of plant derived vaccines could have important implications for their 
effectiveness. 
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Maize-derived LTK63 induced serum and mucosal antibodies that were higher than 
bacterial LT-B and comparable to the response induced by the native LT. Mutant LTK63 
synthesized in bacteria has been shown to consistently induce serum and systemic antibodies 
that were higher than those induced by bacterial LT-B (Pizza et al, 2001). However, high 
variability in the data impedes clear statistical analyses. 
We demonstrated that the two genes can be successfully expressed in transgenic 
maize callus and accumulate in pentameric Gmi binding form. The extracts from transgenic 
calli expressing the mutant LTK.63 protein induced anti-LT-B antibodies upon oral 
immunization of BALB/c mice by gavage. Maize synthesized LT-B induced elevated IgA 
and IgG serum antibodies and elevated fecal IgA against diarrhea-inducing LT. This work 
demonstrates that maize synthesized LTK63 is an effective immunogen, inducing in BALB/c 
mice an antibody titer which is comparable to bacterial derived LT-B and LT. Continuing 
work in our laboratory involves expression of the mutant LTK.63 in transgenic maize kernels 
under the control of the 27 kDa gamma zein promoter. The LTK63 can be used as an oral 
vaccine itself or as an adjuvant co-administered with conventional or co-expressed antigens. 
ELISA analyses of P51P94 callus were used to detect recombinant proteins and to 
demonstrate assembly of the LT-B and LT-A/S fusion proteins. Assays in which the plant 
extracts were captured on a mixture of monoclonal antibodies against the S gene were carried 
out to determine the presence of S gene peptides in the plant extracts. Absorbance (OD450) 
readings confirmed the presence of peptides that were recognized by anti-TGEV polyclonal 
sera, indicating that the transgenic calli were expressing the LT-A/S gene. Because of the 
lack of purified TGEV virus, the amount of S gene peptides expressed in transgenic calli 
could not be quantified accurately. ELISA assays in which plant extracts were captured on 
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Gm i gangliosides were used to detect the level of LT-B gene expression and also the amount 
S protein peptides associated with the LT-B gene, if any. LT-B could be detected in plant 
extracts captured on anti-S protein monoclonal antibodies, yet bacterial LT-B alone did not 
bind to these monoclonal antibody. These results suggest assembly of LT-B and the LT-A/S 
fusion protein. A reciprocal of this experiment (capturing the extracts on Gmi antibodies and 
probing for S gene protein fragments) could not be used to demonstrate assembly of these 
two proteins because it was shown that the TGEV virus and the plant synthesized S gene 
fragments had a very strong affinity for Gmi gangliosides. This finding was perhaps not 
surprising because the Gmi gangliosides are parts of receptors on epithelial cells in the gut, 
and some others. The TGEV and PRCV virus make contact with the host through epithelial 
surface on the respiratory and gastrointestinal mucosa respectively, and Gmi gangliosides 
may play a role in this contact. 
The affinity of the S protein for Gmi gangliosides could find utility in assays to detect 
the TGEV and PRCV viruses, and also to capture the virus in anti-TGEV and anti-PRCV 
antibody determination in various sera using an ELISA method. Assembly of the LT-B and 
LT-A/S fusions could not be confirmed by immunoprecipitation experiments. This could be 
attributed to the low LT-B expression in the transgenic events in which strong S gene 
expression was detected. The rationale for co-expressing LT-B and LT-A/S fusions was that 
in the scenario that assembly was achieved, the LT-B was expected to deliver the LTA2/S 
fusion protein to the G ALT. Without assembly, it was expected that the LT-B gene in its 
role as an adjuvant would stimulate the induction of antibodies against the LT-A/S fusion 
proteins with which it was co-administered. Anti-LT-B antibodies were detected in mice 
gavaged with plant extracts expressing LT-B and the LT-A/S fusion proteins. However, no 
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anti-S gene antibodies were observed in mice gavaged with the ST lysates enriched for the 
TGEV virus or in mice gavaged with plant extracts expressing LT-B and the LT-A/S fusion 
proteins. There are several possible explanations for this observation. For the plant group 
gavaged with plant extracts containing LT-B and the LT-A/S fusion proteins, it is possible 
that the concentration of either LT-B, the S protein or both was not high enough to induce an 
antibody response by the oral route of administration. Administering the plant extracts 
parenterally could induce antibodies to prove that the fragment selected had the antigenic 
epitopes required to induce the virus neutralizing antibodies in mice. As for the group 
administered with the virus-enriched lysates, it is possible that mouse is not appropriate 
model for induction of anti-TGEV inducing antibodies by oral administration of the 
inactivated virus. It is also possible that there was low immune response, which could not be 
detected by the methods of analyses used. Recovery of transgenic events with high 
expression of both LT-B and the fusion would be essential to the conclusion of this 
experiment. 
Yu and Langridge (2001) demonstrated that expression of CT-A and CT-B oligomers 
successfully provides a valuable approach to target plant synthesized antigens to the G ALT. 
These authors fused a 22 amino acid immunodominant epitope of the murine rotavirus 
enterotoxin NSP4 (66 bp) to the CTB sub-unit and the ETEC fimbrial colonization factor 
CPA1 (43lbp) to the N-terminus of CTA2 sub-unit. We attempted to express a much larger 
S gene fragment (1.12 kb) in fusion with the LT-A2 subunit. Determining the size limit of 
fragments that could be fused to these subunits is an area that warrants further investigation. 
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Figure 1. Schematic diagram of constructs used for maize callus transformation to generate 
LT-B-expressing transgenic plants. All constructs are in a pUC19 vector and contain the 
CaMV 35S promoter, 35S promoter; TEV, tobacco etch virus translational enhancer leader 
sequence; sLT-B, the synthetic LT-B gene; sLT-A, the synthetic LT-AK63; gene Tvsp, 
soybean vegetative storage terminator; SEKDEL, endoplasmic reticulum-retention sequence 
motif; PRCV S, the N-terminal half of the PRCV gene common to TGEV; BSP, bacterial 
signal peptide from LT-B; ASP, bacterial signal peptide from LT-A. 
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Figure 2. Western blot analyses of total protein extracts of P5194 and P5195 callus. 30-
50|il of extracts containing 50-100|ig of total protein for P5195 and 100-200|ig of total 
protein for P5194 were loaded onto a 12% SDS-PAGE and transferred to a 0.45 micron 
nitrocellulose membrane. (A) P5195 extracts probed with anti-CT-B antibodies. (B) P5194 
extracts probed with anti-CT-B antibodies. (C) P5194 extracts probed with anti-TGEV 
antibodies. 
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Figure 3. Anti-LT-B antibody analysis in orally immunized mice. Mice in each feed 
category were gavaged with nontransgenic maize callus extracts (negative), plant derived 
LT-B from P51 calli (plant LT-B), plant derived LTK.63 from P5195 calli (plant LT), 
bacterial LT-B and bacterial LT on days 0, 3, 7 and 21, 41 and 53. A. The levels of serum 
anti-LT-B IgG. The levels of fecal anti-LT-B IgA. The levels of serum anti-LT-B IgA. 
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Figure 4. Anti-LT-B antibody analysis in orally immunized mice. Mice in each feed 
category were gavaged with non-ransgenic maize callus extracts (negative), plant derived 
LT-B and LTA/S fusion from P51P94 calli (LTB-TGE) and TGEV enriched ST cell lysates 
(TGE), on days 0, 3, 7 and 21,41 and 53. The levels of serum anti-LT-B IgG. The levels of 
fecal anti-LT-B IgA. The levels of serum anti-LT-B IgA. 
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Construct/ Proteins # of mice Group Designation 
Genotype assigned 
B73 none 8 Negative 
P51 Plant synthesized LT-B 8 Plant LT-B 
Plant synthesized 
P5195 LTK63 8 Plant LT 
N/A Bacterial LT-B 8 Bacterial LT-B 
N/A Bacterial LT 8 Bacterial LT 
p5194 Plant LT-B/LTA/S 4 LTB-TGE 
N/A Virus enriched lysates 4 TGE 
N/A indicates categories that did not derive from plant extracts 
Table 1. Categories of material gavaged and number of mice assigned to each 
category and group reference for result description 
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Construct Event ID LT-B 
PCR (+/-
P94 or P95 
PCR(+/-) 
% LT-B in 
TAEP 
Northern transcript 
transcript P94 or P95 
) (Y/N) 
3 + 4- 0.005 -
4 4" + 0.03 -
5 4- -r- 0.01 nt 
7 + -r 0.06 -
9 + + 0.01 -
10 + + 0.02 nt 
13 - 0.01 -
15 + + 0.04 -
19 + -r 0.02 -
20 + + 0.03 -
25 + 0.01 -
26 + + 0.03 -
27 + - 0.07 -
28 + - 0.04 -
29 + + 0.005 nt 
30 + - 0.04 -
31 + 0.005 -
32 + + 0.01 -
1 + - 0.005 nt 
2 + + 0.06 nt 
3 + - 0.03 -
4 + -r 0.005 nt 
9 + + 0.04 -
11 + - 0.005 -
12 + + 0.005 -
13 + 0.005 -
15 + - 0.01 -
16 + + 0.005 -
17 + + 0.01 -
19 + + 0.005 
20 + + 0.005 -
21 + + 0.005 -
22 + + 0.01 -
26 + + 0.15 -
27 + + 0.01 -
28 + - 0.05 -
30 + 0.11 -
P51P94 
P5IP95 
nt indicates events that were not tested in RT-PCR 
Table 2. Analysis of selected P94 and P95 transgenic events. LT-B levels expressed as 
% LT-B in total aqueous extractable protein. 
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CHAPTER 6. 
Comparison of antigenic and evolutionary relationships among some 
Coronaviruses: implications for the elucidation of structure function 
relationships and development of oral vaccines. 
Rachel Chikwamba and Gavin Naylor 
Manuscript in preparation 
Summary 
The S glycoprotein is the structural protein of the large, petal-shaped spikes which are 
characteristic of the coronaviruses, and plays a major role in critical processes such as host 
cell receptor binding, induction of fusion of viral envelope with cell membrane, induction of 
neutralizing antibodies and eliciting cell-mediated immunity. Protein sequences of the spike 
(S) protein of 12 coronaviruses were collected from GenBank, aligned and subjected to 
phylogenetic analysis. The analysis of the sequence data produced dendograms. which 
supported the traditional groupings based on serological evidence. The high confidence level 
along the tree as reflected by bootstrap values suggests the inferred evolutionary history is 
reliable. While the relatedness of these viruses supports their classification into serological 
subgroups, specific genomic sequences are yet to be directly associated with specific 
functions such as virion binding, alterations in biological activity, or even tissue tropisms. 
and virulence. Regions of high and low sequence homology suggest that regions which code 
for protein domains that define cross-reactive group epitopes and virus specific epitopes may 
be highly conserved. As the crystal structure of the S protein has not yet been resolved, it is 
difficult to assess the significance of non-conserved regions. 
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Epitopes inducing virus-neutralizing antibodies have been mapped to the S protein of 
several coronaviruses. We examined the conservation of epitopes and other regions of 
known function across the S genes in the different coronaviruses with reference to the 
coronavirus TGEV. The result of this analysis was that critical epitopes are highly conserv ed 
within the antigenic clusters. Regions thought to be involved in the conformation of the 
peplomer protein are also highly conserved in all the sequences analyzed. Viruses evolve 
rapidly, yet certain key sequences have remained highly conserved. This paper examined 
how the sequences have changed within antigenic clusters and from one antigenic cluster or 
evolutionary clade to the next. Some potentially function-determining changes were 
observed that we speculate to be major contributors to the antigenic cluster. Although 
sequence alignment is not commonly used for elucidation of structure function relationships 
in viruses, it is becoming increasingly common in fields such as bioinformatics. Ultimately 
sequence alignment could contribute to the resolution of the viral protein three-dimensional 
structure. 
Introduction 
Coronaviruses are a genus in the family Coronaviridae. They are large, enveloped, 
positive strand RNA viruses and are important pathogens in humans and domestic animals. 
They are noted as having the largest genomes of all RNA viruses and replicate by a unique 
mechanism, which results in a high frequency of recombination (Holmes and Lai, 1996). 
The unique replication strategy involves discontinuous RNA synthesis and polymerase 
jumping, and can result in recombination rates of up to 25% (Baric et al, 1974). 
Coronaviruses were initially recognized as a separate virus group by their distinctive virion 
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morphology in negatively stained preparations, (Macintosh, 1974) (Figure 1). The viral 
envelopes are studded with long, petal-shaped spikes, and the nucleocapsids are long flexible 
helices. Typically, coronaviruses are characterized by a restricted host range and tissue 
tropism. Other classifying features include their replication strategy, genome organization 
and mRNA structure, nucleotide sequence homology, serology and properties of other 
structural proteins. 
Serological classification 
Coronaviruses have been grouped into three serologically distinct groups on the basis 
of antigenic relationships (Table 1). Within each sero-group, their natural hosts and 
antigenic cross-reactivity identify viruses (Sanchez et al. 1990). Viruses within an antigenic 
group can be distinguished from one another by virus neutralization titers or 
hemagglutination inhibition tests when homologous and heterologous antibody titers are 
compared (Gema et al, 1985). Most coronaviruses naturally infect only one species or 
several closely related species. Virus replication in vivo can cause systemic infections or. 
localized infections if restricted to a few cell types, usually the epithelial cells of the 
respiratory or enteric tracts and macrophages. 
Coronaviriis structural proteins 
The genomic organization and RNA sequences of many coronaviruses have now been 
determined. Coronavirus viral RNA codes for three types of protein the nucleocapsid (N) 
phosphoprotein, the membrane (M) and the spike (S) or peplomer protein. Exceptions to this 
include the human coronaviruses of the OC43 group, bovine coronavirus (BCV). porcine 
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hemagglutinating encephalomyelitis (HEV), turkey coronavirus (TCV), which possess an 
additional surface glycoprotein, the haemagglutinin-esterase (HE) (Hogue and Brian. 1986. 
Holmes and Lai, 1996). The M, N and S viral proteins are all important for inducing the 
immune response to coronaviruses (Buchmeir et al 1984, Delmas et al, 1990) but studies of 
the induction of protective immunity have focused on the S gene as the major inducer of 
neutralizing antibodies. The S glycoprotein is the structural protein of the large, petal-shaped 
spikes (peplomer) (Figure 1 ). Each peplomer consists of a dimer or trimer of S proteins 
(Cavanagh, 1983). In coronaviruses such as MHV and infectious bronchitis virus (IBV) but 
not FIPV or TGEV, the S glycoprotein is cleaved into two non-identical sub-units, amino-
terminal SI and carboxy-terminal S2, probably containing the global and stem portions of the 
molecule respectively (Spaan et al 1988). The precise residue where the stem part of the S 
peplomer might start could be revealed by the elucidation of the S protein's atomic structure. 
The deduced amino acid sequences of many coronavirus S genes shows many 
potential N-linked glycosylation sites and 4 structural domains which include a short 
carboxy-terminal cytoplasmic domain, a transmembrane domain and two large external 
domains called SI and S2 (Wesseling et al, 1994, Holmes and Lai, 1996). The cytoplasmic 
domain is rich in cysteine residues, which could be part of a complex tertiary structure 
involved in the assembly of the spikes or in interaction with other viral proteins (Holmes and 
Lai, 1996). The lengths and nucleotide sequences of the SI glycoproteins of different 
coronaviruses are quite diverse and such variation has been observed even in different strains 
of a single coronavirus. Holmes and Lai (1996) suggest that the diversity in SI probably 
results from mutation and recombination between coronaviruses and strong positive selection 
in vivo, and such changes in S1 have been associated with altered antigenicity and virulence. 
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However, several hypervariable regions in the SI sequence where large deletions or 
insertions commonly occur may represent externally oriented loops that are not essential for 
the structure of spikes (Paul et al, 1994). 
The S protein has many important biological functions (Paul et al, 1994). including 
binding to specific host cell receptor glycoprotein, induction of fusion of viral envelope with 
cell membrane,and induction of neutralizing antibodies and eliciting cell-mediated immunity. 
Of interest to this discussion, is the fact that monoclonal antibodies to S can neutralize virus 
inactivity and inhibit membrane fusion, effectively curtailing viral replication in host cells. 
Recently there has been a surge in the desire to develop recombinant oral vaccines 
against coronaviruses by expressing antigenic proteins in baculovirus and adenovirus 
(Callebautt et al, 1996, Torres et al, 1995, Shoup et al 1997 and Tuboly et al 1994). Oral 
vaccines can be developed through the expression of immunogenic viral epitopes in a viral 
expression vector or in edible parts of crops that are used as feed. Expression of proteins in 
baculovirus allows for production of foreign proteins in high amounts and allows for post-
transcriptional glycosylation where necessary (Shoup et al 1997). Considerable effort is 
being made toward the development of plant based oral vaccines (Welter et al, 1996. Mason 
et al 1998). One of the critical aspects of such initiatives is to decide which antigenic 
epitopes to express in the vaccine delivery system. The S gene has been the candidate antigen 
in most cases. In this paper we examined the conservation of epitopes across the S genes in 
the different coronaviruses. Conservation of epitopes across those viruses that affect 
gastrointestinal and respiratory tracts has practical implications in the development of oral 
vaccines. Shoup and coworkers 1997 showed the immunogenicity of various fragments of 
the S protein expressed in baculovirus and their potential to neutralize the swine TGEV. 
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Human trials of an oral vaccine against traveler's disease, a bacterial disease that causes 
diarrhea in humans (Mason et al, 1998) indicate that plant based oral vaccine have a lot of 
potential as effective vaccines against pathogens. Expression of animal viral proteins in 
plants may necessitate a redesign of the immunogenic protein gene to optimize codon use 
and enhance expression. This wholesale codon optimization requires redesigning the gene in 
question so usually the relevant epitope(s) is chosen for expression because it is usually 
smaller and easier to redesign. It would be prudent to select an antigenic site, which 
produces virus-neutralizing antibodies against a virus as well as other closely related viruses. 
This paper aims to examine the evolutionary relationships among coronaviruses by 
comparing the S genes. Because of the key role of the S glycoprotein in immunogenicity in 
coronaviruses, considerable effort has been made to study the structure and functional 
importance of the various domains in different coronaviruses. While immunogenic epitopes 
have been identified on the S protein for the different viruses, specific genomic sequences 
have yet to be directly associated with alterations in the biological activities in the 
coronaviruses. We expect that regions, which code for protein domains that define cross-
reactive group epitopes and virus specific epitopes to be highly conserved. The S gene of the 
swine transmissible gastroenteritis virus (TGEV) has been extensively characterized, and so 
for the most part, will be used as a reference. 
We have made a simple analysis of evolutionary relationships among several 
members of the Coronaviridae based on deduced amino acid sequences for the S gene to 
determine if they reflect the serological sub-groupings into which the family members have 
been classified. Aligning the sequences has permitted examination of just how conserved 
certain key features of the protein are across the different groups, to see how they correlate 
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with function (e.g. tropisms). It is expected that this type of analysis will shed light on 
structure function relationships. The results of our analyses of relatedness of S sequences 
support the classification of the viruses into their serological sub-groups. This reinforces the 
importance of this protein as a potential candidate for the development of oral vaccines. 
Materials and Methods 
Twelve coronavirus S protein gene sequences were collected from the GenBank 
database on the World Wide Web and they included the S genes from porcine transmissible 
gastroenteritis virus (TGEV), porcine respiratory coronavirus (PRCV), murine hepatitis virus 
(MHV), feline infectious peritonitis virus (FIPV), feline enteric coronavirus (FECV), human 
respiratory coronavirus (HCV strains 229E and OC43), bovine coronavirus (BCV), canine 
coronavirus (CCV strains Insavc and K378), avian infectious bronchitis virus (IBV) 
Beaudette strain and another novel avian IBV strain (designated avian). There were several 
viruses shown in the antigenic clusters in Table 1, for which sequences were not readily 
available on the public databases. These DNA sequences were converted to amino acid 
sequences using the computer program Se-AL (version 1.0 alpha 1, 1996). The sequences 
were aligned using the computer program Clustal X, and analyzed using the programs PAUP 
(Version 4.0), for construction of evolutionary trees and in McClade (Version 3.07) to 
determine character states, conservation of domains and other features. 
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Results and Discussion 
Evolutionary relationships and antigenic clusters 
The clades on the evolutionary tree shown in Figure 2 reflect the antigenic clusters 
shown in Table 1. The bootstrap support values (Felsenstein, 1985) shown in (Figure 2) are 
very high, with a consistency index of 0.97 reflects the strength of the evolutionary 
relationships among these groups. The same tree topology resulted for neighbor joining, 
UPGMA and parsimony. The concordance between antigenic classification and the clades 
on the evolutionary tree might be expected as the evolutionary tree was determined on the 
basis of homology in the S protein, which, as mentioned earlier, is the main site of several 
immunogenic motifs. The fact that the evolutionary relationships developed from the S gene 
show such unambiguous support as reflected by bootstrap suggests the relationships between 
these viruses are correct. It also implies that the S gene is the major site of evolutionary 
change that has led to, or at least contributed significantly to the appearance of new strains. 
The S gene is the site of viral binding to host cells and other critical regions. In this case, 
HCV-229E was used to define the out-group on the basis of its nucleotide distinctness from 
the rest of the coronaviruses, including HCV-OC43, another human coronavirus. 
Comparison amino acid profiles 
An analysis was made of the general conservation of amino acids across the protein 
for all 12 sequences in the data set using McClade (Version 3.07, 1997). This profile shows 
that generally residues are quite variable across the proteins, although some regions are 
obviously more variable than others are. However, when the data is split into the two major 
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clades on the evolutionary tree, very striking differences are observed (Figures 3). The 
antigenic cluster I group show marked conservation in the N-terminus, as shown in figure 
3(a). According to the literature, the critical antigenic motifs for sero-group I are present as 
small highly conserved sites in the N-terminus, which for the most part is highly variable 
(Delmas et al, 1986). Delmas and others (1990) propose that the high level of cross 
neutralization in this group is due to a clustering of most of the critical neutralization 
epitopes within the structurally conserved and immunodominant N-terminal 26K. region. The 
antigenic clusters II and III combined on the other hand, show conservation in the C-terminus 
as reflected by figure 3(b). It therefore seems that the antigenic determinants for these two 
groups are found on opposite ends of the S protein. 
Analysis was also made of the frequency of amino acid residues. Hydrophobic amino 
acids such as leucine are most prevalent. Other prevalent hydrophobic amino acids such as 
valine, serine and threonine are also quite abundant. While the specific amino acids are 
variable, the hydrophobic profiles of these proteins are well conserved. Figure 4 shows 
bubble plots showing the relative frequency of amino acid changes counted over the inferred 
evolutionary tree, split along the antigenic clusters I and II and III combined. Most of the 
prevalent changes are between the hydrophobic amino acids, which effectively does not 
change protein function. Changes like this include those from leucine to phenylalanine and 
from valine to isoleucine. This is consistent with the generally hydrophobic nature of this 
protein and can perhaps be explained by the fact that the S protein has several hydrophobic 
domains. These include a trans-membrane domain and a second strongly hydrophobic 
domain in the carboxy-terminus, the trans-membrane anchor (Figure 6(a)) (Rasscheaert and 
Laude, 1987). Another contributor to the protein's hydrophobicity is 14-19 amino acid 
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stretch at the amino terminus of the S protein, which comprise the signal peptide. What is 
most striking is the difference in the two profiles of unambiguous changes for the two main 
subgroups (Figure 4). While the changes within the hydrophobic group are most prevalent, 
cluster I seems to have fewer changes than clusters II and II combined. 
Changes within antigenic clusters 
Substitution of hydrophilic for hydrophobic amino acids is of particular interest as 
this may relate to differences in function (virulence, tropism etc). An analysis between 
particular strains, which highlights such changes, would be particularly useful. These 
changes would be especially useful in regions whose functions are known. For example, in 
some proteins, regions with enzymatic action can barely tolerate such changes. We examined 
the alignments for such functionally important changes between and within antigenic 
clusters. There are several regions that have many successive changes as the clades branch 
off, some of them are conserved within the clades and some are not. It is not easy to discern 
the importance of such changes, especially when they occur without some obvious or 
systematic pattern, although it can be concluded that the conserved ones must be of some 
functional importance. Where cluster I branches of, there is a region of rapid change that is 
observed from residues 560-583. These changes are occurring within the immunodominant 
site A, which is highly conserved in this cluster. In view of the antigenic importance of this 
site, these could be part of the defining changes for this cluster. Changes at residues 560 
(Ser-Met), 563 (Val-Ser) and 566 (Lys-Gly) occur with such regularity they display the 
periodicity of a helix, a feature that is important in functional regions, which this region is. 
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Analysis of regions of known functions 
Several alignments were made after with different values for a gap penalty and the 
antigenic clusters are consistently maintained to reflect the strength of these relationships. 
Differences in variability profiles can be used to identify shifts in function at molecular level. 
On the other hand, regions that are structurally important are more tightly constrained 
therefore less free to vary. Sequence comparisons can also shed light on functionally 
important candidate sites for experimental verification using site directed mutagenesis, 
circumventing the need for random mutagenesis (Naylor et al, 2000). Variations in regions 
in which some function is known were examined and are discussed individually below. 
Signal peptides 
There is a 14-19 amino acid stretch of hydrophobic amino acids at the beginning of 
each protein, which contribute to the overall hydrophobicity of the S glycoprotein. This 
hydrophobic signal peptide is required to ensure that the S protein attached to the 
endoplasmic reticulum where the virions are assembled. The signal peptides of viruses in 
each antigenic cluster consistently align. 
Antigenic Epitopes 
The S gene is the site of critical immunogenic epitopes, which induce virus-
neutralizing antibodies in the host. In the swine transmissible gastroenteritis virus, the 
critical antigenic epitopes have been mapped to the N-terminal half of the S gene. 
Immunogenic epitopes (A-D) have been mapped in the S gene (see cartoon in Figure 5). 
Sites A and D (Figures 6(a) and (b) respectively) are fairly well defined and have been 
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demonstrated to be capable of inducing virus neutralizing antibodies the host system. Site A 
is the immunodominant epitope and is necessary for induction of virus neutralizing 
antibodies in vivo. This epitope is thought to be conformation and glycosylation dependent 
and in TGEV this stretches from residues 538-591. Site D (figure (6b)) on the other hand is 
thought to be continuous and linear, in TGEV stretches from residues 378-395 and includes 
the critical residues SSFSYGEI. Mutations in site D in TGEV were noted to lead to 
markedly reduced pathogenicity. Sites A and D are highly conserved in the first antigenic 
cluster, and both have hydrophilic residues as the critical residues, indicating that they are 
most likely exposed on the surface of the spike protein to interact with the host cells. In the 
different alignments that were made, these residues consistently align, and corresponding 
positions in sequences that are not in the same antigenic cluster are noted to have neither the 
same nor similar hydrophilic residues. 
Site B in TGEV stretches from residues 97-144, this sequence is only partly 
conserved in other viruses in this cluster. Site C on the other hand is poorly defined, and in 
PRCV, a mutant strain of TGEV, these sites are missing. TGEV and PRCV are very closely 
related and deserve special mention. Nucleotide sequences of PRCV have a characteristic 
deletion in the 5" end of the S gene compared to TGEV. TGEV causes severe diarrhea with 
high mortality in neonatal swine. It replicates in and destroys the enterocytes of the villus 
epithelium in the small intestine, which causes the subsequent malabsortion and dehydration 
characteristic of transmissible gastroenteritis. TGEV has also been shown to replicate to a 
limited extend in the respiratory tissue of infected swine. PRCV is believed to be a mutant of 
TGEV, as it has been shown to be antigenically and genetically related to TGEV but has a 
selective tropism for respiratory tissue with very little or no replication in the intestinal tissue 
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of infected swine. Since TGEV and PRCV are closely related and yet display differences in 
tissue tropism and pathogenicity, they serve as useful models for the study of coronavirus 
genes involved in tropism and virulence (Vaughn et al 1995). 
Receptor Binding sites 
Sanchez and others (1990) suggest that tissue tropism of coronaviruses is conditioned 
by the S glycoprotein and the respiratory or enteric tissues could recognize receptor-binding 
sites in the S proteins. Virus spikes mediate the entry of TGEV into host cells through the 
interaction of a specific domain of the S protein with amino peptidase N (APN). an 
ectoenzyme abanduntly expressed on the small intestine enterocytes (Delmas, 1990). The S 
protein therefore mediates APN receptor recognition (Godet et al, 1994). Mutations have 
been noted in the S encoding gene, which do not affect the replication of the virus in cell 
cultures but lead to dramatic attenuation of enteropathogenicity. These mutations were noted 
to occur in the amino acid stretch from residue 145-155 from the mature protein N terminus. 
Using a recombinant protein containing the amino terminal 330 residues of the SI sub-unit. 
Kubo et al (1994) also demonstrated that receptor-binding activity was attributed to these 
residues. This domain is well conserved in the antigenic cluster I viruses with the exception 
of PRCV, which turns out to have a tropism for respiratory tissue compared to the rest of the 
cluster which have a tropism for the digestive tract. It is also possible that other viral or 
cellular regulatory mechanisms affecting critical steps of viral replication other than virion 
binding could be located on other genes. These genes could also have an influence on tissue 
tropisms 
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Transmembrane Anchor 
There is a region of very strong homology in the carboxy-terminus of all the 
coronaviruses, and this sequence is flanked by the sequence KWPWYVLW on the amino 
terminal side (Figure 7 (a)). The region is strongly hydrophobic and is thought to be the 
putative membrane anchor (de Groot et al, 1987). The membrane anchor has is more 
precisely defined in CCV, from residues 1395-1415, has the residues 
VWLLIGLVVIFCIPLLLFC. This region is highly conserved in all coronaviruses in all 
alignments. 
Stem Structure 
On the carboxy-terminus side, a cysteine cluster (Figure 7 (b)) flanks the membrane 
anchor. It has been proposed that at least some of the cysteine residues in this region be 
involved in the acylation of the S protein (Raaschaert and Laude 1987). Heptad repeat 
structures have been observed in the S proteins (which have been proposed by (de Groot et 
al, 1987 and Rasschaert and Laude 1987) to be essential elements in forming the elongated 
structure of the peplomers. In CCV, there are 2 regions with heptad periodicity (residues 
1068-1150 and 1336-1381), which are proposed to be essential elements for the formation of 
the elongated stem structure (de Groot 1987). The shorter domain adjacent to the 
transmembrane domain and is a leucine zipper motif (Briton, 1991). The role of this region 
will only be fully understood when the structure of the S protein has been fully resolved 
(Wesseling et al, 1994). Delmas and Laude (1990) have led to the proposal that the S protein 
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is a homotrimer. The S oligomer is possibly stabilized by an interchain coiled-coil elongated 
structure predicted from the sequence near the C-terminal quarter of the polypeptide chain. 
Fusion Peptide 
A common feature of viral fusion proteins is the presence of a fusion peptide, which 
is believed to participate directly in the fusion process. Fusion peptides are typically 
composed of 16-26 amino acid residues and conserved within virus families. They are 
relatively hydrophobic and generally show an asymmetric distribution of hydrophobicity 
when modeled into an alpha helix; they are also rich in alanine and glycine. Fusion peptides 
can also be internal, and have the same features described above. Furthermore, these internal 
fusion peptides are bounded by charged residues on both ends and may contain a proline 
residue in the center. Coronaviruses could possibly have an internal fusion peptide. Luo and 
Weiss made a mutational analysis of the possible fusion peptides in MHV and examined the 
effect of the mutations on cell-to-cell fusion, protein processing and cell surface expression. 
Mutations in these residues KMIASAFNNALGAIQDGFD were found to result in failure of 
cell fusion in MHV and are therefore a likely candidate for a fusion peptide. In the analysis 
of the sequences in this paper, this region is highly conserved in all the coronaviruses. 
Residues HILSLVQNAPYGLYFIH (also highly conserved in all viruses examined) were 
noted to play a role in the ability of S proteins to be retained in the ER and eventually 
expressed on cell surface. Mutations in this region are thought to interfere with these 
processes (Luo and Weiss, 1998). 
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Selection of Antigenic Peptides for Oral Viruses 
As mentioned earlier, research efforts have recently increased towards determining 
essential sequences to express in baculoviruses and plants with the ultimate goal of making 
oral vaccines. In TGEV, four antigenic sites (A, B, C and D), with sites A and D, the major 
inducers of neutralizing antibodies, being highly preserved in antigenic cluster 1. These are 
therefore candidates for oral vaccines in plants or baculovirus. Site A is antigenically 
dominant. Some monoclonal antibodies on S detect linear and others conformation dependent 
epitopes. Site A is both conformation and glycosylation dependant while site D is 
glycosylation independent (Delmas et al. 1986). The requirement for glycosylation in site A 
is a critical one but both higher plants and insect cells have been shown to be capable of 
glycosylation, although they might do this slightly differently than would animal cells. 
However, site a on its own was shown to be incapable of producing virus neutralizing 
antibodies in the absence of other immunogenic epitopes, site D in particular. Site D is 
defined by the residues between amino acid residues 378 to 395 (underlined in Figure 6(b)) 
in TGEV whereas the residues MKRSGYGQPIA are well conserved within the A site. 
Interestingly, all the viruses that are closely evolutionarily related to TGEV have these 
residues very well conserved (Figure 5). In view of the S protein's role in binding to host 
cells, and the fact that sites A and D on this protein induce neutralizing antibodies, Sanchez 
and co-workers (1990), suggest that these residues must be important for viral replication. 
This process starts with the binding of virions to host cells. 
This conservation of residues in site A and D could potentially increase the utility of 
an oral vaccine developed using amino acid residues from the immunogenic site. Site D 
elicits antibodies with four epitope specificities identified by 4 different monoclonal 
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antibodies. According to Delmas and co-workers (1990) all TGEV strains that they tested 
maintain one or more of these epitopes, which makes unlikely the appearance of escaping 
mutants for all the epitopes in one virion. 
Conclusions 
To summarize, evolutionary relationships among the 12 coronaviruses in the data set 
used for this study reflect the antigenic clusters that were determined on the basis of 
serological relationships. These results are not surprising, because S gene protein that was 
used to determine the evolutionary relationships is the site of immunogenic epitopes and viral 
binding to host cells. It therefore makes sense that relationships based on this protein should 
reflect the different antigenic clusters. What was striking about the results is the precision 
with which the evolutionary relationships match the antigenic clusters. The S gene was 
therefore a prudent choice of viral protein to use for this purpose, validating the relationships 
determined on the basis of serological data. Precise correlation of specific sequences and 
function will require molecular characterization of isolates of the same virus, strains selected 
for virulence and mutants to locate genomic changes associated with alterations in biological 
characteristics. We believe that the evolutionary relationships of the coronaviruses we 
deduced, which reflect serological sub-groupings are the likely phylogeny for the viruses in 
this study. The bootstrap ratings for the evolutionary tree provide strong support for this. 
Aligning sequences helps to identify conserved sequences whose conservation may 
indicate a functional role. Sequence alignment coupled to protein structure and function 
could also be a useful tool in the development of oral vaccines. Comparative analyses have 
not permitted us to identify specify amino acid sequences with functions. However, as more 
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members and strains of these coronaviruses are sequenced, more solid conclusions about 
structure function relationships can be made after more in-depth molecular analysis of 
specific strains/mutants of the same virus with regards structural conformation and tropisms. 
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S protein 
RNA genome 
Figure 1. A cartoon representation of a coronavirus particle indicating the structural Proteins 
(from the web) 
N - Nucleocapsid protein 
M - Membrane protein 
S - Spike protein 
HE - Hemagglutinating esterase protein (not present in all coronaviruses) 
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Figure 2. Evolutionary relationships between some coronaviruses. Bootstrap ratings were 
generated in a heuristic search with 100 replicates and a thousand characters were sampled in 
each replicate. 
Tree Length: 3746 
Consistency Index: 0.96 
Homoplasy Index: 0.04 
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(b) 
Figure 3. The Amino Acid Variation across the two main clusters of coronaviruses. 
Variation across 
(a) cluster I with a window size of 5 and 1500 residues. There is strong residue 
conservation in the N-terminus of this cluster 
(b) cluster II and III combined with similar residues and window size. The figure shows 
conservation in the C-terminus. 
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Figure 4. Bubble plots showing unambiguous changes in the two major clusters. 
(a) Frequency of unambiguous residue changes for antigenic cluster I. 
(b) Frequency of unambiguous residue changes for antigenic cluster II and III 
combined. 
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(a) Conserved residues in site A (underlined) 
icv_s VNTTCTLHNFIFHNETGANPNPSGVQNIQTYQTKTAQSGYYNFNFSFLSSFVYKESN'FMY 
Avian_s VNTTLTLTNFTFSNESGAPPNTGGVDSFILYQTQTAQSGYYNFNLSFLSSFVYRGSNYMY 
prcv_s SFLTHTIVNITIGLGMKRSGYGQPIASTLSNITLPMQDNNTDVYCVP.SDCF3VYVH3T ZY 
iipv-s SFFTYTAVNITIDLGMKLSGYGQPIASTLSNITLPMQDNNTDVYCIRSNQFSVYVH2T??' 
tgev_s SFHT.HTIVNLTIDLGMKRSGYGQPIASTLSNITLPMQDNNTDVYCIRSCQFSVYVP.37Cr' 
ccv_s SFYSHTSVNITIDLGMKRSGYGQPIASTL3NITLPMQDNHTDVYCIRSM?. FSVYFHSTCf 
feline_s IFFAHTAINITIDLGMKRSGYGQPIASTL3NITLPMQDNNTDVYCIP.SNÇFSVYVH3:ZY 
ccv-insavc SFYSHTSVNITIDLGMKRSVTVTI-ASPLSNITLPMQDNNIDVYCIRSNQFSVYVH3~:r' 
ccv_s KAPKNFCPCKLDGSLCVGNGPGID-AGYKNSGIGTCPAGTNYLTCHNAA.QCDCLCTP:?: 
.Tihv_s GASYCPCANPSIVSPCTTGKPKFA—NCPTGTT NRECNVLALGSN'LFKCCCTCM ?3 
ncv_3c4 2_s KAPKNFCPC-KLNGSCVGSGPGKN NGIGTCPAGTNYLTCDNLCT?D?:7FT37Y 
ncv-22 9E VYHKHTFIVLYVDFKPQSGGGKCF-NCYPAGVN ITLANFîiETKGr L3V373HF77?" 
(b) Conserved residues in site D (underlined) 
:bv_s MAWSSSQFCTAHCNFSDTTVFVTHCYKHG-GCPLTG MLQQNLIRVSAMKN--GQLFY 
A v i a n s  M S W S T A S F C T A H C N F T S Y I V F V T H C F K S G P S C P L T G L I  P S C - Y I R I A A M F H G S A M P G H L F Y  
C rcv_s FTTNVQSGKGATVFSLNTTGGVTLEISCYNDTVSDSSFSSYGE:PFGVTMGPP.YCYVLY:; 
:;ÇV-; FTADVQSGMGATVFSLNTTGGVILEISCYSDTVSESSSYSYGE:PFG:~DGPSYCYVLY:: 
-gev_ 5  FTTNVQSGKGATVFSLNTTGGVTLEISCYNDTVSCSSFS3YGE:?FGVT3GPFY3YVLY:: 
ccv_s FTALVQSGMGATVFSLMTTGGV:LEISCYNDTVSESSFYSY3E:SF3-VT3GP?V:FALV:: 
f e l i n e _ s  FTADVQSGMGATVFSLNTTGGVILEISCYNDTVSES3FYSYGE:?FG:T3GPPY3YVLV:: 
ccv-insavc FTTDVQSGMGATVFSLNTTGGVILEISCYNDTVSESSFYSYGEIPFGVTDGPPYCYV-Y:: 
ccv s TGVYELNGYTVQPIADVYRRIPNLPDCNIEAWLNDKS--VPSPLNWER.KTFSNC-NFNM3 
mhv_s TGVYDLSGYTVQPVGLVYRRVRNLPDCRIEDWLAAK--TVPSPLNWER.KTFQNC-NFNL3 
hcv_oc4 3_s TGVYELNGYTVQPIADVYRRKPNLPNCNIEAWLNDKS--VPSPLNWERFTFSNC-ÏIFNM3 
hcv-22 9E LNFEENLRRGTILFKTSYGVWFYCTNNTLVSGDAHIPFGTVLGNFYCFVNTTIGNE773 
Figure 6. Conservation of regions containining critical residues from antigenic sites A and 
D. Conserved residues are underlined. 
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icv_s VP—ILDIDSEIDRIQGVIQGLNDSLIDLEKLSILKTYIKWPWYVWLAIAFATIIF:: 
Aviar._s IP—VLNIIYDIDKIEEVIKGLNDSLIDLETLSILKTYIKWFWYTWLAI FFAC I I FC ; 
pr :v_s LEFRSEKLHNTTVELAILIDNINNTL'/NLEWLMP.IETYVKV/PWYVWLLIGLVVZFC::--
f  icv-s LEFRSEKLHNTTVELAILIDNINMTLVNLEWLMP.IETYVKVJPWYVrtLLIGLVVVFC:;  
:Jev_s LQFR5EKLHNTTVELAILIDNINNTLVNLEWLN'RIETYVKWPWYTWLLI3L77IFCI :  
S LEF?.5EKLHNTTVELA:L:DN:N'NTLVNLEWLN?:ETYV:-"W?WY7WLI:31VV:FC:; 
rei  ir .e_s LEF=3EKLHNTT7ELAILIDN:NNTL7MLEWLN?.:ETY7:-"A PWYTWLL IGLVV :  FC :  :  
ir .savc LEFRSEKLHNTTVELAI LIDN INNTLVNLEWLN'R I  ET Y7KWPWY7WLL: 3L77I F C :  ;  
CJY_S FL—CLQEEMNRLQEAIKVLNQSY—:NLKD:GTYEYYVKWPWY7WLL:GFAG7AM:.". 
.-I.-.V_S 7TFLDLSDEMNRIQEAIKKLNESY—INLKEIG7YEMYVKWPWYVWLL 13LAG7A7 C. 
r .cv_oc4 3_s FL—DLQVEMNRLQEAIKVLNQSY— INLKDIGTYEYYVKWPWYVWLLICLAGVANL'. -
r .cv-22 ?E LENKSAELNYTVQKLQTLIDNINSTLVDLXWLN?.VETYIKWPWWWLC:SVYL:rYV: 
"Indicates perfectly conserved residues in all the sequences in the database. 
Figure 7 (a). Highly conserved regions in the C -terminus domain, which is strongly 
hydrophobic and is thought to be the putative membrane anchor. 
;cv_s GWVFFMTGCCGCCCGCFGIMPLMSKCGKKSSYYTTFCNDVVTECYRPKKS7SK7P? P5YF 
. - .v:ar ._s GWVLLMTGCCGCCCGCFGIIPLMSKCGKKSSYYTTFDNCTVTECYP.PK-^.'FTFCYLCC;. 
pr;v_s LFCCCSTGCCGC:-GCLGSCCHS:FSRRCFEMYEP:EKVH7H 
:  .pv-s LFCCF3TGCCGC:-GCLGSCCHS:CSRRCFEMYE?:E:<7:-:7H:5GC:N£IRT:-'L:2HY?C 
I GEV_S IFCCCSTGCCGC:-GCLGSCCKSICSRRCFENYEL:EK7H7H::;7:;F:FI33HY:7?-LHI 
:cv_s LFCCCSTGCCGCI-GCLGSCCHSICSRRQFESYEPIEKVHVH 
fel ine_s LFCCCSTGCCGCI-GCLGSCCHSMCSRRQFENYEPIEKVHVHICRÇLFLLENTSELNL— 
ccv- ir .savc LFCCCSTGCCGCI-GCLGSCCHSICSRGQFESYEPIEKVHVH 
bcv_s FFICCCTGCGTSCFKICGGCCDDYTGHQELVIKTSHDDVRLFI 
: r .hv_s FFICCCTGCGSCCFKKCGNCCDEYGGHQDSIVIHNISSHED 
r .cv_oc-t  3_s FFICCCTGCGTSCFKKCGGCCDDYTGYQELVIKTSHDDVRLF:AIISC:FLCSS:CSCGH 
r .c-.--::?E LLCCCSTGCCGFF-SCFASSIRGCCESTKLPYYDVEK:H:CWL7CSHC:;LCLL 
*** 
Figure 7(b). Cysteine rich domain thought to be important in the formation of heptads 
repeats required for the stem structure of the S protein. 
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Table 1. Antigenic Clusters of coronaviruses (from Holmes and Lai, 1996) 
Antigenic Virus Host Respiratory Enteric Hepatitis Neurologic Other 
Group Infection infection Infection 
1 HCV- Human X 
229E 
TGEV Pig X X X 
PRCV Pig 
CCV Dog X 
FECV Cat X 
FIPV Cat X X X X X 
RbCV Rabbit X 
II HCV-
OC43 
Human X ? X 
MHV Mouse x X X X 
SDAV Rat X 
HEV Pig x X 
BCV Cow X 
RbEVC Rabbit X 
TCV Turkey x X 
III IBV Chicken x X X 
Abbreviations 
TGEV - transmissible gastroenteritis virus 
PRCV - porcine respiratory coronavirus 
MHV murine hepatitis virus 
FIPV feline infectious peritonitis virus 
FECV - feline enteric coronavirus 
HCV human respiratory coronavirus (HCV strains 229E and OC43). 
BCV bovine coronavirus 
CCV canine coronavirus (CCV strains tnsavc and K378), 
IBV infectious bronchitis virus (avian) 
RbCV - Rabbit coronavirus 
RbECV - Rabbit Enteric Coronavirus 
HEV Porcine hemmaglutinating encephalomyelitis virus 
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CHAPTER 7 
General conclusions 
This work examines the possibility of using transgenic maize as a source of 
functional antigens that could potentially be used as oral vaccines for livestock and humans. 
The heat labile toxin (LT) from E. coli and its subunits (LT-A, LT-B) and the N terminal 
domain of the TGEV S protein were used as model antigens. Work presented in this 
dissertation examined some basic aspects of expression of a foreign gene in transgenic maize, 
such as promoters directing gene expression, characterization of transgenic plants and 
evaluation of the transgene expression in several generations of transgenic plants from select 
transgenic events. Biochemical, biophysical and immunogenic properties of the maize 
synthesized antigens were determined. 
Chapter 2 establishes the possibility of expressing a synthetic LT-B gene in maize. 
Two different promoters, the constitutive CaMV 35S promoter and the seed specific 27 kDa 
gamma zein promoter were used to express the LT-B gene in maize. Evaluation of levels of 
LT-B expression showed that the seed specific gamma zein promoter was more effective 
than the CaMV 35S promoter in achieving high-level expression in maize kernels. The 
combination of the SEKDEL signal motif and the seed specific promoter resulted in 
enhanced LT-B gene expression in the first generation of transgenic plants. The stability of 
LT-B gene expression in several generations was studied in selected transgenic events. The 
general trend observed was that the LT-B expression increased several fold from the R, 
putative to the R3 generation. The explanation put forward for this observation is that 
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subsequent generations are free from the stress of in vitro culture and that at each stage, only 
the expressing individuals were planted. Significant variation was observed between 
transgenic events. This was attributed to differences in transgene copy number and site of 
transgene integration within the genome of transgenic plants. Significant differences were 
also observed between individual plants within the same event. This is a phenomenon that is 
not easily explained, but has been observed by other groups working with transgenic maize. 
The results of this section demonstrated the ability of maize to synthesize LT-B with the 
same biophysical and biochemical features as the native bacterial LT-B. 
The role of signal peptides in determining the subcellular localization of LT-B in 
transgenic maize kernels is presented in Chapter 3. Subcellular localization is important for 
the proper assembly, accumulation and functionality of a protein in any expression system. 
The study determined the subcellular location of LT-B protein fused to either the bacterial or 
zein signal peptide. Immunogold labeling/electronmicroscopy and western analysis revealed 
that LT-B in transgenic maize was localized in starch granules. The results from this work 
present strong evidence that the bacterial signal peptide targets the LT-B protein to the starch 
granules in maize endosperm. To our knowledge, this is the first report of a bacterial signal 
peptide targeting a protein to the starch granules of a high plant. Further experimentation is 
required to make a conclusive determination that the bacterial signal peptide directs LT-B to 
maize endosperm starch. Encapsulation of LT-B has important implications for the 
production of other antigens, biopharmaceuticals or other industrial proteins in starch 
granules. The observation also potentially provides another tool for studying protein 
translocation. 
Immunogenicity of maize generated LT-B was determined through a mice feeding 
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experiment. This work, presented in Chapter 4, showed that maize synthesized LT-B was 
similar to the native LT-B and could induce strong mucosal and serum antibody when orally 
administered in mice. The transgenic maize synthesized LT-B induced a much stronger 
immune response than an equivalent amount of bacterial LT-B spiked into transgenic maize. 
We speculate that the starch encapsulation of LT-B in transgenic maize could have protected 
the LT-B from the acidity and degradative enzymes of the stomach, and that its slow release 
from starch could have prolonged exposure to the gut associated immune system. This 
resulted in the significantly higher immune response observed. 
Having established the capacity of maize to synthesize properly folded immunogenic 
protein, the next phase of research focused on the design of a recombinant subunit vaccine 
against swine transmissible gastroenteritis. This work is described in Chapter 5. A mutant, 
non-toxic LT holotoxin was expressed in transgenic maize callus, and it was demonstrated 
that the holotoxin could be assembled in maize. The next step was to replace the Al subunit 
of the mutant holotoxin and replace this with an immunogenic fragment from the S protein of 
the porcine respiratory coronavirus bearing TGE virus-neutralizing antibodies. The objective 
was to make a recombinant holotoxin utilizing the immunogenic, adjuvant and delivery 
capacity of LT-B. The result of this work was co-expression of the antigen/recombinant A 
subunit and the LT-B subunit in maize callus. No TGE neutralizing antibodies were 
observed. It was concluded that the recovery of transgenic events with low TGEV peptides 
could be the reason for this observation. 
Chapter 6 presents an analysis of the evolutionary relationships of coronaviruses 
based on their spike protein, using TGEV as the reference protein. Results of this analysis 
show an evolutionary tree similar to that observed when serological methods are used to 
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establish this relationship. The analysis also shows that the critical epitopes required for 
virus neutralization are strongly conserved in coronaviruses in the same antigenic structure. 
Although sequence alignment is not commonly used for elucidation of structure function 
relationships in viruses, it is becoming increasingly common in fields such as bioinformatics. 
Such analysis could have important implications in elucidation of protein structure and 
contribute to the determination of residues required for determination of such important 
aspects as tissue tropisms. 
Appendix I describes regulatory aspects relating to the release of transgenic plants 
into the environment. Formal proceedings were followed to obtain a permit for releasing 
transgenic plants carrying the LT-B gene into the environment. These plants were grown in 
the field in the summer of 2001 in accordance to the regulations stipulated by USDA-APHIS. 
The work presented in this dissertation demonstrates that maize can be used as a 
production and delivery vehicle for the production of functional antigens. Targeting antigen 
expression to kernels offers an opportunity to produce the antigens in an industrially 
convenient tissue for processing. Regulatory sequences can be used to enhance expression of 
the antigens and the use of standard agronomic and plant breeding techniques can result in 
the production of stable transgenic lines with the desired levels of novel protein. Subcellular 
localization of antigens can be manipulated to target organelles in which the antigens are 
protected from the stomach environment and to enhance exposure to the immune system in 
the gut. This study also made available transgenic maize germplasm expressing LT-B 
protein to be used for co-administration with other antigens or conventional vaccines. The 
germplasm can also be used in transformation and breeding programs to achieve 
coexpression with other antigens to be used as vaccines. Expression and assembly of 
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LTK63, a more complex molecule than LT-B, illustrates that maize expressed antigens are 
capable of higher order folding. Because of the pivotal role of maize as a major ingredient in 
livestock feed, expression of antigens in maize kernels can have a major impact in the 
administration of vaccines to commercial herds. In other countries, maize is a staple of many 
diets and therefore there is great potential to impact development and delivery of human 
vaccines. 
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APPENDIX 
FIELD RELEASE OF LT-B EXPRESSING CORN 
1 Introduction 
Transgenic plants have become attractive systems for the production of vaccines and 
therapeutic proteins for humans and livestock. However, there are potential risks associated 
with this technology that have led to the development of guidelines to regulate the release of 
the genetically engineered crops into the environment. The general concern is the possibility 
of transfer of the transgenes from the engineered crops into the weedy relatives, among other 
concerns. For transgenic plants carrying genes that encode biologies (antigens for use as 
vaccines, antibodies) or biopharmaceuticals, the concern has been that of the transfer of the 
genes into seed and commercial crops. 
Indeed, the possibility of gene transfer from transgenic crops to weedy relatives and 
other crops have been demonstrated (Mikkelsen et al, 1996, Chevre et al, 1997). The 
potential risks can be reduced using a variety of technologies. These technologies will not be 
addressed in this dissertation, but there are several possible options including the use of 
promoters that govern spatial and temporal expression of the transgenes and even 
strategically restricting the period of transgene expression. 
While experimentation is ongoing to provide data to separate real and perceived risks 
regarding environmental release of genetically modified plants, compliance with the 
regulations that are currently in place is a major tool in minimize these risks. During my 
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PhD training I interacted with the Animal and Plant Health Inspection Service (APHIS), the 
US government department overseeing the implementation of safety regulations to minimize 
the environmental risk posed by the release of transgenic organisms into the environment. 
Field planting/testing of transgenic crops usually requires a Notification to APHIS. 
However, in the case of transgenic plants containing biopharmaceuticals and other biologies, 
a release permit is required. In March of 2001, I initiated proceedings to obtain a permit to 
field test the LT-B expressing com under the close supervision of my major Professor. Dr 
Kan Wang. The following is the information required to support the application. 
2 Procedure 
The procedure was initiated by submitting to APHIS a form designated Form 2000. 
which is available from the APHIS website. This form is accompanied by enclosures, 
providing all the information that is required before the release permit is issued. I researched 
for and provided this information with the help of Dr Kan Wang. The following section 
provides this information. 
2.1 Enclosures 
a. Names Addresses and Telephone Numbers of Responsible Persons 
b. A description of the anticipated or actual expression of the altered genetic material 
in the regulated article and how that expression differs from the expression in the 
non-modified parental organism. 
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The regulated article in this request is transgenic corn carrying a subunit gene from 
the E. coli heat labile enterotoxin (LT-B corn). This work is supported by USDA-NRI 
(Grant #99-35504-7799). The purpose of this project is to develop a corn-based oral vaccine 
delivery system for livestock. 
The expression of the LT-B gene under the maize gamma-zein promoter will 
accumulate LT-B subunit protein in endosperm of com seed. Non-transgenic com does not 
contain this protein naturally. No LT-B protein has been detected in any other part of com 
plant. 
No phenotypical difference (in terms of height, color or other morphological changes) 
of LT-B com was and should be observed in whole plant or seed. 
c. A detailed description of the molecular biology of the system (e. g., donor-recipient-
vector), which is or will be used to produced the regulated article. 
The Gene 
LT-B is part of the LT toxin produced by enterotoxigenic strains of E. coli. a 
bacterium responsible for producing traveler's diarrhea, mostly in developing countries. The 
LT toxin is an 84-kilodalton polymeric protein composed of 2 major non-covalentlv 
associated immunologically distinct regions or domains designated (LT-A and LT-B). The A 
region (27 kDa) is responsible for the diverse biological effects of the toxin. LT-B is a 
55kDa region and is responsible for binding of the toxin to the host cell receptor, GM1 
(galactosyl-N-acetylgalactosaminyl-sialyl galactosyl glucosyl ceramide), which is found on 
the surface of all eukaryotic cells (Clements and Finkelstein, 1979). 
Although the LT-B protein is a constituent of the E. coli toxin holoenzyme, the LT-B 
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protein alone has no toxic activity and cannot cause disease (Spangler, 1992). However, it 
can stimulate immune system of mammal so it can be used as a vaccine against the disease. 
It was reported that transgenic potato carrying LT-B protein could be used as a vaccine for 
human for prevention of travelers' disease (Mason et al, Nature Medicine, 1998). 
The construct 
The constructs introduced to com plants are shown in Appendix 1 and 2. The codon-
optimized LT-B gene (Mason et al, Vaccine, 1998) was cloned behind the maize gamma zein 
promoter and terminated by the soybean vegetative storage terminator. This construct was 
named as pRC4. The vector for this construct was the commonly used vector pUC19. 
Transformation 
The transgenic com plants were produced using microprojectile bombardment (Frame 
et al, 2000). The construct pRC4 was co-transformed with pBAR184, a construct carrying 
the selectable marker (see below for detail). 
Selectable genetic marker genes 
The genetic constructs include the well-characterized genetic marker gene bar, which 
encodes the enzyme phosphinothricin acetyl transferase and confers resistance to the 
herbicides Basta or its active ingredient Bialophos. This marker gene is used to facilitate 
selection of transformed plant tissues in the laboratory. The bar gene is derived from the 
bacterium Streptomyces hygroscopicus (Murakami et al, 1986). 
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Non-coding DNA regulatory sequences 
Some of the DNA regulatory sequences introduced into the transgenic com plants 
were derived from the com, the 27kD gamma zein promoter (Larkins et al, 1985) and the 
VSP terminator is part of the regulatory sequence of the soybean vegetative storage proteins 
(Mason et al, 1993). The bar gene is regulated by the maize ubiquitin promoter and the 
nopaline synthase terminator from Agrobacterium tumefaciens nopaline synthase gene in the 
vector pUC8 (Messing et al, 1985)). None of the regulatory sequences introduced into the 
transgenic maize lines can cause plant disease by themselves or in conjunction with the 
genes, which they regulate. 
Gene Copy numbers 
Three independent transgenic events with transgene copy number ranging from 2-5 as 
characterized by Southern blot analysis in our laboratory, and the introduced genes should 
remain stably integrated in the com genome. 
d. Country and locality where the donor organism, recipient organism, and vector or 
vector agent were collected, developed and produced. 
The constructs pRC4 and pBAR184 were developed in the Plant Transformation 
Facility of the Department of Agronomy at Iowa State University, Ames, Iowa 50011-1010 
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e. A detailed description of the purpose of the introduction of the regulated article 
including a detailed description of the proposed experimental and/or production 
design. 
The field release of the regulated article will be for the purpose of bulking of seed for 
further molecular and biological studies for this project. We are interested in developing a 
corn-based edible vaccine system for livestock. The future study aims at optimizing 
production and accumulation of vaccine in transgenic com using LT-B protein as a model 
system. We will analyze the biochemical properties including antigenecity and 
immunogenicity of the transgenic protein as well as the glycosilation system in com plant. 
We also want to look at the stability of expression of LT-B in field conditions 
Using transgenic plants to produce industrial or therapeutic biomolecules is one of 
fastest developing areas in agricultural biotechnology. The advantages of expression and 
production of these molecules in plants include 1) safe; 2) less costly; 3) can be scaled up: 
and 4) product maybe stable for long time. 
There are no immediate plans to commercialize these plants. 
Similar research using other transgenic plant was reported before. One example is 
transgenic alfalfa plants carrying cholera toxin B subunit (CT-B). The cholera toxin is 
produced by the bacterium Vibrio Cholerae, the causative agent of cholera disease. The CT-
B component that was been engineered into alfalfa plants and field-tested by the Noble 
Foundation under APHIS permit #92-185-01R. APHIS issued a finding of no significant 
environmental impact when an environmental impact assessment was carried out for CTB. 
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f A detailed description of the processes, procedures, and safeguards which have 
been used or will be used in the country of origin and in the United States to 
prevent contamination, release, and dissemination in the production of the donor 
organism; recipient organism; vector or vector agent; constituent of each regulated 
article which is a product; and regulated article. 
The field release is scheduled begin in May 15 of 2001. on a site in Story County, I A. 
The process should be completed by October 31, 2001. The proposed field test is a 
controlled release of the regulated article into the environment. The procedures for 
containment of the plant material and the procedures for termination of the field test, as 
described (Enclosure #h), should be sufficient to ensure that none of the modified plants 
persist in the environment. In corn, genes can escape by the wind-borne pollen or the 
persistence of seed in the environment. The measures described below (Enclosures #h and 
#1) will minimize dissemination of pollen to receptive, sexually compatible and persistence 
of the plant material after the conclusion of the test. 
g. A detailed description of the intended destination (including final and all 
intermediate destinations), uses, and/or distribution of the regulated article. 
The regulated article is now stored in a locked seed storage room in the Agronomy 
Hall at Iowa State University. 
For field release, the seed of regulated article will be germinated in small pots in the 
greenhouse of Agronomy Department. We will then transplant 200-300 com plants that 
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carrying the LT-B gene to the field. 
The field release will take place on agricultural land at the Iowa State University 
transgenic nursery, Story County, IOWA. An electrical fence to prevent animals or 
unauthorized personnel from entering will enclose the site. Frequent site monitoring of the 
field trial and agronomic management practices that create a non-propagative environment 
are expected to provide the necessary degree of both biological and physical containment. 
These factors are described below (Enclosure #h). 
h. A detailed description of the proposed procedures, processes, and safeguards, 
which will be used to prevent escape and all dissemination of the regulated article 
at each of the intended destination. 
Plot design 
The total area required for this project will not exceed one-fifth of an acre in which 
500 transgenic plants will be in rows. 
Breeding procedure 
The transgenic plants will be either sel fed or crossed to their sibling plants, so both 
the silk and tassels will be bagged individually during the crossing season. This plot will be 
isolated by a minimum of 400 meters from any other com plants to prevent the unwanted 
introduction of transgenic material into non-target plants. An isolation distance of 400 
meters is double the isolation distance prescribed for the production of certified com seed in 
the United States. 
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Agricultural practices 
Agricultural practices consistent with growing healthy com plants will be used. The 
plot will be kept reasonably weed free by mechanical or hand weeding. If necessary, 
pesticides such as insecticides and/or fungicides will be used to control pests such as com 
rootworm, com leaf aphids, European com borer, earworms, and various leaf diseases that 
would reduce the health of the plant and subsequent grain yield. Any pesticides used will be 
applied by personnel trained in their use and application. The plot will be inspected weekly at 
first, and then daily during the pollination period. 
Field Observation and Monitoring 
During the field tests, authorized personnel will inspect the test site at least once a day 
and will report on seedling emergence, plant vigor, physiological status, reproductive 
development, disease incidence, insect infestations and bird and small mammal damage. 
Security of the field test plot 
An electrical fence will be used for isolation of the plot from unexpected or 
unauthorized entering of animal or human. 
i. A detailed description of the proposed method of final disposition of the regulated 
article. 
Any pollinated ears from this plot will be hand-harvested at maturity. The ears will be 
placed in doubled nylon harvest bags both of which would be independently capable of 
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preventing seed loss from the ears. After harvest, any remaining plant material will be 
mowed and incorporated into the soil using a disc or chisel plow. 
Following harvest, the test site (including the 10-meter surrounding border zone) will 
be monitored for any volunteer plants. The plot area will be flagged after harvest and 
monitored for volunteers throughout the following growing season (2002). In order to 
facilitate easy identification of any volunteer transgenic plants from the 2001 test, the test 
plot and surrounding 10-meter border will not be planted with com in the 2002 season. Any 
volunteer com plants will be destroyed before they produce pollen. 
Any seed being carried to and from the two fields will be double-bagged to ensure no 
seed spillage. All seeds harvested from field will be transported and stored in a locked seed 
storage room in Agronomy Hall of Iowa State University. 
All transgenic seeds will be processed to evaluate level of LT-B expression, and the 
biochemical and immunological properties of the com derived LT-B will be compared to that 
of bacteria derived LT. Seeds will be destroyed and rendered nonviable during the process of 
extraction of LT-B. Any transgenic seeds not used for extraction will be stored securely or 
devitalized before disposal. 
3 Field planting and harvesting 
Transgenic maize expressing LT-B subunit protein was grown from May 15 to October 31, 
2001 at the Transgenic Nursery at Iowa State University in Washington Township , Story 
County, IA. Two hundreds transgenic com seeds were planted in May 29, 2001. Because of 
the adverse weather at the time of planting, only 135 actually germinated. Sixty five more 
seeds were planted on June 18th, 54 of these actually germinated. A total of 189 transgenic 
plant were raised. The plot was isolated by a minimum of 400 meters from any other non-
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transgenic com plants to prevent the unwanted introduction of transgenic material into non-
target plants. During the entire period of field release, a two-strand electrical fence that 
encloses the site was used to prevent animals or unauthorized personnel from entering. 
Transgenic com plants were harvested on October 16, 2001 according to the regulations 
stipulated by APHIS. The Field Manager will continue to monitor the plot for any volunteer 
plants for the next growing seasons. 
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